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Abstract
Slip-resistant footwear to reduce slips among health-care
workers: the SSHeW RCT
Sarah Cockayne ,1* Caroline Fairhurst ,1 Michael Zand ,2
Gillian Frost ,3 Mark Liddle ,3 Rachel Cunningham-Burley ,1
Catherine Hewitt ,1 Heather Iles-Smith ,4 Lorraine Green ,5
Emily Bain ,2 Misbah Mogradia 2 and David J Torgerson 1
1York Trials Unit, Department of Health Sciences, University of York, York, UK
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3Health and Safety Executive, Buxton, UK
4Leeds Teaching Hospitals NHS Trust, Leeds, UK
5National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Chapel
Allerton Hospital, Leeds, UK
*Corresponding author sarah.cockayne@york.ac.uk
Background: In Great Britain, 100,000 injuries due to slips, trips and falls on the level (as opposed to
falls from a height, e.g. a ladder) occur in the workplace each year. They are the most common cause of
non-fatal injury in the workplace, accounting for 30% of all those injuries reported to the Health and
Safety Executive. Nearly 1 million working days are lost because of slips, trips and falls each year.
Objectives: To assess the clinical effectiveness and cost-effectiveness of 5-star, GRIP-rated,
slip-resistant footwear in preventing slips in the workplace compared with usual footwear.
Design: A two-arm, multicentre, randomised controlled trial with an economic evaluation and
qualitative study.
Setting: Seven NHS trusts in England.
Participants: NHS staff aged ≥ 18 years, working at least 22.5 hours per week in clinical, general or
catering areas who owned a mobile phone. Staff required to wear protective footwear were excluded.
Interventions: Intervention participants were offered 5-star, GRIP-rated, slip-resistant footwear. The
waiting list control group were asked to wear their usual work shoes for the duration of the study and
were offered the trial footwear at the end of their participation.
Main outcome measures: The primary outcome was the incidence rate of self-reported slips in the
workplace over 14 weeks. Secondary outcomes included the incidence rate of falls either resulting
from a slip or not resulting from a slip, proportion of participants reporting a slip, fall or fracture,
time to first slip and fall, health-related quality of life and cost-effectiveness.
Results: A total of 4553 eligible NHS staff were randomised (2275 to the intervention arm and 2278
to the control arm). In total, 6743 slips were reported [2633 in the intervention group (mean 1.16 per
participant, range 0–36 per participant) and 4110 in the control group (mean 1.80 per participant,
range 0–83 per participant)]. There was a statistically significant reduction in the slip rate in the
intervention group relative to the control group (incidence rate ratio 0.63, 95% confidence interval
0.57 to 0.70; p < 0.001). Statistically significant reductions were observed in falls from a slip (incidence
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rate ratio 0.51, 95% confidence interval 0.28 to 0.92; p = 0.03), the proportion of participants who
reported a slip (odds ratio 0.58, 95% confidence interval 0.50 to 0.66; p < 0.001) or fall (odds ratio
0.73, 95% confidence interval 0.54 to 0.99; p = 0.04) and the time to first slip (hazard ratio 0.73, 95%
confidence interval 0.67 to 0.80; p < 0.001). Half of the intervention participants wore the shoes all the
time at work. Incremental cost per quality-adjusted life-year in the base case was £38,900 from the
NHS perspective and –£60,400 (i.e. cost saving) from the societal perspective.
Limitations: This was an unblinded trial in which outcome data were participant self-reported, which
may have led to inaccuracies in the reported slip data. Exposure to the trial footwear was lower
than hoped.
Conclusions: The offer and provision of 5-star, GRIP-rated footwear reduced slips in the workplace,
was acceptable to participants and could be cost-effective.
Future work: Replication of the study within other settings may be required to evaluate the clinical
effectiveness and cost-effectiveness in other environments settings, such as catering and factories.
Trial registration: Current Controlled Trials ISRCTN33051393.
Funding: This project was funded by the National Institute for Health Research (NIHR) Public Health
Research programme and will be published in full in Public Health Research; Vol. 9, No. 3. See the NIHR
Public Journals Library website for further project information. The Health and Safety Executive provided
some research costs.
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S lips, trips and falls on the level (as opposed to falls from a height, e.g. a ladder) are the main causeof injury in the workplace. Last year, > 100,000 people hurt themselves as a result of having a slip,
trip or fall at work in Great Britain, resulting in nearly 1 million days taken off work. The health and
social care sector has some of the highest numbers of slips and trips at work, often due to the type of
flooring they walk on. The floors are often smooth and become very slippery when they are wet or
dirty. In addition, staff who visit patients in their homes cannot control the type or condition of the
flooring on which they walk. One possible way of reducing the number of slips that workers have could
be for them to wear slip-resistant footwear.
The Stopping Slips among Health-care Workers trial tested whether or not slip-resistant footwear
could stop people slipping at work. We recruited 4553 NHS staff in England to the trial. The people
recruited worked in general, clinical and catering areas, and included doctors, nurses, ward clerks, and
catering and cleaning staff. A total of 2275 people were offered one free pair of slip-resistant shoes to
wear at work. The other 2278 people were asked to wear their own work footwear, but were offered a
free pair of slip-resistant shoes once they had finished the trial.
We found that the trial shoes were successful at reducing the number of slips at work, as staff who
were provided with the trial shoes had fewer slips than those who wore their own shoes to work.
They also had fewer falls after having a slip at work. On the whole, staff liked the slip-resistant shoes.
The shoes are potentially good value for money for the NHS.
DOI: 10.3310/phr09030 Public Health Research 2021 Vol. 9 No. 3
Copyright © 2021 Cockayne et al. This work was produced by Cockayne et al. under the terms of a commissioning contract issued by the Secretary of State for Health and
Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use,
distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/.




Material throughout the report has been reproduced from Cockayne S, Fairhurst C, Frost G, Hewitt C,Liddle M, Zand M, et al. SSHeW study protocol: does slip resistant footwear reduce slips among
healthcare workers? A randomised controlled trial. BMJ Open 2018;8:e026023 and Cockayne S, Fairhurst C,
Frost G, Liddle M, Cunningham-Burley R, Zand M, et al. Slip-resistant footwear reduces slips among
National Health Service workers in England: a randomised controlled trial [published online ahead of
print January 15 2021]. Occup Environ Med 2021. These are Open Access articles distributed in
accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits
others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the
original work is properly cited, a link to the licence is given, and indication of whether changes were
made. See: https://creativecommons.org/licenses/by/4.0/. The text below includes minor additions and
formatting changes to the original text.
Background
In Great Britain, 100,000 injuries due to slips, trips and falls on the level (as opposed to falls from a
height, e.g. a ladder) occur in the workplace each year. They are the most common cause of non-fatal
injury in the workplace, accounting for 30% of all those reported to the Health and Safety Executive.
Nearly 1 million working days are lost because of slips, trips and falls each year.
There are several factors that can contribute to slips and resulting falls in the workplace. These include
the floor surface, floor contamination, the cleaning regime, the level and type of pedestrian activity,
footwear choice, the working environment and human factors. In the UK, employers have a duty to
assess risks and decide what suitable and effective control measures will prevent slips. In many
instances, straightforward measures, such as that ensuring floor surfaces are kept clean and dry, are
sufficient. However, if it is not practicable to prevent the floor surface becoming slippery, employers
may consider the use of slip-resistant footwear.
Aim
To assess the clinical effectiveness and cost-effectiveness of the offer and provision of 5-star,
GRIP-rated, slip-resistant footwear in preventing slips in the workplace compared with usual footwear.
Methods
Study design
We undertook a multicentre, two-arm, randomised controlled trial with an internal pilot trial, economic
evaluation and embedded qualitative study.
Participant recruitment
Recruitment took place within seven participating NHS trusts in England. NHS staff were given a
recruitment pack inviting them to take part in the Stopping Slips among Health-care workers (SSHeW)
trial. Staff who returned a baseline questionnaire and valid consent form were screened for eligibility
against the following criteria.
Inclusion criteria for the main SSHeW trial
Staff were eligible to participate in the trial if they:
l were aged ≥ 18 years
l were employed by the participating NHS trust
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l were required to adhere to a dress code
l worked in a clinical, general or catering area
l worked more than 30 hours per week (reduced mid-way through the trial to 22.5 hours per week)
l had a mobile phone and were willing to receive and send text messages for data collection.
Exclusion criteria for the main SSHeW trial
Staff were ineligible to participate if they:
l were provided with, and required to wear, protective footwear
l were agency staff or staff with < 6 months remaining on their employment contract
l were predominantly office or theatre based.
Pilot trial
An internal pilot trial was conducted during the first 6 months of the trial. The objectives of the pilot
trial were to:
l test and refine recruitment strategies for the study
l check the sample size calculation assumptions by reviewing the proportion of control group
participants who experienced a slip
l check the attrition rate
l explore and address any issues regarding footwear compliance.
Sample size
There were limited published data on which to base a sample size for this trial. A prospective cohort
study found that 49 of 422 (11.6%) workers in a restaurant setting in the USA reported at least one
‘major’ (i.e. resulting in a fall and/or injury) slip over a 12-week follow-up period. We expected that the
proportion of workers who experienced any type of slip to be higher than this, but we conservatively
assumed a proportion of 10% for the sample size calculation. We proposed to randomise 4400
participants using a randomisation ratio of 1 : 1. This sample size gave us 90% power to show a 30%
relative reduction in the proportion of participants who reported at least one slip over a 14-week
period (a 3-percentage-point absolute reduction from 10% to 7%), allowing for 20% attrition. It also
gave us 80% power to see an absolute reduction of 2 percentage points in the risk of falls from 5.5%
to 3.5%, allowing for 20% attrition. We considered a sample of 800 participants in the pilot trial to be
sufficient to test the objectives.
Randomisation
Eligible participants who provided written consent, completed a baseline questionnaire and returned at
least two of the weekly text messages providing slip data were eligible for randomisation. Participants
were randomised using the York Trials Unit’s secure, web-based randomisation system, based on an
allocation sequence generated by an independent data systems manager at the York Trials Unit (the
systems manager was not involved in the recruitment of participants). Block randomisation stratified by
trust was used with variable block sizes. Participants were randomised at a particular site in batches of 1 : 1
between the intervention and control group (depending on when sites had capacity to order and deliver
footwear). The block size was equal to the number of participants to be randomised at each time frame.
Trial intervention
Participants allocated to the intervention arm were offered and provided with a free pair of 5-star,
GRIP-rated, slip-resistant shoes to wear for the 14-week trial period. The GRIP rating scheme was
developed by the Health and Safety Executive. Slip resistance of shoes is rated on a scale of one to
five stars, with five stars being awarded to those shoes with the highest level of slip resistance. Those
participants allocated to the control group were asked to continue to wear their usual work footwear for
the 14-week trial period. They were informed that they would receive a free pair of 5-star, GRIP-rated,
slip-resistant shoes at the end of the 14-week trial period.
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Follow-up
Participants were followed up with weekly text messages for 14 weeks post randomisation to collect
slip data (i.e. the number of slips participants had at work in the past week). Participants were sent a
group-specific postal questionnaire at 14 weeks post randomisation. Participants who reported a slip in
their weekly text response were sent a questionnaire for further details about their first reported slip,
including any resultant injury, health service use and time off work. Any participant who reported an
injury was asked to complete, on a monthly basis until the injury was resolved or the trial ended, the
EuroQol-5 Dimensions, five-level version, as well as a questionnaire that asked whether or not the
participant had recovered from the injury, date of recovery and health-care use.
Primary outcome
The primary outcome for the trial was the incidence rate of self-reported slips, not necessarily
resulting in a fall or injury, in the workplace over a 14-week period, as reported via weekly text
messages (or the 14-week questionnaire when no slip text message data were provided). A slip was
defined as ‘a loss of traction of your foot on the floor surface, which may or may not result in a fall’.
Secondary outcomes
Secondary outcomes included the incidence rate of falls (both resulting and not resulting from a slip)
over 14 weeks; the proportion of participants who reported a slip, fall or fracture over 14 weeks; time
to first slip and fall; and health-related utility, as measured by the EuroQol-5 Dimensions, five-level version.
Other data collected
Compliance data on how often participants were wearing their trial shoes were collected at 6, 10 and
14 weeks. Any adverse events relating to being in the study or wearing the trial shoes that were
reported to the York Trials Unit were recorded.
Statistical methods
All analyses were conducted in Stata v15 (StataCorp LP, College Station, TX, USA) following the
principles of intention to treat, with participants’ outcomes analysed in accordance with their original,
randomised group. Significance tests were two-sided at the 5% level. The trial was reported in
accordance with the Consolidated Standards of Reporting Trials guidelines for parallel-group
randomised trials. Baseline data were summarised descriptively overall and by randomised arm.
The primary outcome was analysed using mixed-effect negative binomial regression, adjusting for
gender, age, job role and baseline weekly slip rate as fixed effects and centre as a random effect.
Two-stage, instrumental variable, complier-average causal effect analyses were used (with randomised
group as the instrumental variable) to obtain an unbiased treatment estimate. Three separate models
were run defining compliance in the following ways: receipt of the trial shoes within 7 weeks of
randomisation, receipt of trial shoes within 14 weeks of randomisation, and as a continuous measure
incorporating amount of wear.
Subgroup analyses considered whether or not the intervention effect differed by gender and area of
work by repeating the primary analysis, including the factor and an interaction term between the
factor and group allocation in the primary model.
The incidence rate of falls (both resulting and not resulting from a slip) over 14 weeks was analysed in
the same way as described for the primary outcome.
The following outcomes were analysed using mixed-effects logistic regression, adjusting for the same
fixed-effect covariates as the primary analysis, with centre as a random effect. First, the proportion of
participants who slipped at least once over 14 weeks (two separate analyses: one in accordance with
weekly slip text message data or 14-week questionnaire if no text message data were provided; and
one using only 14-week questionnaire data). Second, the proportion of participants who fell at least
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once over 14 weeks. The number of participants who reported a fracture was small and, therefore,
no formal analyses of this outcome were undertaken.
Time to first slip was analysed using Cox proportional hazards regression, with shared centre frailty
and adjusting for the same covariates as in the primary analysis model. Time to first fall was not
formally analysed because a valid date of fall was provided for relatively few falls.
Adverse events are summarised descriptively by treatment arm.
Qualitative study
A qualitative study was undertaken via interviews to explore participants’ thoughts about, and personal
experiences of, slips and slip prevention within the NHS workplace, experiences of the trial footwear
and being a trial participant. Topic guides were developed based on the study’s research questions and
provided the framework for the interviews.
Sampling strategy and recruitment
A purposive sample of 35 intervention trial participants, from all participating trusts, took part in the
qualitative study. Participants who indicated that they would be willing to participate in the interview
were sent a patient information sheet and invitation letter in the post or by e-mail or contacted
directly by members of the trust’s research and development department.
Interview design
The interviews lasted between 10 and 35 minutes, were semistructured and were conducted over
the telephone.
Analysis
Following transcription, the interviews were analysed thematically.
Economic analysis
An economic evaluation was conducted to assess whether or not the intervention was cost-effective in
reducing the risk of slips. The primary outcome measure for the economic evaluation base case was
injuries due to slips, as slips that do not result in injury are unlikely to lead to material economic costs.
The following incremental cost-effectiveness ratios were estimated from the perspectives of the NHS
budget and of society: cost per quality-adjusted life-year, cost per averted injury and cost per averted slip.
The analysis modelled the impact of slip-resistant footwear on the expected number of slip-related
injuries across the trial population, and mean unit costs per injury were estimated by aggregating the
outcome data across treatment groups. The costing framework accounted for intervention costs in
addition to the costs of health-care resource use, worker absenteeism and expected compensation
claims, using data collected via trial questionnaires and from secondary sources. Health-related
quality-of-life data were collected using the EuroQol-5 Dimensions, five-level version, and converted to
utility values consistent with the three-level value set using the van Hout et al.’s ‘crosswalk’ approach
(van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the
EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15).
Results
A total of 8524 recruitment packs were handed out between March 2017 and November 2018.
A completed baseline form was received from 5309 (62.3%) potential participants, of whom 498 (9.4%)
were ineligible. A total of 4554 participants were randomised (an increase of 154 participants on
the 4400 participants planned). One participant was discovered to be ineligible after randomisation
and so was immediately withdrawn, resulting in 2275 participants in the intervention group and
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2278 participants in the control group. The recruited participants were predominantly female (n= 3869,
85.0%) and the average age was 42.7 (range 18–74) years. Participants worked a median of 37.5 hours per
week and qualified nurse or midwife was the most represented job role (n = 1937, 42.5%). At baseline,
just over one-third of participants reported experiencing a slip at work in the previous 12 months
(median of two slips), of whom 10.7% had suffered an injury as a result of one of these slips.
Overall, weekly response rates to the 14 post-randomisation slip text messages exceeded 86%. In total,
6743 slips were reported: 2633 over 28,002 person-working weeks in the intervention group (mean
1.16 per participant, standard deviation 2.9, median 0, range 0–36) and 4110 over 28,595 person-
working weeks in the control group (mean 1.80 per participant, standard deviation 4.6, median 0,
range 0–83). There was a statistically significant reduction in the slip rate in the intervention group,
relative to the control group (incidence rate ratio 0.63, 95% confidence interval 0.57 to 0.70; p < 0.001).
A total of 1523 (66.9%) intervention participants received a pair of trial shoes within 7 weeks of
randomisation and 1930 (84.8%) participants received a pair of trial shoes within 14 weeks. The median
time to receipt of shoes was 27 days after randomisation. The complier-average causal effect estimate for
receiving a pair of shoes within 14 weeks was (incidence rate ratio) 0.65 (95% confidence interval 0.59 to
0.73; p< 0.001). On receipt of shoes, around 50% of intervention participants reported wearing the trial
footwear all of the time when at work. Further complier-average causal effect analysis indicated that those
who received the shoes earlier and/or wore them more often were more likely to have a reduced slip rate.
Statistically significant differences were also observed in falls resulting from a slip in the workplace
(incidence rate ratio 0.51, 95% confidence interval 0.28 to 0.92; p = 0.03), the proportion of
participants who reported a slip (odds ratio 0.58, 95% confidence interval 0.50 to 0.66; p < 0.001) or
fall (odds ratio 0.73, 95% confidence interval 0.54 to 0.99; p = 0.04) and time to first slip (hazard ratio
0.73, 95% confidence interval 0.67 to 0.80; p < 0.001).
There were no related serious adverse events.
An incremental cost per quality-adjusted life-year in the base case was estimated at £38,900 from
the NHS perspective and –£60,400 from the societal perspective (i.e. cost saving). One- and two-way
sensitivity analyses indicated that the intervention would be cost-effective at plausible values from the
NHS perspective at a threshold of £30,000 per quality-adjusted life-year.
Conclusions
The slip-resistant shoes used in this study reduced the number of slips, and falls resulting from slips.
The results indicate that the intervention could be cost-effective at the £30,000 per quality-adjusted
life-year threshold from the NHS perspective and is cost saving from the societal perspective. The
majority of participants found the shoes comfortable.
Trial registration
This trial is registered as ISRCTN33051393.
Funding
This project was funded by the National Institute for Health Research (NIHR) Public Health Research
programme and will be published in full in Public Health Research; Vol. 9, No. 3. See the NIHR Journals
Library website for further project information. The Health and Safety Executive provided some
research costs.
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for any purpose, provided the original work is properly cited, a link to the licence is given, and indication
of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. The text below
includes minor additions and formatting changes to the original text.
Slips, trips and falls on the same level (STFL) are a major contributor to the burden of workplace injury
in Great Britain (GB; refers to England, Scotland and Wales). They are the most common cause of
non-fatal injury to employees, accounting for around 30% of those injuries reported to GB’s Health and
Safety Executive (HSE).3 It is estimated that there are around 100,000 non-fatal workplace injuries due
to STFL every year.4
The consequences of work-related STFL are rarely fatal, but the resulting injuries are not always trivial.
Nearly 40% of the STFL injuries reported to the HSE in 2017/18 were ‘specified’ injuries,5 which means
that the injury appeared on a predefined list that tends to represent the more serious workplace injuries,6
with the vast majority being fractures.7 Fractures can sometimes have long-lasting effects, such as nerve
damage, decreased strength and increased discomfort around the site of the fracture. It is estimated that,
on average, a worker takes around 9 days off work if injured by a workplace STFL, which equates to
nearly 1 million working days lost through STFL injuries every year.4
Furthermore, the workforce is ageing and the employment rate for those aged ≥ 65 years has doubled
over the last 20 years.8 Older workers are more susceptible to falls and tend to sustain more serious
injuries when they occur.9,10 In the workplace, normal age-related physiological factors, such as diminished
balance, vision changes and hearing loss, can contribute to increased STFL work hazards.11 Hence,
workplace STFL are an increasing concern, particularly within the context of an ageing workforce.
Slips in the workplace and the role of slip-resistant footwear
Injury-reporting systems rarely differentiate between slips, trips and other causes of falls on the same
level, but it is thought that slipping is a major contributor. Courtney et al.12 reviewed six reporting
systems in the USA, the UK and Sweden, and found that just three (in the USA and Sweden) provided
sufficient information to attempt to isolate the contribution of slipping to the overall burden of STFL.
The authors12 suggested that slipping contributed to between 40% and 50% of STFL-related injuries.
Workplace slips and their resulting falls happen for a number of reasons. Factors that can contribute to
slips in the workplace include the floor surface, the presence and characteristics of any contamination
of the floor (wet or dry), the cleaning regime, the level and type of pedestrian activity, footwear choice,
the working environment (e.g. lighting or noise levels) and human factors (how people interact with
their working environment).13 A multitude of factors may be present at the same time and so it is
rarely just one factor that causes a specific slip incident.
In the UK, employers have a duty to assess risks (including slip risk) and, when necessary, take action
to address them. This is done through a risk assessment, when the employer considers what workplace
risks may lead to slip injuries and decide what suitable and effective control measures could prevent
them. In many instances, straightforward measures can readily control risks (e.g. ensuring that the floor
surface is kept clean and dry or by installing a floor surface that is sufficiently slip resistant when
contaminated). However, when it is not practicable to prevent the floor surface becoming slippery,
employers may consider the use of slip-resistant footwear.
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The choice of slip-resistant footwear is important and the selection of inappropriate footwear
(i.e. with poor slip resistance) could potentially add to the problem rather than provide a solution.
Choosing appropriate footwear can be difficult, as there is a lack of robust testing and reliable
information to help guide the decision-making process.
It has been suggested that testing footwear under more lifelike conditions will provide a more accurate
assessment of the slip-resistant properties of the footwear.14,15 In response to this, and to help guide
the selection process, the HSE developed the ‘GRIP’ rating scheme.16 This scheme utilises a test regime
designed to reflect the biomechanics of walking, and categorises footwear in accordance with the level
of slip resistance it provides on a smooth surface contaminated with (1) water and (2) a 75% volume
per volume glycerol solution (aqueous). ‘GRIP’ star ratings, ranging from one to five stars, are assigned
to the footwear soling units on the basis of the results obtained, with five stars being awarded to those
with the highest level of slip resistance. The risk assessment process can help guide the employer on
which star rating is required for their workplace.
Current evidence relating to the use of slip-resistant footwear
A number of publications have described studies investigating the influence of footwear on slip risk
using a range of laboratory tests. The evidence suggests that the level of slip resistance provided by
different types of footwear varies considerably and that the effectiveness of footwear at preventing
slips and falls depends on factors such as the footwear material, the tread design, the type of
contamination and the characteristics of the floor.17–19
The HSE has developed tests to accurately assess the slip resistance of footwear and has helped to
inform the footwear selected by some companies that have subsequently seen a reduction in accidents
and personal liability claims. For example, one case study20 showed how the test method could be used
to remove inadequate footwear from use and identified alternatives. As a consequence, the risk of
workplace accidents was reduced.20 However, these are individual, non-peer-reviewed before-and-after
case studies and the findings are not in the context of a randomised controlled trial (RCT).
There is, however, some evidence to support this suggestion in studies that have measured a reduction
in slips occurring in the workplace by the use of appropriate slip-resistant footwear. Bell et al.21
evaluated a comprehensive slip, trip and fall prevention programme for hospital employees in the USA.
The programme included slip-resistant footwear for certain employee subgroups, but also included
many other prevention strategies, such as hazard assessments, changes to housekeeping, general
awareness campaigns and flooring changes. The study suggested that the programme reduced workers’
compensation claims for slips, trips and falls by 58%, but it was not possible to disentangle the specific
effect of slip-resistant footwear from the other preventative interventions.21
An uncontrolled before-and-after study among fishermen in Denmark suggested that slip-resistant
boots led to a reduction in self-reported slips, trips and falls.22 In contrast, a cross-sectional study23 of
125 fast-food restaurant workers in the USA did not find an association between slipping and use of
footwear perceived to be slip resistant. The authors suggested that the null finding could have been
due to the method of classifying footwear as slip resistant (through visual inspection of the tread),
possibly leading to misclassification and the potential for reverse causality (people who had
experienced a slip or fall in the past being more likely to wear slip-resistant footwear).
More recently, in the USA, a prospective cohort study24 of 475 fast-food restaurant workers found that
the use of slip-resistant footwear was associated with a 54% reduction in the reported rate of slipping.
A case-crossover study nested within the same cohort found that rushing and walking increased the
rate of slipping, but that use of slip-resistant footwear reduced the effects of rushing and walking on
slip risk when on a contaminated floor.25 Further analysis of the cohort indicated that slip-resistant
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shoes worn for < 6 months were marginally more effective at preventing slips than slip-resistant shoes
worn for > 6 months.26
We are aware of only one RCT27 assessing the effectiveness of slip-resistant footwear. This cluster
randomised trial of food service workers from 226 school districts in the USA found that the
probability of a slipping injury fell by 67% in the intervention group, who received slip-resistant
footwear. By contrast, the control group (who wore slip-resistant footwear that they purchased
themselves in accordance with company policy) saw a slight increase in the probability of slipping
injury during the follow-up period.
Overall, there seems to be promising evidence that slip-resistant footwear can substantially reduce
the burden of accidents at work, but much of this evidence has been gathered for footwear with
slip-resistant properties that are ill-defined. It was therefore considered important to test the clinical
effectiveness and cost-effectiveness of appropriately specified slip-resistant footwear in a large
pragmatic trial within a UK setting.
Trial setting
It is estimated that the health and social care sector employs 1 in 10 of the working population28 and has
one of the highest numbers of non-fatal STFL compared with other industries in GB. It is estimated that
every year around 14,000 workers in this industry sector are injured as a result of STFL [Health and
Safety Executive. Estimated Incidence of All Self-Reported Workplace Non-Fatal Injury Resulting in a Slip, Trip
or Fall on the Same Level, Sustained in Current or Most Recent Job, By Industry, for People Working in the Last
12 Months, Averaged 2014/15–2016/17 (Unpublished data). London: Labour Force Survey; 2018].
The NHS is the biggest employer in the sector and the fifth biggest employer in the world.29 NHS sites,
particularly hospitals, present challenging working environments with respect to slip risk. For example,
the floor is generally smooth and not carpeted to aid regular cleaning, there are multiple sources
and types of contamination, there is a relatively high level of pedestrian activity and of varied types
(e.g. walking, pushing and pulling) and people frequently walk at speed, often multitasking or focused
on a more critical objective than the environment around them. Many large hospital sites are a
conglomeration of buildings and so people often switch between indoor and outdoor environments,
and community staff are mainly offsite with no control over their surrounding environment. In such
circumstances, it would seem potentially beneficial for staff to consider wearing slip-resistant footwear.
It is for these reasons that NHS staff were considered to be a good population on which to base research
into the potential effectiveness of appropriately specified (in this study, 5-star, GRIP-rated) slip-resistant
footwear. In addition, the NHS includes different working subpopulations (e.g. nursing staff, kitchen staff,
porters and people who work in the community). This will help to generalise any research to other
industries that share many of the same risk factors, such as retail, hospitality, education and manufacturing,
and maximise the impact of the research. One other potential benefit of undertaking the trial within
the NHS is that its staff are generally used to the research environment although it is usually patients
rather than the staff who take part in research. However, it seemed likely that, for this reason, participation
in this research would be higher among NHS staff than among those of other employers.
Objectives
Primary objective
The primary objective of this research was to assess whether or not the offer and provision of 5-star,
GRIP-rated, slip-resistant footwear to NHS employees working in general, clinical or catering areas
leads to a reduction in the incidence rate of self-reported slips.
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Secondary objectives
The secondary objectives of this study were to:
l undertake an internal pilot RCT to (1) check the feasibility of the study, including if it is possible to
recruit, randomise and follow up 800 participants; (2) check the sample size calculation assumptions
and the attrition rate; and (3) explore and address any issues regarding footwear compliance
l assess if the provision and use of 5-star, GRIP-rated footwear leads to a reduction in slips and is
cost-effective
l disseminate the findings of this study using the HSE, NHS trust managers and health and safety
managers (in addition to publishing the results of the study in key journals and in this Public Health
Research monograph).
INTRODUCTION




The Stopping Slips among Health-care Workers (SSHeW) trial was a pragmatic, two-arm, open RCT
with an internal pilot trial, economic evaluation and qualitative study. Participants were randomised
to either the intervention group and were offered a pair of 5-star, GRIP-rated, slip-resistant shoes to
wear at work (free of charge to themselves), or to the waiting list control group and were asked to
wear their usual work footwear for the trial period and offered a pair of the slip-resistant shoes at the
end of their participation in the trial (free of charge to themselves). The trial included an economic
evaluation (see Chapter 4) and a nested qualitative study to explore the experiences of participants in
the trial (see Chapter 5). The SSHeW trial also served as a host trial for an embedded study within a
trial (SWAT) to evaluate the effectiveness, on response rate, of enclosing a pen with the 14-week
post-randomisation postal follow-up questionnaire.
Ethics approval and research governance
Ethics approval for the study was obtained from the University of York, Department of Health
Sciences Research Governance Committee (DHSRGC), on 28 November 2016. The study was approved
by the Health Research Authority (HRA) on 7 March 2017 (HRA reference number 17/HRA/0435). The
HRA did not require Research Ethics Committee approval for the study, as the participants were NHS
staff (as opposed to NHS patients). Approval and ‘confirmation of capacity and capability’ was obtained
for each participating trust prior to commencement of the trial at that site (see Appendix 1). Substantial
amendments to the protocol were submitted to the DHSRGC, the HRA and each site’s research and
development office during the course of this study.
The trial was registered with the International Standard Randomised Controlled Trial Number registry
as ISRCTN33051393. The trial protocol is published.1
Setting
Recruitment of participants took place in seven NHS trusts in England. The participating trusts ranged
from large acute hospital trusts to smaller trusts, and included district general hospitals serving local
communities, a trust that provided mental health services and a community trust.
Recruitment procedure
Recruitment of participants into the study took place in multiple sites within participating NHS trusts,
facilitated by members of the research and development teams, and assisted by members of the HSE team
and University of York researchers in some sites. Sites used a variety of recruitment strategies to recruit
participants, which were developed during the pilot phase of the study. These included holding ‘shoe shops’
(where interested staff could learn more about the study, and see and try on samples of 5-star, GRIP-rated,
slip-resistant footwear) and stands promoting the trial in convenient hospital locations, such as reception
foyers or the canteen, or at staff conferences or induction days. Other recruitment activities included
promotion of the trial via posters, information on the staff intranet, screensavers and weekly staff
bulletins. Direct staff recruitment occurred by members of the research team attending staff meetings and
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ward areas, particularly at shift handover time, and via word of mouth as participants discussed the trial
with colleagues who then approached research staff to discuss participation.
At recruitment, research staff provided information about the study and demonstrated the 5-star,
GRIP-rated, slip-resistant shoes being tested in the trial. Sample styles and sizes were available for
interested staff to try on. Research staff briefly assessed eligibility of interested staff by asking if
they were employed by the recruiting trust, their area of work and the average number of hours they
worked per week, before giving them a recruitment pack. The recruitment pack contained an invitation
letter from the principal investigator at the NHS trust (see Report Supplementary Material 1), a participant
information sheet, which included contact details for the research team should they have had any queries
about the study (see Report Supplementary Material 2), a flier with pictures of the shoe styles being offered
at the trust (see Appendix 2 for an example of this document offered at one trust), a baseline questionnaire
including more detail on the eligibility criteria (see Appendix 3), a consent form (see Report Supplementary
Material 3) and a prepaid envelope for returning the completed paperwork.
Consent process
Participation in the SSHeW trial was voluntary. Participants who wished to take part in the trial
after receiving information about the trial from a member of the research team and/or reading the
participant information sheet provided in the recruitment pack were asked to complete the consent
form by initialling that they had read the items listed, and signing and dating the form.
The consent form also asked if participants were willing to take part in a telephone interview about
the study (for the qualitative component of the study, further consent was obtained from the
participant by post prior to undertaking a telephone interview). Participation in the SSHeW trial was
not affected if the member of staff did not consent to participate in a telephone interview.
Baseline assessment
On receipt of completed written consent, researchers at the York Trials Unit (YTU) assessed the
participants’ responses to the baseline questionnaires for eligibility in accordance with the following criteria.
Participant eligibility
Inclusion criteria
1. Aged ≥ 18 years.
2. Employed by (named) participating NHS trust.
3. Were required to adhere to a dress code.
4. Worked in a clinical, general or catering area.
5. Worked at least 30 hours per week [80% working-time equivalent (WTE)] (reduced mid-way
through the trial to 22.5 hours/week or 60% WTE).
6. Had a mobile phone and were willing to receive and send text messages for trial data collection.
Exclusion criteria
1. Not employed by the participating NHS trust.
2. Did not have a mobile phone, or were unwilling or unable to receive and send text messages.
3. Were provided with, and required to wear, protective footwear by their employer (e.g. steel
toe-capped boots).
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4. Were agency staff or staff with < 6 months remaining on their employment contract.
5. Worked < 60% WTE (22.5 hours/week).
6. Were predominantly office or theatre based.
Note that the eligibility criterion with respect to the number of working hours was changed from
the initial requirement of working, on average, at least 80% WTE (equivalent to 30 hours/week) to
working, on average, at least 60% WTE (equivalent to 22.5 hours/week) (protocol version 5.0, dated
26 April 2018 and approved 2 September 2018). This change was made to facilitate the recruitment of
participants to meet the required sample size. Participating sites had saturated the eligible workforce
and found that the number of hours worked was the predominant factor limiting others from taking
part. The required working hours were dropped to no lower than 22.5 hours to ensure that participants
were working a sufficient amount of time to (1) provide a sufficient work-related slip rate and (2) retain
the ability to detect a reduction in this slip rate. It was felt that if we reduced the working hours further
then we would not have been able to do this.
Participants who were assessed as being ineligible for the study were notified in writing and no further
correspondence was sent. Participants who were deemed eligible were entered into the trial and sent
a welcome text message that said:
Welcome to the SSHeW trial. We very much value your agreement to participate. You will shortly start to
receive text messages asking about any slips you have at work. These texts will always come from this
number and will begin with the word SSHeW so that you can recognise them. Thank you.
All participants who were eligible to take part were sent a copy of their signed consent form and a
paper diary enabling them to record slips, falls and injuries when they occurred, and any time off work
as a result (see Appendix 4). This was intended as a memory aid to help participants complete the text
message responses and the 14-week questionnaire.
Pre-randomisation phase
After the welcome message was sent, all eligible participants were sent a text message each Sunday at
18.30 for 4 weeks, unless they requested that these be stopped. We chose to send text messages at
this time as we anticipated that fewer participants would be at work, which would lead to higher
response rates. This message read:
SSHeW trial: How many slips did you have at work between [DD/MM/20YY] and [DD/MM/20YY]?
Please provide a single number (e.g. 2) or 0 if you did not slip. Thank you.
The dates were populated with the previous Monday and the current date. Those who provided a valid
response (a numerical value or written number, rather than a written text response or other message,
such as a symbol) to at least two of the slip data collection text messages were randomised into the trial.
It became apparent during the trial pilot phase that some eligible participants had misunderstood the
trial process. Instead of providing slip data in response to their text messages, they reported not
having received their trial shoes as they mistakenly thought that they needed to report slip data only
once they had received their trial shoes. Therefore, the protocol was amended (substantial amendment 6,
approved 20 June 2018) to allow two additional text messages to be sent to participants who had not
responded to their pre-randomisation text messages, along with a reminder that they needed to reply to
these messages if they wished to be included in the trial.
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Randomisation
Participants who fulfilled the eligibility criteria, provided written consent to take part in the study,
completed a baseline questionnaire and returned at least two of the weekly text messages providing
slip data were eligible for randomisation. Participants were randomised using the YTU’s secure
web-based randomisation system based on an allocation sequence generated by an independent data
systems manager at the YTU. The systems manager was not involved in the recruitment of participants.
Block randomisation, stratified by trust, was used with variable block sizes. Participants were randomised
at a particular site in batches of 1 : 1 between the intervention and control group (depending on when
sites had capacity to order and deliver footwear). The block size was equal to the number of participants
to be randomised in each ‘batch’. Participants were notified of their group allocation by letter from
the YTU.
Blinding of trial participants to group allocation was not possible because of the nature of the
intervention. Members of the study team, including the statistician, health economist and those
involved in the administration of the study, were not blinded to group allocation.
Group allocation
Intervention
Individuals allocated to the intervention arm were offered a pair of 5-star, GRIP-rated, slip-resistant
shoes. The footwear was provided by a single manufacturer [Shoes For Crews (Europe) Ltd] and the
cost covered by the NHS trust. A range of intervention shoes were offered as part of the trial. The
shoes included a variety of styles, to suit different people and job roles, including dress shoes, casual
styles and ‘trainer’-type designs. The shoes had either a water-resistant leather or synthetic mesh
upper (the synthetic materials being vegan). Each individual trust reviewed the footwear available in
terms of style; to offer a range of footwear representative of that already worn by staff; health and
safety issues, for example potential for needlestick injuries; potential infection control issues; and cost.
They then produced a list of footwear which was deemed suitable for staff at their trust to wear. All
participants were asked to indicate on their baseline questionnaire, prior to randomisation, which style
and size of trial shoe they would like to wear. This facilitated swift ordering of the shoes by the trust
for participants subsequently randomised to the intervention group. The indicated shoes were ordered
for the participant, who was then provided with instructions about how to collect their trial shoes.
Further information was provided to participants about how to exchange their shoes if required.
(Participants were able to exchange their shoes if they were found to be unsuitable, for example
incorrect size, as long as the shoes were unworn and returned in their original box.) We had hoped
that this process would facilitate shoes being available for intervention participants to collect no
later than 2 weeks after randomisation; however, we know that in some sites, and at certain times,
there were delays in ordering and/or delivery of the trial shoes. In addition, we know that not all
intervention participants collected their shoes if they were delivered to a ‘collection point’ at the
hospital, and those that did may not have done so in a timely manner. More information on receipt,
and timing of receipt, of trial footwear is provided in Chapter 3, Receipt of shoes.
The shoes used in the trial had been assigned a 5-star GRIP rating from the HSE. The GRIP rating scheme
was developed by the HSE to allow footwear users to identify slip-resistant footwear to help prevent
slipping accidents. During GRIP-rating assessment, the soling of footwear is tested under very challenging
conditions (i.e. a smooth surface contaminated first with water and then with a glycerol solution). Slip
resistance of shoes is rated one to five stars on the basis of the results, with five stars being awarded to
the highest performing footwear. The shoes used as the intervention in the trial had a rubber sole with an
intricate tread pattern that provided higher levels of slip resistance than most other types of footwear on
surfaces that are contaminated with non-clogging substances (Figure 1). This level of slip resistance is
achieved by the soles providing a relatively large surface contact area, while also effectively dispersing
METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
8
any surface contamination.When walking surfaces are clean and dry the trial footwear would be
expected to behave like any other footwear; however, their slip resistance is not compromised to the
same extent as other footwear when walking on surfaces that are contaminated.
Control
Participants allocated to the control arm were asked to continue to wear their usual work shoes for
the 14-week trial period. They were informed that they would receive a free pair of 5-star, GRIP-rated,
slip-resistant shoes at the end of the 14-week trial period, the size and style of which they indicated on
their baseline questionnaire. The footwear was provided by a single manufacturer (Shoes For Crews Ltd)
and the cost covered by the NHS trust. Control group participants were also sent a copy of their signed
consent form and a slip diary, the same as the intervention group, at the start of their participation in
the trial.
Participant follow-up
All participants in the SSHeW trial were sent weekly text messages for 14 weeks post randomisation
to collect slip data (i.e. the number of slips the participant had experienced at work in the past week).
As with the pre-randomisation messages, these were sent on a Sunday evening (18.30) and the
wording was the same, with dates inserted relative to the past week:
SSHeW trial. How many slips did you have at work between [DD/MM/20YY] and [DD/MM/20YY]?
Please provide a single number (e.g. 2) or 0 if you did not slip. Thank you.
These messages started, for all participants, the first Sunday after they were randomised, regardless of
whether or not the intervention participants had received their shoes.
Non-responders did not receive reminder text messages, as there was limited time to send these
because of the short time frame of 1 week before the next text message was sent. Participants were
also sent a group-specific postal questionnaire at 14 weeks post randomisation to collect data on slips,
falls, injuries, time off work, health-care resource use, if participants were worried about slipping and
falling, how often they had worn the trial shoes while at work and if participants had any views on
trial shoes (intervention group only) (see Appendices 5 and 6). Participants who did not return this
questionnaire within 3 weeks were sent a postal reminder. Participants who reported a slip in their
weekly text response were sent a questionnaire for further details regarding their first reported slip,
including whether or not they were wearing the trial shoes when they slipped, any resultant injury,
health service use and time off work. Furthermore, participants reporting an injury were sent an injury
follow-up questionnaire.
FIGURE 1 Example of sole of intervention footwear. Photograph received and reproduced with permission from Shoes
for Crews (Europe) Ltd.
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Slip data collection sheet
On reporting their first slip via a weekly post-randomisation text message, participants were posted a
questionnaire asking for further details about that slip, with reference to the week in which the slip
occurred (see Appendix 7). This collected information about the date of the slip, whether or not the
slip resulted in a fall, any consequence of the slip (such as superficial or other injury), whether or not
the participant sought health-care advice and if the participant required any time off work. The
questionnaire also included the EuroQol-5 Dimensions, five-level version (EQ-5D-5L), health-related
quality-of-life (HRQoL) measure.30 A reminder letter and further copy of the questionnaire was sent to
those participants who had not returned the questionnaire after 2 weeks. Initially, data were going to
be collected over the telephone, rather than by post, for each slip that occurred; however, it quickly
became apparent that this would place too great a burden on the participant and study team.
Injury follow-up
An injury follow-up questionnaire was sent when a trial participant reported an injury. A participant may
have reported an injury via one of several means: by text message, direct telephone call or e-mail to
either a member of the trial team at the YTU or a member of the research team at participating sites,
reported on a returned slip data collection sheet (SDCS) or reported on the 14-week questionnaire. If
the participant reported an injury between randomisation and the 14-week questionnaire, an injury
questionnaire was sent asking for EQ-5D-5L data, whether or not the participant had fully recovered
from the injury and the date they recovered (see Appendix 8). If the participant had not fully recovered
from the injury, a further injury follow-up questionnaire was sent 1 month later. This continued until
the injury was resolved, the participant no longer wished to be contacted or the trial ended. If the
participant reported an injury after completion of the 14-week questionnaire then they were also sent
an injury follow-up questionnaire (see Appendix 9). This questionnaire collected the same data as the
injury form sent out during the trial (i.e. EQ-5D-5L scores and details of any time required off work) and
also included questions asking about health-care services used for the injury after the 14-week trial
period. This continued until the injury was resolved, the participant no longer wished to be contacted or
the trial ended.
Compliance text message follow-up
In addition to the weekly text messages collecting data on the number of slips per week, participants
in the intervention arm of the trial were sent a text message at 6, 10 and 14 weeks post randomisation
to gather information about how often the participant was wearing their trial shoes:
SSHeW trial. In the past month, how often have you worn your trial shoes at work? Reply 0, 1 or 2
(0 = none of the time, 1 = some of the time, 2 = all of the time).
Wear testing
The soles of all footwear degrade over time and so it was important to have a concept of how long
the slip resistance of the trial footwear lasted in a real-world setting. This information could help
determine any replacement schedule, and results from this fed into the health economic analysis for
the trial.
To assess the serviceable life of the intervention footwear, we asked eligible participants from three
trusts who had continued to wear their trial shoes beyond the trial period to return them for
assessment. Participants from the intervention group who had been in possession of the trial footwear
for 6, 9 or 12 months since randomisation, and had reported wearing the footwear either all of the
time or most of the time in response to the 14-week questionnaire, were contacted to establish if they
had continued to wear the footwear. Those who had were then asked if they would be willing to return
their trial footwear in exchange for a new pair. The exchange of footwear was co-ordinated by the
participating trusts.
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The soles of each pair of footwear were cleaned, rinsed and allowed to dry prior to the assessment.
A visual inspection was carried out to assess the condition of the footwear and identify any defects.
Each pair of footwear was inspected by one member of the HSE research team and a HSE colleague
who was not involved in the study to provide layperson corroboration. The condition of the upper was
rated as good, reasonable or poor, and any defects were recorded. The depth of tread was measured
to determine the approximate proportion of sole area that had tread depth below the 2 mm minimum
recommended by the manufacturer.
The slip resistance of the worn footwear was then tested on the HSE’s simulated slip test31 and the
results compared with those generated for the same styles of footwear when new. Each pair was
tested in line with the conditions set out in the HSE GRIP scheme handbook.32
Outcomes
Primary outcome
Parts of this text have been reproduced with permission from Cockayne et al.2 This is an Open Access
article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0)
license, which permits others to copy, redistribute, remix, transform and build upon this work for any
purpose, provided the original work is properly cited, a link to the licence is given, and indication of
whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. The text below
includes minor additions and formatting changes to the original text.
The primary outcome in this study was the incidence rate of self-reported slips, not necessarily
resulting in a fall or injury, in the workplace over a 14-week period, as reported via weekly text
messages. A slip was defined as ‘a loss of traction of your foot on the floor surface, which may or may
not result in a fall’. A fall was defined as ‘an unexpected event in which you come to rest on the
ground, floor or lower level’.
Participants were also asked on the 14-week questionnaire, ‘How many times did you slip (with or
without falling) while at work in the past 14 weeks?’. Responses to this question were used when the
participant did not provide any text message data.
Secondary outcomes
l The incidence rate of falls resulting from a slip in the workplace over 14 weeks (14-week
questionnaire).
l The incidence rate of falls not resulting from a slip in the workplace over 14 weeks (14-week
questionnaire).
l Proportion of participants who reported a slip over 14 weeks (weekly slip text message and
14-week questionnaire).
l Proportion of participants who reported a fall (whether or not resulting from a slip) over 14 weeks
(14-week questionnaire and SDCS).
l Proportion of participants who reported a fracture over 14 weeks (SDCS).
l Time to first slip (number of days between randomisation and date of first slip, as reported via
text message).
l Time to first fall (number of days between randomisation and date of first fall, as reported on the
14-week questionnaire or SDCS).
l Health-related utility (measured by the EQ-5D-5L) and cost-effectiveness.
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Sample size
Parts of this text have been reproduced with permission from Cockayne et al.2 This is an Open Access
article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0)
license, which permits others to copy, redistribute, remix, transform and build upon this work for any
purpose, provided the original work is properly cited, a link to the licence is given, and indication of
whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. The text below
includes minor additions and formatting changes to the original text.
There were limited published data on which to base a sample size calculation for this trial. A prospective
cohort study24 found that 49 of 422 (11.6%) workers in a restaurant setting in the USA reported at least
one ‘major’ (i.e. resulting in a fall and/or injury) slip over a 12-week follow-up period. The exact number who
experienced any type of slip was not reported in that study, but could reasonably be expected to be higher
than this. For our sample size calculation, we required an estimate of the proportion of individuals in the
control group who would experience at least one slip over a 14-week follow-up period; we conservatively
assumed a proportion of 10%.We proposed to randomise 4400 participants using 1 : 1 allocation (i.e. 2200
per group) to have 90% power to show a 30% relative reduction in the proportion of participants who
report at least one slip over a 14-week period (a 3-percentage-point absolute reduction from 10% to 7%),
allowing for 20% attrition. This sample size would also give us 80% power to see an absolute reduction of
2 percentage points in the risk of falls, from 5.5% to 3.5%, allowing for 20% attrition. Although we based
the sample size calculation on detecting a difference in proportions, the primary outcome is the incidence
rate of slips over the 14 weeks and so we used a mixed-effects negative binomial regression model to
compare this outcome between the two groups. As this analysis uses more information than a simple
binary outcome, we expected it to still be adequately powered.
Trial completion and exit
Participants completed the trial if they completed the 14-week trial period post randomisation.
Participants exited the trial if they had completed the 14-week follow-up period, had fully withdrawn
from the trial (no further follow-up by text or post), were lost to follow-up or had died.
Participant change of status and participant withdrawal
Participants could withdraw from the trial at any time without giving a reason. If, however, a reason
was provided, then it was recorded. If we were informed that a participant wanted to withdraw from
the trial, a member of the research team would attempt to clarify to what extent they wished to
withdraw (i.e. fully or partially). Participants could partially withdraw from the trial in two ways; first,
by withdrawing from the intervention only, meaning that they would not wear the trial shoes but
continue to provide text and questionnaire data; and, second, participants could withdraw from data
collection either by declining to respond to text messages or by declining to complete the follow-up
questionnaires. Data were retained for withdrawn participants unless a participant requested specifically
that their data be removed. A change of circumstance form was completed by a member of the research
team for any participant changing status during the trial (see Report Supplementary Material 4).
Adverse events
Adverse events (AEs) were reported by participants to the research team at the YTU via telephone
or text message or by writing free-text comments in the postal questionnaires. AEs could also be
reported through the local research teams at the participating sites. Details of AEs were recorded
on a SSHeW AE form (see Report Supplementary Material 5). The AE reporting period started at the
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point when the participant gave their consent to be in the trial and ended at 14 weeks after they
were randomised.
Serious AEs that were related to being in the study and were unexpected were recorded. Non-serious
AEs were not recorded, unless they were related to being in the study or were related to the intervention.
A serious AE was defined as any untoward occurrence that:
l resulted in death
l was life-threatening
l required hospitalisation or prolongation of existing hospitalisation
l consisted of a congenital anomaly or birth defect
l was otherwise considered medically significant by the investigator.
Expected events
Slips and falls were not recorded as AEs in this trial, as these were recorded as trial outcomes. It was
expected that some participants could experience foot problems associated with the new footwear.
These could range from minor superficial problems associated with skin irritation and pressure, such
as blisters or calluses, to more mechanical foot complaints, such as plantar fasciitis and tendonitis. In
severe cases, when shoe styles were not suited to the participant’s foot shape, changes or exacerbation
of foot structure, such as toe deformities, could be expected.
The occurrence of AEs during the trial was reported and monitored by the combined Trial Steering
Committee (TSC) and Data Monitoring and Ethics Committee (DMEC). The TSC and DMEC were
immediately sent all serious AEs that were thought to be related to treatment.
The SSHeW internal pilot trial
An internal pilot trial was conducted during the first 6 months of the study (March–September 2017).
The objectives of the pilot trial were to:
l test and refine recruitment strategies for the study
l check the sample size calculation assumptions by reviewing the proportion of participants in the
control group who experienced a slip
l check the attrition rate
l explore and address any issues regarding footwear compliance.
To progress to the main SSHeW trial, the pilot phase had to meet the following criteria:
l at least 400 participants recruited in 6 months
l 80% of participants contributing at least 50% of the requested follow-up text data (i.e. responding
to 7 of the 14 weekly post-randomisation text messages)
l 90% of participants responding to at least one post-randomisation text message
l a slip rate in the control group of at least 7%.
Data analysis
Analysis
There were two analyses: (1) a descriptive analysis of the internal pilot data and (2) a single effectiveness
analysis of the trial data at the end of follow-up of all participants. All analyses were conducted in
Stata v15 (StataCorp LP, College Station, TX, USA) and followed the principles of intention to treat,
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with participants’ outcomes analysed in accordance with their original randomised group, irrespective
of deviations based on non-compliance. Statistical tests are two-sided at the 5% significance level and
95% confidence intervals (CIs) are used.
The trial is reported in accordance with the Consolidated Standards of Reporting Trials (CONSORT)
guidelines for parallel-group, randomised trials [URL: www.consort-statement.org/ (accessed 19 May 2020)].
The flow of participants through each stage of the trial, including reasons for non-eligibility, is presented
in a CONSORT diagram (see Figure 2).
Figure 3 presents the overall recruitment by month, and the actual compared with target recruitment.
Follow-up response rates to the weekly text messages (both pre and post randomisation), the compliance
text messages (for the intervention group only), SDCSs and the 14-week participant questionnaire
(including time to response) are summarised overall and by treatment group when appropriate.
The number of intervention participants receiving a pair of trial shoes and the time taken from
randomisation to receiving the shoes is summarised. The date provided by the participant on their
14-week questionnaire was the primary source of data for the date when shoes were received, with
the date provided by the sites used, when available, if participants did not provide a date. We primarily
used the participant-reported date, as the date provided by the site may be the date the shoes were
delivered to the shoe collection point for the participant and not necessarily the date the participant
collected the shoes, which could potentially have been significantly later.
Withdrawal
Type and timing of withdrawals are presented overall and by randomised group, with reasons
when available.
Baseline data
Baseline data are summarised descriptively overall and by randomised arm. Continuous measures are
reported using descriptive statistics [mean, standard deviation (SD), median, minimum and maximum],
whereas categorical data are reported as counts and percentages. No formal statistical comparisons
of baseline data were undertaken between the trial arms. Comparisons are made based on visual
observation only.
Primary analysis
The difference in slip rate between the intervention and control groups over 14 weeks was analysed using
a mixed-effect negative binomial regression model, adjusting for gender (three categories: male; female;
prefer not to say or missing), age at enrolment (continuous) and job role [four categories: administration
and information technology (administrator/receptionist/secretarial, ward clerk); facilities workers (catering,
porter); direct patient care (doctor/consultant, qualified nurse/midwife, physiotherapist, occupational
therapist, health-care assistant, pharmacist/pharmacy technician, social worker, support worker, podiatrist,
other qualified staff/health-care professional); other/missing (imaging, other)], and baseline weekly slip rate
ascertained from the pre-randomisation text message responses as fixed effects. Trial site was included as
a random effect to account for potential clustering by recruitment site. The total number of hours that
participants worked in the weeks for which they provided slip data was calculated (by multiplying the
number of weeks the participant provided valid post-randomisation text message slip data by the number
of hours they indicated they worked, on average, per week on the baseline questionnaire). This amount of
time was accounted for in the negative binomial model (using the exposure option in Stata).
The incidence rate ratio (IRR) and associated 95% CI and p-value for the treatment effect
are presented.
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This analysis primarily included slip data from the weekly text message responses. When no
post-randomisation responses were returned, data from the 14-week questionnaire were used
for a participant, when available.
The primary analysis included all participants who had full baseline covariate data. The model could
accommodate participants who did not provide a valid response to any weekly text messages or the
14-week questionnaire by considering that they reported zero slips over a negligible exposure time of
0.1 hours.
The primary analysis was checked by a second statistician (GF), who reviewed the analysis syntax,
the derivation of variables required for the analysis, and the reporting and interpretation of the results.
Sensitivity analysis
Missing data
In our prespecified analysis plan, we said that if > 5% of randomised participants did not provide any
slip data then, to account for possible selection bias in the primary analysis, a mixed-effect logistic
regression would be run to predict non-response (no post-randomisation slip text message responses
or 14-week questionnaire received), including all baseline variables collected prior to randomisation
and trial site as a random effect. The primary analysis would then have been repeated including as
covariates all variables found to be significantly predictive of non-response, to determine if this
affected the parameter estimates. However, as < 5% of randomised participants did not provide slip
data, this analysis was not performed.
Intervention compliance
Information on how often participants reported wearing their shoes, as recorded for the intervention
group in the compliance text messages at 6, 10 and 14 weeks post randomisation and on the 14-week
questionnaire, are summarised. Differences between responses provided via the different methods
are discussed.
Complier-average causal effect (CACE) analysis to assess the impact of non-compliance on treatment
estimates was undertaken. CACE analysis allows an unbiased treatment estimate of, in this case, the
IRR of slips between the two groups in the presence of non-compliance with the shoes to be obtained.
It is less prone to biased estimates than the more commonly used approaches of per-protocol or
‘on-treatment’ analysis, as it preserves the original randomisation. A two-stage instrumental variable
approach was used, with randomised group as the instrumental variable.
The difficulty with this type of analysis is precisely how ‘compliance with the intervention’ is defined
and quantified. This requires identifying a measure of how well a participant followed the intended
elements of the intervention that can be applied to all participants. In this scenario, the intervention
was the offer and provision of the trial slip-resistant footwear within the follow-up period. ‘Compliance’
was therefore defined, initially, in two very simplistic ways in separate compliance analyses, receiving
the trial shoes:
1. during the first 7 weeks of the follow-up period
2. within the 14-week follow-up period.
However, these analyses do not account for how often the shoes were actually worn. A third and more
complex definition of exposure to the trial shoes was therefore defined based on receiving the shoes
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and the responses to the 6-, 10- and 14-week compliance text messages (and response to the
compliance question on the 14-week questionnaire when compliance text responses were missing):
3. A score between 0 and 12 was calculated based on the number of weeks the participant had the
shoes, assigning a score of 0 for each week that, according to the participants, the shoes were worn
‘none of the time’, a score of 0.5 for each week the shoes were worn for ‘some of the time’ and a
score of 1 for each week the shoes were worn ‘all of the time’ (this analysis allows for 2 weeks
immediately after randomisation for participants to receive their shoes).
The CACE analysis was repeated using this continuous ‘compliance score’.
Subgroup analysis
We considered whether or not the intervention effect differed by gender and area of work by
repeating the primary analysis and by including the factor and an interaction term between the factor
and group allocation in the model. Area of work was categorised as areas with higher risk of spillages
or contamination (food preparation areas, clinical rooms/areas, wards, indoor hospital grounds/
corridors, theatres, laboratories) and areas with lower risk (community, pharmacy, office, podiatry).
Secondary analysis
All secondary outcomes and other important collected data (including data from the SDCSs) are
summarised descriptively overall and by trial arm.
The IRR of falls (both resulting and not resulting from a slip) over 14 weeks was analysed in the same
way as described for the primary outcome of slips (not including the exposure option in the model as
the follow-up is time fixed).
The following outcomes were analysed using mixed-effects logistic regression, adjusting for the same
fixed-effect covariates as the primary analysis, with NHS trust as a random effect. The first outcome
was the proportion of participants who slipped at least once over 14 weeks (two separate analyses:
one according to weekly slip text message data or 14-week questionnaire if no text message data were
provided, and one using only 14-week questionnaire data), and the second was the proportion of
participants who fell at least once during the 14 weeks. The number of participants who reported a
fracture was very small and so no formal analyses of this outcome were undertaken (see Chapter 4).
Odds ratios (ORs) and their associated 95% CIs are provided.
Time to first slip and the time to first fall were calculated. Participants who did not report a slip were
treated as censored at their date of trial exit (completion of follow-up or withdrawal). The proportion
of participants yet to experience a slip is summarised by a Kaplan–Meier survival curve for each group.
Time to first slip was analysed using Cox proportional hazards regression with shared centre frailty
and adjusting for the same covariates as in the primary analysis model. Hazard ratios (HRs) and their
associated 95% CIs are provided. The proportional hazards assumption was evaluated using Schoenfeld
residuals. Time to first fall was not analysed via a Cox proportional hazards regression model for two
reasons: (1) relatively few falls were reported and (2) the date of the fall was poorly reported for any
falls that were reported.
Adverse events
Adverse events are summarised descriptively by treatment arm.
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Patient and public involvement in research
The SSHeW trial was informed by the involvement of NHS staff from diverse roles. These included
nurses, health-care assistants, radiographers, physiotherapists, catering staff, and maintenance and
housekeeping staff of different ages (age range 20–71 years) and genders. The study design was
discussed with ward managers at their ward management task and finish group meeting and among
NHS staff. The staff provided feedback about the rationale for the trial, the range of shoe styles to be
offered in the trial, the use of text messages to collect data, the use of a slip diary and the length of
the follow-up period. We had originally planned to follow-up participants for 12 months. However, the
patient and public involvement (PPI) group felt that 12 months was too onerous and that participants
would not provide outcome data for this length of time. We therefore reduced this to 3 months
(12 weeks), but added an additional 2 weeks to allow for the ordering and delivery of shoes. During
the trial, further views on the footwear, footwear buying habits and testing of staff’s usual shoes to
determine slip resistance took place. In total, 30 pairs of shoes were tested.
Changes to the trial protocol
Minor changes to the trial protocol were submitted during the trial. These are listed in Appendix 10.
Study within a trial: pen substudy
To add to the body of evidence relating to making trial processes more efficient, a SWAT33 was
conducted. The aim of this SWAT was to evaluate the effectiveness of enclosing a YTU, University of
York pen with the 14-week postal questionnaire, on the response rates to the questionnaire.
Participants in the SSHeW trial who were to receive their 14-week questionnaire were randomised
using simple randomisation in the ratio of 1 : 1 (receive a pen or not receive a pen). Generation of
the allocation sequence was conducted by the trial statistician, who was not involved with sending
the questionnaires.
The pen substudy was embedded into the trial part-way through recruitment. All participants in the
main trial who were to be sent their 14-week questionnaire between 4 July 2018 and 12 February
2019 were included in this SWAT (unless they had withdrawn from follow-up). Participants in the main
trial who had already been sent their 14-week questionnaire before the SWAT was introduced were
excluded. No pens were included with questionnaires sent after 12 February 2019.
The primary outcome measure for the pen substudy was the proportion of participants in each group
who returned the questionnaire. Secondary outcome measures included length of time taken to
respond to the questionnaire, number of items completed and whether or not a reminder notice to
return the questionnaire was required. As is usual with an embedded trial, no formal power calculation
was undertaken, as the sample size was constrained by the number of participants to be sent the
14-week questionnaire. Binary data were compared using logistic regression, time to response by a
Cox proportional hazards model and number of items completed by a linear regression model. All
models were adjusted for the main trial allocation.
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Chapter 3 Effectiveness results
Pilot phase
The findings from the pilot phase of the trial evaluating the progression criteria are presented in
Table 1. As all of the progression criteria were met, the trial continued seamlessly.
Recruitment
Participants were enrolled into the SSHeW trial from seven NHS trusts in England: (1) Cheshire and
Wirral Partnership NHS Trust (CWP), (2) Leeds Teaching Hospitals NHS Trust, (3) York Teaching
Hospital NHS Foundation Trust, (4) Lancashire Care NHS Foundation Trust, (5) Nottingham University
Hospitals NHS Trust, (6) Harrogate and District NHS Foundation Trust and (7) University Hospitals of
Derby and Burton NHS Foundation Trust. York Teaching Hospital NHS Foundation Trust was split into
two geographical locations. Theses were considered as two distinct populations (Scarborough and
Bridlington areas, and York and Malton areas) and formed eight trial sites. A total of 8524 recruitment
packs were estimated to have been handed out in the eight sites between March 2017 and November
2018 (Figure 2), with follow-up occurring until June 2019. Varying numbers of recruitment packs were
sent to the sites from YTU to be handed out to potential participants, depending on the size of the
site and its capacity. The number of unused packs was reported to the YTU at the end of the trial.
The number of packs handed out was estimated at 8524 by subtracting the number reported unused
from the number originally sent to the site, on the assumption that the rest were distributed (CWP,
n = 2029; Leeds, n = 1686; York, n = 642; Scarborough, n = 775; Lancashire, n = 1251; Nottingham,
n = 1240; Harrogate, n = 401; and Derby, n = 500).
A completed baseline form was received at YTU from 5309 (62.3%) potential participants, of whom
498 (9.4%) were ineligible. Reasons for ineligibility were not mutually exclusive. One of the most
common reasons was not working enough hours, on average, per week. Initially, the inclusion criteria
specified that potential participants had to work, on average, at least 80% WTE (30 hours/week,
TABLE 1 Evaluation of progression criteria from the pilot phase to the main trial
Criterion Evaluation Conclusion
Recruit at least 400 participants in 6 months
(March–September 2017)
714 participants recruited and randomised Fulfilled
80% of the participants will provide a valid
response to at least 50% of the follow-up text
data (i.e. 7 of the 14 weekly post-randomisation
text messages)
335 participants sent all 14 of their post-
randomisation text messages, of whom 302 (90%)
provided a valid response to at least 50% (n= 7)
of messages
Fulfilled
90% of the participants will respond to at least
one post-randomisation text
714 participants sent at least one post-
randomisation text message (minimum five
messages sent), of whom 707 (99%) responded to
at least one message
Fulfilled
The slip rate in the control group will be at
least 7%
Considering the post-randomisation text message
responses from all participants in the control group
(n = 357), regardless of the length of time they had
been in the trial, 137 participants reported at least
one slip (38%, 90% CI 34% to 43%). Across the
168 participants who had completed the trial (i.e. sent
all 14 post-randomisation text messages) 53 (32%)
reported at least one slip (90% CI 26% to 38%)
Fulfilled
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assuming 37.5 working hours/week as full time). When it was observed that this was a predominant
reason for ineligibility, it was, with the agreement of the TSC, DMEC and the funder, decided to lower
this to 60% WTE (22.5 hours/week).
A total of 4811 participants were eligible to be sent the pre-randomisation text messages. Three
participants withdrew before these text messages were started (one participant moved out of the
trust, one participant was discovered to be a duplicate and one participant had an issue with their
mobile telephone number that was never resolved), and 254 participants did not provide a valid
response to at least two text messages. Therefore, 4554 participants were randomised (a slight
increase of 154 participants on the 4400 planned). One participant was discovered to be ineligible
after randomisation and so was immediately withdrawn (their data are not included in summaries of
randomised participants). The flow of participants is illustrated in a CONSORT diagram (see Figure 2).
Pre-randomisation text message response rates
A total of 4808 participants were deemed eligible for the trial and were sent at least one pre-
randomisation text message. Participants could request that the text messages be stopped at any time
and so not all were sent at least four messages. Send and response rates to the initial four text messages
were all > 86% (Table 2). A total of 4605 (95.8%) participants responded to at least one text message.










































Texts received over 14-week period
reporting number of slips
(mean 12.6, SD 3.0)







Texts received over 14-week period
reporting number of slips
(mean 12.3, SD 3.1)
Week 14 final questionnaire
(n =1383, 61%)
Excluded (n = 501)
• Ineligible (n = 458, not mutually exclusive)
    • Not employed by NHS trust, n = 15
    • Aged < 18 years, n = 6
    • Agency staff or on temporary/<6 month contract,
        n = 62
    • Works < 0.6/0.8 WTE, n = 118
    • Does not have a mobile phone or are unwilling/unable
        to receive/send text messages, n = 13
    • Predominantly office based, n = 118
    • Predominantly theatre based, n = 10
    • Wears prescribed orthopaedic footwear or footwear
        provided by employer, n = 46
    • Other, n = 155; unresolved eligibility query, n = 87;
        missing/invalid consent/contact details, n =68
• Withdrew before pre-randomisation text messages
     started, n =3
• Excluded from analysis (reasons n =1,
    missing covariate data)
• Excluded from analysis (n =0)
FIGURE 2 A CONSORT flow diagram of participants in the SSHeW trial. a, n= 1930 (85%) received trial shoes within the
14-week trial follow-up. Reproduced with permission from Cockayne et al.2 This is an Open Access article distributed
in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy,
redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link
to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
The figure includes minor additions and formatting changes to the original figure.
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A total of 260 participants were sent a fifth text (108 replied, 41.5%) and 245 were sent a sixth text
(103 replied, 42.0%). Overall, 87 of 245 (36%) replied to both messages.
All but one of the 4555 participants who replied to at least two pre-randomisation text messages
(either two of the first four messages, or both the fifth and sixth messages) were randomised into the
trial (one participant withdrew prior to randomisation).
Randomisation
Our required sample size was 4400 participants, which we aimed to achieve by the end of April 2018.
However, recruitment was slightly slower than anticipated and we agreed with the trial sponsor, funder
and HRA to extend recruitment to late 2018 to meet the target.
The first participants were randomised on 1 June 2017 and the last on 10 January 2019. Over this
20-month period, 4554 participants were randomised into the trial (2276 to the intervention group
and 2278 to the control group); however, one participant (intervention group) was randomised in error,
so their data have not been used post randomisation. A median of 529 (range 299–1014) participants
were recruited from each site. Figure 3 presents the target compared with actual recruitment.
TABLE 2 Response rates to pre-randomisation text
messages





























































































































































































































FIGURE 3 Target vs. actual participant recruitment.
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Baseline data
Baseline data are presented by randomised group and overall in Tables 3–6. One participant, allocated
to the intervention group, withdrew shortly after they were randomised and requested that all their
data be removed; they are included in the denominators in Tables 3–6, but all their data are missing.









Mean (SD) 42.7 (11.5) 42.7 (11.3) 42.7 (11.4)
Median (minimum, maximum) 44.0 (19.0, 74.0) 44.0 (18.0, 71.0) 44.0 (18.0, 74.0)
Gender, n (%)
Male 325 (14.3) 355 (15.6) 680 (14.9)
Female 1948 (85.6) 1921 (84.3) 3869 (85.0)
Prefer not to say 1 (0.0) 2 (0.1) 3 (0.1)
Missing 1 (0.0) 0 (0.0) 1 (0.0)
BMI (kg/m2)
Mean (SD) 27.0 (5.5) 27.0 (5.2) 27.0 (5.3)
Median (minimum, maximum) 25.9 (14.4, 56.5) 26.3 (16.1, 54.2) 26.1 (14.4, 56.5)
Education after school leaving age, n (%)
Yes 1839 (80.8) 1844 (80.9) 3683 (80.9)
No 421 (18.5) 423 (18.6) 844 (18.5)
Missing 15 (0.7) 11 (0.5) 26 (0.6)
Degree/equivalent professional qualification, n (%)
Yes 1512 (66.5) 1522 (66.8) 3034 (66.6)
No 747 (32.8) 741 (32.5) 1488 (32.7)
Missing 16 (0.7) 15 (0.7) 31 (0.7)
Ethnic group, n (%)
White/white British 2008 (88.3) 1982 (87.0) 3990 (87.6)
Asian/Asian British 154 (6.8) 176 (7.7) 330 (7.2)
Black/black British 84 (3.7) 82 (3.6) 166 (3.6)
Mixed/multiple 24 (1.1) 28 (1.2) 52 (1.1)
Other 2 (0.1) 3 (0.1) 5 (0.1)
Missing 3 (0.1) 7 (0.3) 10 (0.2)
Average number of hours worked per week
Mean (SD) 35.8 (4.3) 35.8 (4.5) 35.8 (4.4)
Median (minimum, maximum) 37.5 (22.5, 63.0) 37.5 (15.0, 62.0) 37.5 (15.0, 63.0)
BMI, body mass index.
Reproduced with permission from Cockayne et al.2 This is an Open Access article distributed in accordance with the
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix,
transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence
is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. The table
includes minor additions and formatting changes to the original table.
EFFECTIVENESS RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
22








Job type, n (%)
Qualified nurse/midwife 952 (41.8) 985 (43.2) 1937 (42.5)
Support worker 286 (12.6) 276 (12.1) 562 (12.3)
Health-care assistant 272 (12.0) 246 (10.8) 518 (11.4)
Other qualified staff/health-care professional 150 (6.6) 163 (7.2) 313 (6.9)
Domestic services 115 (5.1) 110 (4.8) 225 (4.9)
Administrator/receptionist/secretarial 78 (3.4) 100 (4.4) 178 (3.9)
Occupational therapist 65 (2.9) 65 (2.9) 130 (2.9)
Imaging staff 64 (2.8) 53 (2.3) 117 (2.6)
Physiotherapist 68 (3.0) 36 (1.6) 104 (2.3)
Pharmacist/pharmacy technician 50 (2.2) 53 (2.3) 103 (2.3)
Ward clerk 44 (1.9) 49 (2.2) 93 (2.0)
Doctor/consultant 38 (1.7) 42 (1.8) 80 (1.8)
Catering staff 29 (1.3) 38 (1.7) 67 (1.5)
Phlebotomist 13 (0.6) 17 (0.7) 30 (0.7)
Podiatrist 16 (0.7) 9 (0.4) 25 (0.5)
Laboratory staff 7 (0.3) 10 (0.4) 17 (0.4)
Facilities 9 (0.4) 6 (0.3) 15 (0.3)
Social worker 6 (0.3) 4 (0.2) 10 (0.2)
Porter 3 (0.1) 5 (0.2) 8 (0.2)
Other 9 (0.4) 11 (0.5) 20 (0.4)
Missing 1 (0.0) 0 (0.0) 1 (0.0)
Areas worked in, n (%)a
Ward 1261 (55.4) 1199 (52.6) 2460 (54.0)
Clinical room/area 722 (31.7) 755 (33.1) 1477 (32.4)
Community 260 (11.4) 268 (11.8) 528 (11.6)
Indoor hospital grounds/corridors 160 (7.0) 183 (8.0) 343 (7.5)
Office 91 (4.0) 113 (5.0) 204 (4.5)
Food preparation/serving area 77 (3.4) 87 (3.8) 164 (3.6)
Pharmacy 40 (1.8) 49 (2.2) 89 (2.0)
Laboratory 21 (0.9) 47 (2.1) 68 (1.5)
Theatre 9 (0.4) 14 (0.6) 23 (0.5)
Podiatry 10 (0.4) 8 (0.4) 18 (0.4)
Required to work in the community, n (%)
Yes 552 (24.3) 554 (24.3) 1106 (24.3)
No 1688 (74.2) 1689 (74.1) 3377 (74.2)
Missing 35 (1.5) 35 (1.5) 70 (1.5)
continued
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Time spent on feet at work, n (%)
Most of the time 1843 (81.0) 1829 (80.3) 3672 (80.7)
Some of the time 385 (16.9) 400 (17.6) 785 (17.2)
A little of the time 11 (0.5) 18 (0.8) 29 (0.6)
Missing 36 (1.6) 31 (1.4) 67 (1.5)
a Not mutually exclusive.
Reproduced with permission from Cockayne et al.2 This is an Open Access article distributed in accordance with the
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix,
transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence
is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. The table
includes minor additions and formatting changes to the original table.
TABLE 5 Baseline slip and fall data by group allocation, as randomised







Have you had slip at work?, n (%)
Yes 850 (37.4) 885 (38.8) 1735 (38.1)
No 1318 (57.9) 1297 (56.9) 2615 (57.4)
Do not know 101 (4.4) 91 (4.0) 192 (4.2)
Missing 6 (0.3) 5 (0.2) 11 (0.2)
If yes, how many?
Median (minimum, maximum) 2 (1, 400) 2 (1, 300) 2 (1, 400)
Have you suffered injury from any of these slips?, n (%) 96 (11.3) 89 (10.1) 185 (10.7)
Have you had a fall at work?, n (%)
Yes 188 (8.3) 192 (8.4) 380 (8.3)
No 2039 (89.6) 2040 (89.6) 4079 (89.6)
Do not know 29 (1.3) 31 (1.4) 60 (1.3)
Missing 19 (0.8) 15 (0.7) 34 (0.7)
If yes, how many?
Median (minimum, maximum) 1 (1, 52) 1 (1, 20) 1 (1, 52)
Have you suffered injury from any of these falls?, n (%) 69 (36.9) 74 (39.5) 144 (38.2)
How often do you worry about slipping or falling in the workplace?, n (%)
All of the time 57 (2.5) 63 (2.8) 120 (2.6)
Most of the time 149 (6.5) 121 (5.3) 270 (5.9)
Some of the time 734 (32.3) 746 (32.7) 1480 (32.5)
A little of the time 798 (35.1) 818 (35.9) 1616 (35.5)
None of the time 454 (20.0) 461 (20.2) 915 (20.1)
Missing 83 (3.6) 69 (3.0) 152 (3.3)
Reproduced with permission from Cockayne et al.2 This is an Open Access article distributed in accordance with the
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix,
transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is
given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. The table
includes minor additions and formatting changes to the original table.
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The recruited participants were predominantly female (n = 3869, 85.0%) and the average age was 42.7
(range 18–74) years. Participants worked a median of 37.5 hours per week and qualified nurse or
midwife was the most represented job role (n = 1937, 42.5%). One participant who reported working
15 hours per week (less than the required amount) was randomised in error into the trial. Options to
manage this participant were discussed with the TSC and DMEC and it was agreed that this participant
should be retained in the trial and their data included in the analyses (as the impact of this one
participant would be negligible).
Just over one-third of participants reported experiencing a slip at work in the previous 12 months
(median of two slips), of whom 11% had suffered an injury as a result of one of these slips.








How many months do your usual work shoes last before they need replacing?
Median (IQR) 12 (6–12) 12 (6–12) 12 (6–12)
Normally buy your work shoes from, n (%)a
High street store 2113 (92.9) 2091 (91.8) 4204 (92.3)
Online specialist shop/catalogue 194 (8.5) 225 (9.9) 419 (9.2)
Brand of shoe usually worn at work, n (%)a
General high street brand 1893 (83.2) 1888 (82.9) 3781 (83.0)
General sports shop brand 400 (17.6) 402 (17.6) 802 (17.6)
Any/various/depends on cost 15 (0.7) 23 (1.0) 38 (0.8)
Shoes for Crews Ltd 10 (0.4) 13 (0.6) 23 (0.5)
Magnum (Portsmouth, UK) 9 (0.4) 8 (0.4) 17 (0.4)
Other safety/uniform shoe brand 3 (0.1) 7 (0.3) 10 (0.2)
Alexandra (Bristol, UK) 6 (0.3) 3 (0.1) 9 (0.2)
J&M Medical (Sunderland, UK) 3 (0.1) 6 (0.3) 9 (0.2)
Other 39 (1.7) 41 (1.8) 80 (1.8)
Style of shoes normally worn at work, n (%)a
Trainers 671 (29.5) 661 (29.0) 1332 (29.2)
Pumps 357 (15.7) 361 (15.8) 718 (15.8)
Work/safety boots 39 (1.7) 47 (2.1) 86 (1.9)
Clogs 82 (3.6) 100 (4.4) 182 (4.0)
Heeled shoes/boots 90 (4.0) 119 (5.2) 209 (4.6)
Flat shoes/boots 1115 (49.0) 1098 (48.2) 2213 (48.6)
Casual/dress shoe or boot 404 (17.8) 404 (17.7) 808 (17.7)
Other 81 (3.6) 79 (3.5) 160 (3.5)
Does your usual style of shoe have a secure fastening over the top of foot (e.g. laces or velcro strap)? n (%)
Yes 1309 (57.5) 1308 (57.4) 2617 (57.5)
No 932 (41.0) 943 (41.4) 1875 (41.2)
Missing 34 (1.5) 27 (1.2) 61 (1.3)
IQR, interquartile range.
a Not mutually exclusive.
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Via the pre-randomisation slip text messages, a total of 3891 slips were reported (2035 from participants
who were subsequently randomised to the intervention group and 1856 from participants subsequently
randomised to the control group). Both groups provided pre-randomisation text message slip data
for an average of 3.4 (SD 0.8, median 4, range 2–4) weeks. Overall, 1627 (35.3%) participants (of the
4605 participants who responded to at least one text) reported at least one slip in the pre-randomisation
text messages. The average number of reported slips was 0.89 (SD 2.00, median 0, range 0–22) in the
intervention group and 0.81 (SD 1.76, median 0, range 0–26) in the control group. The baseline slip
rate was calculated as the average weekly number of slips: 0.27 (SD 0.59, median 0, range 0–7) in the
intervention group and 0.24 (SD 0.51, median 0, range 0–6.5) in the control group.
The treatment groups, as randomised, appear to be comparable on all measured baseline data.
Post-randomisation text message response rates
Following randomisation, participants were sent up to 14 weekly slip text messages. At any time,
participants could request not to be sent any further messages. Response rates to the post-randomisation
text messages are presented in Table 7 by group allocation. Of the 4553 participants sent at least one
post-randomisation text message, a valid response to at least one message was received from 4494
(98.7%). Participants in the intervention group responded to an average of 12.3 (SD 3.1, median 14) text
messages and participants in the control group to an average of 12.6 (SD 3.0, median 14) text messages.
Withdrawals
There were 35 (0.8%) full, post-randomisation withdrawals [n = 26 (1.1%) from the intervention group,
n = 9 (0.4%) from the control group]. The majority (n = 28) were requested during the 14-week follow-up
period (median of 35 days after randomisation, range 6–93 days). Reasons for these withdrawals included
TABLE 7 Response rates to post-randomisation text messages
Week post randomisation
Intervention group (n= 2275),
n received/N sent (%)
Control group (n= 2278),
n received/N sent (%)
Total (n= 4553),
n received/N sent (%)
1 2109/2275 (92.7) 2112/2278 (92.7) 4221/4553 (92.7)
2 2117/2272 (93.2) 2101/2278 (92.2) 4218/4550 (92.7)
3 2079/2270 (91.6) 2094/2278 (91.9) 4173/4548 (91.8)
4 2052/2269 (90.4) 2075/2276 (91.2) 4127/4545 (90.8)
5 2063/2267 (91.0) 2068/2275 (90.9) 4131/4542 (91.0)
6 2033/2265 (89.8) 2047/2272 (90.1) 4080/4537 (89.9)
7 1967/2265 (86.8) 2055/2271 (90.5) 4022/4536 (88.7)
8 1963/2261 (86.8) 2028/2271 (89.3) 3991/4532 (88.1)
9 1962/2261 (86.8) 2034/2271 (89.6) 3996/4532 (88.2)
10 1936/2259 (85.7) 2012/2271 (88.6) 3948/4530 (87.2)
11 1948/2259 (86.2) 1996/2271 (87.9) 3944/4530 (87.1)
12 1926/2256 (85.4) 1988/2271 (87.5) 3914/4527 (86.5)
13 1921/2255 (85.2) 1996/2271 (87.9) 3917/4526 (86.5)
14 1924/2253 (85.4) 1985/2269 (87.5) 3909/4522 (86.4)
Reproduced with permission from Cockayne et al.2 This is an Open Access article distributed in accordance with the
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participant left the trust or was on long-term absence (e.g. sickness, adoption leave) (n = 15); did not
want to take part, issue with trial shoes (n = 7); unhappy with sizing and/or appearance of shoe (n = 5);
shoes were causing trips and blisters (n = 1); saw colleague trip on carpet in trial shoes and participant
works in similar area and concerned about tripping (n = 1); and unknown reason (n = 6). Seven of the full
withdrawals were requested after the 14-week questionnaire was sent and none of the questionnaires
was returned. Six of these withdrawals were in the intervention group, with four participants reporting
issues with the shoes as a reason for not completing the 14-week questionnaire and choosing to formally
withdraw. Issues reported included being unable to select suitable footwear (n = 1), did not wear shoes
as they did not fit (n = 1), shoes caused trips (n = 1) or shoes were unsuitable after a change in job role
(n = 1). The other two withdrawals did not provide a reason for withdrawing. One further participant
withdrew from postal follow-up 84 days into their participation in the trial (no reason recorded) and so
was not sent a 14-week questionnaire, but continued to receive text messages.
There were two reported deaths [one in each group (0.04%); both deaths were reported after
sending the 14-week questionnaire, which was not returned, and in both cases the date of death
was unknown].
Final (14-week) questionnaire response rates
The first set of 14-week questionnaires was sent out on 7 September 2017. A total of 4524 (99.4%)
questionnaires were sent out [intervention group, 2254/2275 (99.1%); control group, 2270/2278
(99.7%)], of which 2839 [62.8%; intervention group, 1383/2254 (61.4%); control group, 1456/2270
(64.1%)] were returned. Overall, a questionnaire was received from a slightly higher proportion of
randomised participants in the control group (63.9%) than the intervention group (60.8%). The median
time between the questionnaire being sent and completed was 6 days in the control group (range
1–140 days) and 7 days in the intervention group (range 1–146 days).
Primary outcome
Raw data
In total, 4494 (98.7%) trial participants provided a valid response to at least one slip text message
following randomisation [intervention group, n = 2254 (99.1%); control group, n = 2240 (98.3%)], with
2689 (59.1%) participants returning a complete 14 weeks’ worth of responses [intervention group,
n = 1289 (56.7%); control group, n = 1400 (61.5%)].
Of the 59 participants who did not provide a response to at least one post-randomisation text
message, 11 provided data for number of slips experienced on the 14-week questionnaire. These
data were used for these participants in the analysis and therefore post-randomisation slip data
were available for 4505 randomised participants [98.9%; intervention group, n = 2258 (99.3%);
control group, n = 2247 (98.6%)]. In total, 6743 slips were reported: 2633 slips in the intervention
group (mean of 1.17 per participant, SD 3.0, median 0, range 0–36) and 4110 in the control group
(mean of 1.83 per participant, SD 4.7, median 0, range 0–83) (Figure 4).
For the analysis, participants who did not provide any follow-up slip data were ‘censored’ immediately
following randomisation (i.e. they were recorded as having reported zero slips over a minimal follow-up
time of 0.1 hours). Therefore, all randomised participants were accounted for in the primary analysis
model except those missing relevant covariate data (summary statistics for slips per group in the
analysis: intervention group – mean of 1.16 per participant, SD 2.9, median 0, range 0–36; control
group – mean of 1.80 per participant, SD 4.6, median 0, range 0–83).
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Covariates
The primary analysis model controlled for gender, age at randomisation, job role and baseline weekly
slip rate ascertained from the pre-randomisation text message responses. Covariate data were missing
for one participant and so the primary model was based on 4552 participants (2274 participants in the
intervention group and 2278 participants in the control group).
Slip data collection sheet: response rates and data
Slip data collection sheets were sent for the first slip reported via a post-randomisation slip text
message. In total, 1821 (40.0%) participants reported at least one slip post randomisation via text
message [intervention group, n = 803 (35.3%); control group, n = 1018 (44.7%)]. A slip data collection
form was received for 1159 (63.6%) of those participants [intervention group, n = 497 (61.9%); control
group, n = 662 (65.0%)]. Participants predominantly reported slips without falling (n = 1033, 89.1%)
and participants in the intervention group tended not to be wearing the trial shoes when they slipped
(n = 363, 73.0%) (Table 8). Nearly all slips occurred on a ward or other clinical area and most were on a
smooth surface. The vast majority of slips did not result in an injury (95.1%, assuming that missing data
implies no injury).
Primary analysis
In total, the intervention group contributed 28,002 person-working weeks of slip data and the
control group contributed 28,595 person-working weeks of slip data. The incidence rates of slips per
person-working week were approximately 0.10 (95% CI 0.09 to 0.11) in the intervention group and 0.15
(95% CI 0.14 to 0.17) in the control group. The median working week was 37.5 hours; however, at baseline
participants reported working up to 63 hours per week. Poisson regression is a common method used to
analyse count data; however, it is limited in that it assumes that the mean and variance of the data are equal
(i.e. that the data are not overdispersed). Negative binomial regression is the recommended alternative in
such cases, as it does not share this assumption and so allows for overdispersion. The variance for
number of slips per person over the 14-week follow-up period was larger than the mean, which gave
an indication that the data were overdispersed. Therefore, a mixed-effect negative binomial model was
run within which, in Stata, a likelihood ratio test of the overdispersion parameter (alpha) is conducted.


































FIGURE 4 Histogram displaying the distribution of the number of reported slips, by randomised group (participants with
at least 1 week of slip text message data). (a) Intervention; and (b) control.
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A significant p-value for the likelihood ratio test indicated that the data were overdispersed and therefore
that Poisson regression was not appropriate. Additionally, a key assumption of Poisson regression is that
the counts are of independent events; however, it is reasonable to assume that slips in this population are
not independent, as a person who slips once is more likely to slip again. Negative binomial regression
allows for this lack of independence.








Hours worked in week of first slip
Mean (SD) 35.7 (7.8) 35.6 (7.0) 35.6 (7.4)
Median (minimum, maximum) 37.5 (3.5, 75.0) 37.5 (5.0, 75.0) 37.5 (3.5, 75.0)
Type of slip, n (%)
Slip without falling (however minor) 437 (87.9) 596 (90.0) 1033 (89.1)
Slip and fall 12 (2.4) 23 (3.5) 35 (3.0)
Missing 48 (9.7) 43 (6.5) 91 (7.9)
Wearing trial shoes when slipped, n (%)
Yes 82 (16.5)
No 363 (73.0)
Do not know 3 (0.6)
Missing 49 (9.9)
Location of slip, n (%)
On a ward or other clinical area in a hospital 479 (96.4) 644 (97.3) 1123 (96.9)
In a non-clinical area in a hospital (e.g. office, corridor) 5 (1.0) 3 (0.5) 8 (0.7)
In an catering area where food is prepared or served 1 (0.2) 0 (0.0) 1 (0.1)
Outside 4 (0.8) 6 (0.9) 10 (0.9)
Inside a patient’s home 1 (0.2) 0 (0.0) 1 (0.1)
Other 7 (1.4) 9 (1.4) 16 (1.4)
Missing 0 (0.0) 0 (0.0) 0 (0.0)
Slipped on . . . , n (%)
Smooth surface 341 (68.6) 532 (80.4) 873 (75.3)
Textured surface 92 (18.5) 77 (11.6) 169 (14.6)
Missing 64 (12.9) 53 (8.0) 117 (10.1)
Injuries suffered, n (%)a
None 419 (84.3) 582 (87.9) 1001 (86.4)
Superficial wound 12 (2.4) 17 (2.6) 29 (2.5)
Broken bone 0 (0.0) 0 (0.0) 0 (0.0)
Pulled muscle/sprained ligament 10 (2.0) 12 (1.8) 22 (1.9)
Other 5 (1.0) 3 (0.5) 8 (0.7)
Missing 52 (10.5) 49 (7.4) 101 (8.7)
a Not mutually exclusive.
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The adjusted negative binomial model indicated a statistically significant reduction in the slip rate in
the intervention group relative to the control group (IRR 0.63, 95% CI 0.57 to 0.70; p < 0.001). Pre-
randomisation slip rate was seen to be a significant predictor in the model, such that a higher baseline
slip rate was associated with an increased post-randomisation slip rate (IRR 5.73, 95% CI 5.05 to 6.50;
p < 0.001). Females also had a higher post-randomisation slip rate than males (IRR 1.23, 95% CI 1.05 to
1.43; p = 0.01). Age and job role were not statistically significant factors in the model.
Sensitivity analysis
Receipt of shoes
The 14-week questionnaire asked participants allocated to the intervention group if, and when,
they received their trial shoes. Of the 1383 intervention participants who returned a 14-week
questionnaire, 1320 (95.4%) reported having received a pair of trial shoes, 62 said that they had not
received their trial shoes (4.5%) and one did not provide a response (0.1%). Of the 1320 participants
who reported having received a pair of trial shoes, 960 (72.7%) provided a date for when they received
the shoes. Unfortunately, perhaps owing to recall difficulties or recording errors on the part of the
participant, some of the dates provided were invalid (before randomisation or after the date that the
14-week questionnaire was completed), or were inconsistent with responses to the week 6, 10 and
14 compliance text messages.
Sites were also asked to supply the date that they provided the participant with their trial shoes.
A date from the site was provided for 1414 intervention participants (62.2%). In five of the sites,
virtually all their intervention participants were accounted for in these data (Leeds, York, Scarborough,
Nottingham and Harrogate). The majority of the participants were accounted for in Lancashire, but
limited data were provided by CWP and no data were provided by Derby.
The participant-reported date was considered primarily, but this was replaced with the date provided
by the site when the participant-reported date was missing or invalid. This resulted in a date for 1718
(75.5%) intervention participants (mean 33.4, SD 29.3, median 24, range 1–239 days from randomisation).
For the remaining participants, some post hoc data decisions were made to estimate the time between
randomisation and receipt of shoes based on responses to the compliance text messages, when
provided. A time of 42, 70 and 98 days was imputed when the participant indicated that they wore the
shoes some or all of the time in response to the week 6, 10 and 14 compliance messages, respectively.
Following this imputation, there remained 34 participants who had reported receiving a pair of trial
shoes on their 14-week questionnaire but for whom period from randomisation to receipt of shoes was
missing; in these cases a value of 24 days (the median time) was assigned. This left 273 intervention
participants whom we cannot be sure received a pair of intervention shoes; we conservatively assume
that they did not. (Certainly, 48 participants indicated on the 14-week questionnaire that they had not
received a pair by the time they completed the questionnaire.) Therefore, we estimate that 2002
(88.0%) intervention participants received a pair of trial shoes within an average of 36 (SD 29, median 27,
range 1–239) days of randomisation, 1523 (66.9%) intervention participants received a pair of trial
shoes within 7 weeks of randomisation and 1930 (84.8%) intervention participants received a pair of
trial shoes within 14 weeks.
Compliance text messages
Text messages were sent to participants in the intervention group 6, 10 and 14 weeks after
randomisation, asking the following question:
SSHeW trial. In the past month, how often have you worn your trial shoes at work? Reply 0, 1 or 2
(0 = none of the time, 1 = some of the time, 2 = all of the time).
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On occasion, participants responded to tell us that they had not yet received their shoes or that they
had been on leave or off sick during the time we asked them about; these responses were not
considered valid. Valid responses are summarised in Table 9. At 14 weeks, 79% of the intervention
participants who were sent a compliance text provided a valid response. Of these, just under half
reported that they were wearing the trial shoes all of the time, just under one-quarter some of the
time and just over one-quarter none of the time.
On the 14-week questionnaire, intervention participants were asked how often they had typically worn
the trial shoes while at work over the previous 14 weeks. Just over half (n = 704, 55.0%) responded
‘all of the time’, 258 (20.2%) responded ‘most of the time’, 168 (13.1%) responded ‘some of the time’,
106 (8.3%) responded ‘a little of the time’ and 44 (3.4%) responded ‘none of the time’.
Complier-average causal effect analysis
The CACE estimate for receiving a pair of shoes within 7 weeks was similar to the intention-to-treat
estimate (IRR 0.65, 95% CI 0.58 to 0.73; p < 0.001). The CACE estimate for receiving a pair of shoes
within 14 weeks was virtually identical to the 7-week estimate (IRR 0.65, 95% CI 0.59 to 0.73; p < 0.001).
When a continuous measure of exposure to the footwear was used, which considered the timing of the
receipt of shoes and the amount of time they were reported to have been worn, participants in the
intervention group had an average overall ‘compliance score’ of 5.2 (SD 4.4, median 5.1, range 0–12).
A higher score indicates greater compliance. Participants in the control group all had a score of zero.
Among those participants in the intervention group whom we estimate received a pair of trial shoes
within 14 weeks from randomisation, the average compliance score was 6.1 (SD 4.1, median 6, range 0–12),
indicating that some participants reported that they did not wear the shoes at all. The CACE estimate for
this analysis was an adjusted IRR of 0.95 (95% CI 0.94 to 0.97; p< 0.001). This indicates that, for every unit
increase in compliance score, the rate of slipping was reduced by approximately 5%.
As data on the dates that participants received their shoes were limited and untidy, the reliability of
these analyses is likely compromised and the results should be interpreted with due caution.
Subgroup analyses
Gender
When an interaction between gender (male/female) and treatment allocation was included in the
primary model, a weak effect of the interaction was observed (female IRR 1.09, 95% CI 0.89 to 1.33,
p = 0.41; intervention IRR 0.49, 95% CI 0.37 to 0.65, p < 0.001; interaction IRR 1.33, 95% CI 0.98 to
1.82, p = 0.07). Post hoc exploratory analysis of the intervention effect in males and females separately
indicates a greater effect of the intervention in males (males IRR 0.49, 95% CI 0.36 to 0.66, vs. females
IRR 0.65, 95% CI 0.58 to 0.73).
TABLE 9 Response to compliance text messages sent to the intervention group
Week n valid received/N sent (%)
Frequency of wear
All of the time, n (%) Some of the time, n (%) None of the time, n (%)
6 1451/2173 (66.8) 623 (42.9) 386 (26.6) 442 (30.5)
10 1621/2166 (74.8) 815 (50.3) 369 (22.8) 437 (27.0)
14 1694/2159 (78.5) 830 (49.0) 397 (23.4) 467 (27.6)
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Area of work
When an interaction between work area (low/high risk of contamination) and treatment allocation was
included in the primary model, a weak effect of the interaction was observed (high-risk work area IRR
1.16, 95% CI 0.92 to 1.46, p = 0.20; intervention IRR 0.81, 95% CI 0.60 to 1.10, p = 0.17; interaction
IRR 0.75, 95% CI 0.55 to 1.04, p = 0.08). Separate post hoc exploratory analysis of the intervention
effect in participants working in high-risk areas compared with low-risk areas indicates a greater effect
of the intervention in high-risk areas (high-risk area IRR 0.61, 95% CI 0.54 to 0.68, vs. low-risk area
IRR 0.80, 95% CI 0.61 to 1.06).
Secondary outcomes
Slips in the workplace over 14 weeks as reported on the 14-week questionnaire
In total, 2793 participants provided data to the question on the 14-week questionnaire asking how
many times they slipped (with or without falling) while at work in the past 14 weeks. The number
of participants who reported at least one slip was 336 of 1360 (24.7%) in the intervention group,
compared with 549 of 1433 (38.3%) in the control group. One participant in the control group
reported experiencing 650 slips; this appeared to be the number written on the paper questionnaire
but it was not possible to confirm this figure with the participant. As this was such a significant outlier
from the next largest number of slips (n = 92), the analysis was performed with and without this
participant. All 2793 participants had full covariate data and so were included in the analysis models.
Including outlier
The mean number of reported slips was 0.79 in the intervention group (SD 2.5, median 0, range 0–32)
and 2.06 in the control group (SD 17.9, median 0, range 0–650). There was a statistically significant
difference in the rate of slips between the two groups (adjusted IRR 0.44, 95% CI 0.37 to 0.53; p < 0.001).
Excluding outlier
The mean number of reported slips was 0.79 in the intervention group (SD 2.5, median 0, range 0–32)
and 1.61 in the control group (SD 5.3, median 0, range 0–92). There was a statistically significant
difference in the rate of slips between the two groups (adjusted IRR 0.56, 95% CI 0.48 to 0.66; p < 0.001).
Falls resulting from a slip in the workplace over 14 weeks (14-week questionnaire)
Of the 885 participants who reported having at least one slip at work in the past 14 weeks on the
14-week questionnaire, all but nine (1.0%) provided a valid response to the follow-on question asking
how many of these slips resulted in a fall. The number of participants who said that at least one of
their workplace slips resulted in a fall was lower in the intervention group (19 of 332; 5.7%) than in
the control group (38 of 544; 7.0%) but the difference was not statistically significant (IRR 0.72, 95% CI
0.40 to 1.29; p = 0.27). After imputing zero falls (from a slip) for those participants who reported zero
slips, participants in the intervention group reported marginally fewer falls resulting from a slip over
the 14-week follow-up period [mean 0.02 (SD 0.22)] than participants in the control group [mean 0.03
(SD 0.23)]. This difference was statistically significant (IRR 0.51, 95% CI 0.28 to 0.92; p = 0.03).
Falls not resulting from a slip in the workplace over 14 weeks (14-week questionnaire)
In total, 2681 participants provided data in response to the question on the 14-week questionnaire
asking how many times they fell at work for reasons other than a slip in the past 14 weeks. In the
intervention group, 61 of 1302 (4.7%) participants reported at least one fall, compared with 75 of
1379 (5.4%) participants in the control group. The mean number of reported falls not resulting from a
slip was 0.13 in the intervention group (SD 0.9, median 0, range 0–18) and 0.22 in the control group
(SD 2.1, median 0, range 0–48). There was no evidence of a difference in this fall rate between the two
groups from the adjusted analysis (IRR 0.82, 95% CI 0.50 to 1.34; p = 0.44).
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Proportion of participants who report a slip over 14 weeks (weekly slip text or
14-week questionnaire)
Of the 4505 participants who provided slip data via at least one post-randomisation weekly text
message or the 14-week questionnaire, 1824 (40.5%) reported at least one slip [intervention group,
804/2258 (35.6%); control group, 1020/2247 (45.4%)]. The adjusted OR for the intervention was
0.58 (95% CI 0.50 to 0.66; p < 0.001).
Proportion of participants who report a slip over 14 weeks (14-week questionnaire)
In total, 2793 participants provided data in response to the question on the 14-week questionnaire
asking how many times they slipped (with or without falling) while at work in the past 14 weeks:
336 of 1360 (24.7%) participants in the intervention group and 549 of 1433 (38.3%) participants in
the control group reported at least one slip (OR 0.45, 95% CI 0.38 to 0.54; p < 0.001).
Proportion of participants who report a fall (whether or not resulting from a slip) over
14 weeks (14-week questionnaire and slip data collection sheet)
Overall, 2824 participants provided a response to one of the questions on the 14-week questionnaire
asking how many falls (related to a slip or other reason) they had experienced at work in the past
14 weeks, of whom 181 reported at least one fall [6.4%; intervention group, 77/1297 (5.6%); control
group, 104/1346 (7.2%)]. A further six participants reported a slip that resulted in a fall on a SDCS
(three in each group). There was a statistically significant difference in overall likelihood of falling in the
two groups (adjusted OR 0.73, 95% CI 0.54 to 0.99; p = 0.04).
Time to first slip
Figure 5 presents the Kaplan–Meier survival curves for time to first slip for the two groups. The two
lines appear to follow one another reasonably closely until about 2 or 3 weeks, when they start to
diverge. At this point, about one-quarter of participants in each group have had an event. Indeed, the
time for one-quarter of participants to report a slip following randomisation was 18 (95% CI 13 to 19)
days in the control group and 20 (95% CI 18 to 25) days in the intervention group. The time for one-third
of participants to report a slip following randomisation was 27 (95% CI 25 to 32) days in the control
group and 46 (95% CI 34 to 60) days in the intervention group. The intervention group was found to
























FIGURE 5 Kaplan–Meier survival plot for time to first slip, by randomised group.
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Time to first fall
Of the 187 participants who reported at least one fall, a valid date for the fall was provided for 118
(63.1%). The falls were reported a median of 34 days after randomisation in the intervention group
(n = 53, range 0–98 days) and 41 days after randomisation in the control group (n = 65, range 1–97 days).
As there were relatively few falls with a valid date, no formal time-to-event analyses were conducted.
Adverse events
Serious adverse events
No related serious AEs were reported. During the course of the trial, the research team was notified
of two deaths. Limited information was available about these deaths, but it could be ascertained that
neither was related to the intervention. One participant was in the control group. This participant had
responded to all 14 post-randomisation text messages, but not the 14-week questionnaire; we were
informed of this death shortly after the 14-week questionnaire was sent. The other participant was in
the intervention group. This participant did not respond to any of the weekly post-randomisation text
messages or the 14-week questionnaire, and did not collect their shoes. We were informed of this
death after the 14-week questionnaire was sent to the participant, but their date of death is unknown.
Non-serious adverse events
Eleven non-serious AEs that were deemed to be at least possibly related to any of the research
procedures are summarised in Table 10. These were all in the intervention group. Events were
recorded on an AE form if they were reported to the research team through the course of the
TABLE 10 Non-serious AEs
Non-serious AE Intervention group (N= 2275)
Total number of non-serious AEs 11
Number of participants with one or more non-serious AEs, n (%)a 11 (0.5)
Action, n (%)b
None 7 (63.6)
Study treatment interrupted/halted 3 (27.3)
Therapy prescribed 1 (9.1)
Outcome, n (%)b
Resolved 4 (36.4)
Resolved with sequelae 1 (9.1)
Ongoing 6 (54.5)







a Percentage of all randomised intervention participants.
b Percentage of events (n = 11).
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trial (e.g. in response to a slip or compliance text, or on a SDCS). We found that a few participants
were reporting very minor problems from wearing the shoes (e.g. blisters); however, these were
somewhat expected with new shoes and, therefore, with the agreement of the TSC and DMEC, these
were not reported as AEs. Instead, we added some items to the 14-week questionnaire to ask about
experiences of wearing the trial shoes (see Blisters, calluses and other problems caused by shoes).
The non-serious AEs recorded on an AE form were pain in hip after wearing trial shoes; shoes caused
blisters, redness and/or burning of toes; bony lump at base of big toe corresponding to area where the
shoe felt tight; worsening of plantar fasciitis; pain in heels after wearing trial shoes; foot pain after
wearing trial shoes; loss of toenail from big toe perhaps due to pressure of the shoes; infection and
athlete’s foot; slipped on icy flags causing bruising to forearm and lacerations; fell and bruised nose,
face, arms and leg; and fell and hurt knee.
Blisters, calluses and other problems caused by shoes
In the initial stages of the trial, a question was included on the 14-week questionnaire which asked
intervention participants if their trial shoes had caused blisters, calluses or any other foot problems.
Forty-four (20.1%) participants reported that they had experienced an issue of this nature. All 44 of
these participants reported on the 14-week questionnaire that they had received their shoes.
From February 2018, new versions of the 14-week questionnaire were sent to participants. The new
version of the questionnaire aimed to collect further information on problems caused by their footwear.
Questions were added to the version sent to intervention participants which asked whether or not they
had experienced problems and, if so, if (1) they sought treatment for them and (2) they had resolved.
Control participants were also asked these questions in relation to their experience of wearing their
usual work shoes. Responses to these questions can be found in Table 11. The proportion of participants
in the intervention group reporting having experienced a problem with their trial shoes (19.5%) was
similar to the proportion of participants in the control group reporting having experienced a problem
with their usual work footwear (17.8%). More participants in the control group sought treatment for
the problem (control group 14.8% vs. intervention group 8.8%); however, participants in the intervention
group were more likely to report that the problem had resolved (intervention group 78.4% vs. control
group 51.6%).
SSHeW trial footwear testing
Intervention footwear testing
A total of 52 pairs of footwear were recovered, and these were reported to have been worn either all
of the time or most of the time, over periods ranging from 6 to 18 months. However, it later transpired
during a telephone interview that one recovered pair had seldom been worn and so this pair was
subsequently excluded from the assessment. Of the 51 remaining pairs, 23 pairs were recovered from
TABLE 11 Problems caused by trial shoes (intervention participants) or usual work shoes (control participants),








Experienced blisters/callouses/other problems, n (%) 227 (19.5)a 217 (17.8) 444 (18.6)
If yes . . . , n (%)
Treatment sought? 20 (8.8) 32 (14.8) 52 (11.7)
Problems resolved? 178 (78.4) 112 (51.6) 290 (65.3)
a All but nine participants reported on the 14-week questionnaire that they had received their shoes.
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nurse or midwifes, six pairs from support workers, five pairs from health-care assistants, four pairs
from physiotherapists, three pairs from occupational therapists, two pairs from doctors and one pair
from each of the following roles: mental health practitioner, health visitor, administrator, radiographer,
caterer, researcher and fitness instructor. One further pair of shoes was recovered from a participant
whose role could not be determined. A summary of the findings from our assessment of the remaining
51 pairs of recovered footwear is presented in Table 12.
As shown in Table 12, the external appearance of the footwear uppers was considered to be
reasonable or good in most cases (n = 47, 92%). However, four pairs of footwear (8%) had uppers that
were considered to have a poor external appearance: one pair in the 7–9-months group and three
pairs in the 18 months group. Defects were noted on 24 pairs of footwear (47%). In the majority of
cases, these defects related to the internal lining of the footwear, which tended to be minor and were
not considered to render the footwear unusable, provided they did not lead to discomfort. Six pairs of
footwear (12%) were considered to be unusable because of the extent of damage to the internal lining
and/or the presence of other defects: one pair had been worn for 9 months, two pairs had been worn
for 12 months and three pairs had been worn for 18 months.
Damage to the internal lining did not appear to be related to a specific style and appeared to be
influenced by the user as well as the period of wear. For example, the most extensive wear was found
on footwear that had been submitted with its laces tied, which suggested that the user had been
treating them as slip-ons. The extent of wear on the soles also varied from user to user and was
concentrated in different areas of the sole. As expected, the soles of footwear that had been worn for
longer periods (> 12 months) tended to have the greatest level of wear; however, only five pairs of
footwear (10%) had tread depths below the manufacturer’s recommendations (across > 5% of the
sole’s area). Furthermore, the results of our testing showed that most of the worn footwear provided
similar slip resistance to when it was new, with only five pairs (10%) generating lower results.
However, it is important to bear in mind that individual users would vary in the way that they initially
load weight on the shoe and how their foot subsequently functions in the shoe with each step. This
may also vary between the left and right side, depending on overall mechanical factors and their
walking pattern. This would result in specific areas of wear for the user, and our test, as well as all
other known laboratory tests, cannot replicate an individual’s foot placement and concentrate forces in
the same way that a user would. The results are therefore likely to suggest better slip resistance than
the user might experience in reality.
Determining a serviceable duration for footwear is very difficult, and our analysis shows that it
will vary from one individual to another and is also likely to vary between roles and workplace
environments. Consideration was given to using a PPI exercise to obtain the views of NHS staff
regarding the recovered footwear; however, this was ruled out because of concerns relating to































6 7 4 7 (100) 2 (29) 0, 1 7 (100) 7 (100)
7–9 21 8 20 (95) 6 (29) 0, 13 20 (91) 20 (95)
10–12 13 5 13 (100) 9 (69) 0, 6 13 (100) 11 (85)
18 10 6 7 (70) 7 (70) 0, 17 6 (60) 7 (70)
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infection control. Judgements on condition and usability were therefore based on the subjective opinion
of our research team member and a lay colleague. However, it was also self-evident that the NHS staff
from whom we recovered the footwear considered them to be usable up to the point of submission.
Only one pair of footwear with a wear period of < 12 months was considered to be unusable, although
a further two pairs in the 12-month group demonstrated a reduction in slip resistance from when they
were new and so their usability would need to be determined via a risk assessment. In contrast, there
were five pairs of footwear that had been worn for approximately 18 months that were considered
usable and demonstrated no reduction in slip resistance. On the basis of our assessments, we consider
it is reasonable to expect a typical serviceable duration for the footwear to be 12 months, but
acknowledge that some footwear would need to be replaced sooner and some would last longer.
Usual footwear testing
In total, 31 pairs of usual work footwear worn by NHS staff were provided for assessment of slip
resistance, of which 29 pairs were suitable for testing. (Two pairs were unable to be tested: one was
actually the intervention footwear and the other pair could not be fitted securely to the simulated slip
test rig.) The results of the testing are reported in Table 13. The average GRIP rating was found to be
one star, with a significant proportion of the footwear (28%) failing to meet the minimum requirements
to achieve a one-star rating.
TABLE 13 Assessment of staff’s usual footwear by grip rating
GRIP star
rating (n) Role (n) Gender (n) Footwear brand (n) Condition (n)
0 (8) Domestic (4) Female (5) High street brand (2) Heavily worn (3)
Clinical (2) Male (3) Skechers (Manhattan Beach, CA, USA) (2) Worn (2)
Porter (1) Adidas (Herzogenaurach, Germany) (1) Reasonable (1)
IT (1) Asda (Leeds, UK) (1) Good (2)
Clarks (Somerset, UK) (1)
Nike (Beaverton, OR, USA) (1)
1 (10) Clinical (5) Female (6) Clarks (3) Worn (1)
Domestic (2) Male (4) High street brand (3) Reasonable (1)
Administration (1) Skechers (1) Good (8)
Chaplin (1) Adidas (1)
Driver (1) Nike (1)
Timberland (Stratham, NH, USA) (1)
2 (8) Domestic (2) Male (5) Clarks (2) Worn (4)
Clinical (2) Female (3) Dr. Martens (Wollaston, UK) (1) Reasonable (1)
Driver (2) High street brand (1) Good (3)
Chaplin (1) Karrimor (Shirebrook, UK) (1)
Facilities (1) Regatta (Manchester, UK) (1)
Tesco (Welwyn Garden City, UK) (1)
Timberland (1)
≥ 3 (3) Domestic (2) Female (3) Asda (1) Good (3)
Clinical (1) Ecco (Bredebro, Denmark) (1)
Hotter (Skelmersdale, UK) (1)
IT, information technology.
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Study within a trial: pen substudy results
A total of 1453 participants were included in this substudy: 725 participants were allocated to the
control group (no pen) and 728 participants to the intervention group, who were sent a pen with their
14-week questionnaire.
Questionnaire response rates
The total number of SWAT participants who returned their 14-week questionnaire was 962 (66.2%).
There was no evidence of a difference in return rate between the groups [pen, 493/728 (67.7%);
no pen, 469/725 (64.7%); OR 1.15, 95% CI 0.92 to 1.43; p = 0.22].
Time to response
The median time to return the 14-week questionnaire (among 962 returned) was 16 [interquartile
range (IQR) 9–35] days overall: 18 (IQR 9–37) days in the no pen group and 15 (IQR 9–33) days in the
pen group. There was weak evidence of a difference in the time to response between the two groups
(HR 1.12, 95% CI 0.98 to 1.27; p = 0.09).
Completeness of responses
Rounded to one decimal place, the mean number of completed items (out of five) was the same in both
groups, at 4.9 (SD 0.4). There was no evidence of a difference in the number of completed items
between the two groups (adjusted mean difference –0.01, 95% CI –0.06 to 0.05; p = 0.77).
Reminders sent
Of the 1453 participants in this SWAT, 708 (48.7%) were sent a reminder [pen group, 339/728
(46.6%); no pen group, 369/725 (50.9%)]. There was weak evidence of a difference in the proportion
of participants requiring a reminder between those who received a pen with their original 14-week
questionnaire and those who did not receive a pen (OR 0.83, 95% CI 0.68 to 1.02; p = 0.08).
Discussion
This substudy evaluated the effectiveness of including a pen to improve response rates of NHS staff to
a postal questionnaire within the SSHeW trial. The key finding from this study was that including a pen
did not improve response rates to a postal questionnaire in this population, although there was weak
evidence that the time to response and number of reminders required were reduced.
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Chapter 4 Economic evaluation
Introduction
As stated in the Scientific summary and Chapter 1, the primary objective of this research was to assess
whether or not the offer of slip-resistant footwear to NHS staff would lead to a reduction in the
incidence rate of self-reported slips over 14 weeks. A secondary objective was to assess whether or
not the provision of the footwear would be cost-effective.
To address this, an economic evaluation was conducted alongside the SSHeW trial. The aim of this
economic analysis was to help decision-making in determining whether or not the intervention represents
a cost-effective means of mitigating the risk of slips among health-care workers in the UK NHS.
Methods
Overview
Individual participant data collected from the SSHeW trial and a wide range of secondary data were
used to perform a within-trial economic analysis that comprised (1) a cost–utility analysis, in terms of
the incremental cost per quality-adjusted life-year (QALY); and (2) cost-effectiveness analyses (CEAs),
in terms of the incremental cost per averted slip (i.e. using the primary effectiveness outcome of the
trial) and cost per averted injury. Costs are presented in GBP at 2018 prices and the analysis was
undertaken in Microsoft Excel® 2016 (Microsoft Corporation, Redmond, WA, USA).
Base-case analysis
Overview of approach
The primary outcome measure for the economic evaluation base case is injuries due to slips, as slips
that do not result in injury are unlikely to lead to material economic costs. The rarity of injurious
events among SSHeW trial participants means that data collected from the trial are likely to be
insufficient to enable us to directly infer a relationship between slips and injuries. Therefore, we have
modelled the impact of slip-resistant footwear on slip-related injuries.
To model the effect on injuries due to the intervention, it was necessary to determine (1) the
appropriate baseline injury rate (see Determining the baseline injury rate) and (2) the estimated reduction
in injuries attributable to the intervention footwear (see Determining effectiveness in reducing injuries).
Determining the baseline injury rate
Three different baseline measures were considered:
1. an injury rate derived from Labour Force Survey (LFS) data for injuries due to STFL for the relevant
occupation and industry classifications
2. an injury rate derived from responses to a question on the SSHeW trial baseline questionnaire,
which asked participants if they had suffered an injury in the past 12 months due to a slip at work
3. the observed injury rate in the SSHeW trial control group.
The LFS was initially the preferred source of injury rate data in this population, given it is a high-
quality, nationally representative survey used to derive official statistics, and is the HSE’s preferred
data source for workplace injuries.34 LFS data are self-reported: members of sampled households are
asked questions covering many topics, including whether or not they have had an injury at work in the
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past 12 months, and the nature of the injury. The HSE LFS team derived an injury rate of 0.45 (95% CI
0.33 to 0.58) per 100 workers for STFL for Standard Industry Code 86101 (‘Hospital Activities’),
averaged across years 2011/12–2017/18.
The injury rate differs markedly from that reported in the SSHeW trial baseline questionnaire (4.2/100
workers), which also asked about injuries due to slips at work over the past 12 months (see Baseline injuries).
Comparison of the LFS and trial baseline data suggests that individuals were more likely to report less
severe injuries in the trial than in the LFS. Although the reason for this cannot be determined from the
data, it is possible that trial participants answering the baseline questionnaire were primed to recall and
report all injuries, including very minor incidents, as a consequence of participating in a trial focused
on slips alone. By contrast, the LFS is a large survey covering many aspects of household employment
circumstances, which may not elicit the same level of recall and reporting regarding injuries.
Given the large difference from the observed trial data (both the baseline questionnaire and follow-up
reporting), the LFS injury rate was not considered suitable for application in the analysis. Therefore, the
primary baseline for the analysis is the rate derived from the trial baseline questionnaire, for which we
had > 4000 responses. The injury rate observed in the trial control group is used as an alternative
baseline measure.
Determining effectiveness in reducing injuries
The base case applies the primary estimate of the effectiveness of the trial intervention, as determined
by the adjusted negative binomial model applied in the statistical analysis, which implies a reduction
in slip rate of around 37% (central estimate). This assumes that the reduction in the injury rate is
the same as the reduction in the slip rate. The effect of alternative levels of injury reduction on
cost-effectiveness is tested in sensitivity analysis.
Estimating unit costs per injury avoided and total avoided costs
Given the expected small number of injuries, data on the outcomes of slips (work absence, health-care
use, etc.) were likely to be limited, which meant that comparisons between the control and intervention
groups were subject to a high degree of random variability. We therefore pooled data across both groups
to derive a mean unit treatment cost across all injuries. Results based on the difference in mean outcomes
between treatment groups are reported in sensitivity analysis.
Mean unit costs per injury were estimated by aggregating the outcome data by each cost component,
set out in Costing framework, across the control and intervention groups, then dividing by the total
number of injuries observed in the trial, presented in Trial injury data. Outcome data by treatment
group are also presented in the results (see Sensitivity analysis).
Mean costs per injury were multiplied by the expected change in injuries due to the intervention (see
Costing framework) to derive total estimated avoided costs attributable to the intervention across the
trial population. These are subtracted from intervention costs to estimate total net intervention costs.
Cost-effectiveness analysis
The focus of the economic evaluation was a CEA, with results presented in the form of incremental
cost-effectiveness ratios (ICERs) (i.e. the additional cost per extra unit of benefit). The ICERs were
calculated as follows:
ICER =
Change in costs as a result of intervention
Change in outcome as a result of intervention
. (1)
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The following ICERs were estimated, taking net intervention costs over three different outcome measures:
1. cost per averted slip
2. cost per averted injury
3. cost per QALY.
These were estimated from the perspective of both the NHS budget and society. Impacts were
modelled over the expected lifetime of the footwear, which is assumed to be 12 months, based on the
trial footwear testing analysis presented in SSHeW trial footwear testing.
The ICER was compared with the willingness-to-pay threshold (i.e. the amount a decision-maker
is willing to pay for an additional QALY). A willingness-to-pay threshold of £30,000 was used to
determine cost-effectiveness, in line with National Institute for Health and Care Excellence (NICE)
recommendations.35 If the estimated cost per QALY was below this threshold, the intervention was
considered to be cost-effective. A threshold of £0 was also assessed, which represents the point at
which the cost savings from the intervention equal the costs and result in a financial ‘break-even’
for the NHS.
All prices were converted to a 2017/18 base year using the appropriate price index. For health-care costs,
the Hospital and Community Health Service Pay and Prices Index36 was used for all years, except 2017/18,
when the Personal Social Services Research Unit Health Services Index was used.36 For NHS pay rates, the
NHS spring 2018 pay settlement was used.37 For all other costs, HM Treasury gross domestic product
deflators were used.38 No discounting of costs or benefits was required, given that the appraisal period is
1 year. Results in the text are presented to an accuracy of three significant figures, which may result in
rounding errors in presented values. All calculations were undertaken using non-rounded values.
Economic data collection
Data for outcomes and resource use for the economic analysis were collected prospectively from a
wide range of secondary sources. Health service usage and loss of working time was measured using
participant-reported questionnaires at 14 weeks and monthly follow-ups after the 14-week trial
participation period, until the injury had resolved, the participant wished not to be contacted or the
data collection period ended.
Health-related quality of life
Selection of EuroQol-5 Dimensions instrument and value set
The QALY is the metric used to quantify the change in HRQoL due to the intervention. As recommended
by NICE, the EuroQol-5 Dimensions (EQ-5D) instrument was used to measure participant health states.30
The five-level version of the questionnaire was used, with the intention of using utility values for the
English population derived for the EQ-5D-5L instrument.39 However, at the time of writing, NICE does
not recommend using the Devlin et al.39 value set because of concerns raised during quality assurance.35
Instead, NICE recommends that, when data are gathered using the EQ-5D-5L descriptive system,
utility values should be calculated by mapping the five-level descriptive system data onto the three-
level valuation set using the function developed by van Hout et al.40 (also known as the ‘crosswalk’
approach). The EuroQol Group publishes the full crosswalk value sets for several countries, providing
recommended utility values mapped to the three-level value set for each of the 3125 health states in
the five-level descriptive system. The UK value set has been applied in the present study.41
To reduce the burden on trial participants, EQ-5D data were collected for the first slip reported
(whether or not an injury had occurred and whether in the control or intervention group) and then
during follow-up at monthly intervals for those reporting an injury, until the injury was resolved
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(rather than from all participants at all time points). This was on the basis that the individuals were in
employment and working, so were likely to report high health state scores reflective of the generally
healthy working population.
Baseline health utility for the trial population was estimated using EQ-5D data from participants
reporting no injury with complete EQ-5D responses on the SDCS (n = 1002) (see Baseline health utility).
This was preferred to published population norm values (e.g. Kind et al.42) because of the high specificity
of the trial baseline data to the trial population.
Overview of quality-adjusted life-year estimation approach
The total change in QALYs due to the intervention was estimated by:
1. estimating total QALYs for the duration of each reported injury at the participant level, when
complete data on EQ-5D are available, along with dates of injury and form completion, which were
used to calculate duration
2. estimating baseline QALYs for the duration of injury reported by each participant, calculated by
applying baseline health utility
3. subtracting total QALYs lived from baseline QALYs for each injury to estimate per injury QALY loss,
enabling calculation of the mean QALY loss per injury
4. multiplying the mean QALY loss per injury by the expected change in injuries due to the
intervention derived in Measures of effectiveness in reducing injuries.
Utilities derived from EQ-5D were converted to QALYs based on the area under the curve method,
following the trapezium rule and assuming linear interpolation between monthly follow-up points.43
Data exclusions
Observations were excluded if the following data were incomplete:
l EQ-5D data at all follow-up points when an injury was reported and not resolved
l data required to calculate duration: date of slip (on the SDCS) or injury (for monthly follow-ups),
form completion dates and days since fully recovered (when the participant indicates that their
injury has fully resolved during the last period).
EuroQol-5 Dimensions observations were also excluded if the number of fully recovered days was
greater than the number of days elapsed since last observation or since the participant had reported
perfect health (11111), both indicating that the participant had fully recovered prior to completing
the form.
Calculating duration
For observations with complete data, duration of the observed health state is calculated as follows:
l for observations on the SDCS, the difference between the slip date (when an injury was reported)
and the form completion date
l for monthly follow-ups when the participant indicated that they had recovered, the difference
between the previous observation and the number of days since fully recovered
l for monthly follow-ups when the participant had not fully recovered, the difference between the
last observation and the form completion date.
Further considerations in assigning utility values
Several issues with the data required judgements regarding the assignment of utility values. In all cases
there was a lag between the reported slip date and the date of completion of the SDCS, which collected
for first reported slips data on the nature of any injury and HRQoL (EQ-5D). The analysis assumes that
HRQoL for the period between injury and reporting on SDCS is as per the value at SDCS, as the health
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state at the point of injury is not observed. The mean elapsed time between slip date and date of the
SDCS across the sample was 17 (SD 16, minimum 3, maximum 66) days, so it is likely that many
participants would have partially or fully recovered from their inury in this time, meaning that QALY loss
during this period is underestimated.
Additionally, participants were sent a SDCS only for the first reported slip. The primary route to
monthly follow-up was for participants reporting injury on the SDCS (although injured participants
were also identified in several other ways, such as by text message, direct telephone call or e-mail
to a member of the York trial team or local research team at participating sites). Therefore, many
follow-up injuries are different to those reported on the SDCS. To estimate the correct duration and
interpolation of utility weight between observations, and to allow for some recall and reporting error
on the part of participants, the analysis treated follow-up observations as pertaining to the same injury
as reported on the SDCS if the difference between the slip date reported on the SDCS and the injury
date reported on the follow-up was < 10 days.
Costing framework
The conceptual framework applied in the CEA (Figure 6) is based on the HSE’s costs of illness model,44
which is used to produce annual national statistics on the costs of workplace injuries and illnesses in GB.
Intervention costs
NHS trusts implementing the footwear intervention will primarily incur two types of costs: (1) the cost
of the footwear and (2) resources expended in distributing the footwear to staff.
Footwear purchase costs
Data from the trial on the number and style of footwear purchased, along with the purchase cost from
the trial footwear supplier, were used to estimate a weighted average purchase cost per pair. This was
then multiplied by the number of employees in the trial intervention group to estimate the purchase
cost from the NHS perspective. From the societal perspective, the provision of the intervention
footwear displaces footwear that would otherwise be purchased and worn (or, if own footwear is worn
occasionally, as observed in the trial, then own footwear is replaced less frequently because of reduced
wear). If prior to the intervention employees purchase their own footwear, the intervention represents
a transfer from the NHS employer to the member of staff (which, depending on the relative purchase
prices, may entirely cancel out). Data on the costs and longevity of footwear usually worn were
gathered from 311 trial participants at two trusts during recruitment to the trial to estimate the costs
differential between intervention and baseline footwear.
Distribution costs
The trial protocol proposed not to quantify the costs of distributing footwear to staff, on the basis that
the NHS has existing dress requirements and provides staff uniform, and any staff time incurred in
distributing the footwear to staff in addition to existing processes for uniform would be negligible.
Discussions with a small number of staff at participating trusts involved in distributing footwear during the
trial indicated that this had, in some cases, been burdensome, because of the nature of a large number of
orders being created and handled in a short period of time. Other, more cost-effective, methods are likely
to be applied in practice. The ordering and distribution of shoes could be staggered to minimise logistical
costs. An alternative model, confirmed by the footwear supplier as operating in other sectors [T Swinney,
Shoes For Crews (Europe) Ltd, 19 September 2019, personal communication], would be for NHS staff to
obtain the shoes directly from the supplier, using a unique code to pass the charge on to the NHS, with the
footwear delivered to the employee’s home address or other chosen location. The supplier would then
charge the NHS on a periodic basis for all shoes supplied. Delivery and returns would be free of charge
(as confirmed by the supplier).
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Therefore, distribution costs are treated as negligible and accounted for in the existing footwear
purchase price.
Health-care resource use
Health-care resource use data were collected via participant-reported questionnaires at 14 weeks and,
for injuries unresolved after 14 weeks, during the monthly injury follow-up questionnaire (collected until
either the participant reported that the injury had fully resolved or the trial data collection ended).
Participants were asked to provide information on their use of the following services: (1) primary and
community care [e.g. general practitioner (GP) and nurse attendance, physiotherapy and occupational
therapist visits] and (2) secondary and hospital care (e.g. inpatient, accident and emergency, day case
Baseline
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FIGURE 6 Summary of cost-effectiveness model.
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and outpatient attendances, podiatry care). Reported episodes of care were valued using the relevant
NHS reference costs45 and Personal Social Services Research Unit unit costs of health and social care,36
summarised in Table 14.
To derive the unit health-care costs per injury, the total costs of health-care resource use observed
in the trial were divided by the relevant number of trial injuries. For the base case, the calculation
included health-care use relating to injuries resulting from slips and the denominator was the total
number of injuries resulting from slips reported on the 14-week questionnaire. The estimated unit
health-care costs per injury were multiplied by the expected change in the number of injuries due to
the intervention across the trial population, to estimate the total expected avoided health-care costs.
Absenteeism costs
From the NHS perspective, worker absence because of injury gives rise to costs associated with
temporarily replacing the injured worker and sickness payments made to the injured worker (in lieu of
the worker’s wages).
Data on time off work were collected on the SDCS, 14-week questionnaire and at monthly follow-ups
after this period. To avoid double counting, time off work data from the SDCS were not included, as
this period was covered by the 14-week questionnaire.
Hourly pay rates, including on-wage costs (pensions and National Insurance contributions), were
obtained from one NHS trust involved in the trial for each of the occupation types and checked against
published NHS earnings data.
Sickness payments were modelled based on the NHS Terms and Conditions of Service Handbook.46
The rate and duration of sickness pay depends on length of service. Given that 69% of hours lost in
the trial occurred within the first month of absence, no absences were > 4 months, and data on the
duration of service for trial participants were not available, we have assumed for simplicity that all
participants receive sickness payment equivalent to full pay for the duration of their absence.
The NHS can take a range of actions to ensure continuity of service in the event of worker absence
due to injury, including hiring replacement bank or agency staff, seeking overtime cover from existing
staff or absorbing the absence if staffing levels are adequate. A range of scenarios were considered;
TABLE 14 Unit costs of health-care resource use per episode of care
Episode of care Unit cost (£) Source
GP at a general practice or at home 43.40 aUnit Costs of Health and Social Care 201836
Nurse at a general practice or at home 12.61 aUnit Costs of Health and Social Care 201836
Occupational therapist 74.87 aUnit Costs of Health and Social Care 201836
Physiotherapist 50.99 aUnit Costs of Health and Social Care 201836
Podiatrist 44.48 aUnit Costs of Health and Social Care 201836
Clinic outpatient visit 125.00 NHS Reference Costs 2017/1845
A&E visit 160.00 NHS Reference Costs 2017/1845
Hospital day case 742.00 NHS Reference Costs 2017/1845
Non-elective inpatient 1603.00 NHS Reference Costs 2017/1845
A&E, accident and emergency.
a Supplementary table (p. 18). Inflated from 2016/17 to 2017/18 prices using the Hospital and Community Health
Service Index.
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however, modelling these would add considerable complexity to the analysis. Therefore, we made a
further simplifying assumption that all absences were covered by overtime, at the standard NHS rate
of 1.5 times pay, which should provide a reasonable approximation of the likely costs.46
At the societal level, the principal economic cost of worker absenteeism caused by injury is the loss
of output or production due to one less worker (temporarily or permanently) in the labour force.
We apply the conventional assumption that the worker’s marginal productivity is at least equal to
their costs of employment.47 This is equal to (1) the worker’s wage plus (2) on-wage costs (National
Insurance and pensions contributions). This assumes that the replacement worker would otherwise be
doing some other productive activity (i.e. is not involuntarily unemployed). This is reasonable given
(1) the current historically high levels of employment and (2) the high vacancy rate in the NHS relative
to other public sector occupations.
The analysis did not account for presenteeism costs; that is, instances of when staff returned to work
following injury, but before they were fully recovered. This can result in staff being less productive for
some period, because of reduced strength or mobility. Quantifying the incidence of presenteeism, and
its effects on productivity, is challenging,48 and was not undertaken to avoid adding complexity and
uncertainty to the data collection and analysis.
Compensation costs
Workers who suffer an injury caused by a slip or fall at work may submit a claim for compensation.
NHS Resolution handles these claims on behalf of NHS trusts, via the Liabilities to Third Parties
Scheme. The Liabilities to Third Parties Scheme claims are subject to excesses, with NHS trusts
responsible for funding below-excess claims. However, after discussions with NHS Resolution and with
a NHS claims manager who was working in one of the participating trusts, it appears that, in practice,
NHS Resolution handles the vast majority of claims. Damages paid for settled claims represent a
transfer from the NHS to the claimant worker, with additional costs arising from legal resources
expended on behalf of the claimant and defendant.
Data on total non-clinical claims and associated claims cost for injuries with ‘slip or trip’ as the primary
reason code for NHS employees between 2007/8 and 2016/17 were obtained from NHS Resolution
via a freedom of information request (Table 15). Total costs to the NHS are the sum of claimants’
recoverable legal costs (see Table 15, column 2), total damages paid (see Table 15, column 3) and total
defence costs (see Table 15, column 4). From this, the compensation cost per claim can readily be
calculated; there were on average 528 settled claims per year over the period, resulting in an average
annual total claim cost of £12.7M (or £24,000 per claim). However, this is likely to differ from the cost
per injury, as many injuries will not result in a claim.
Claim costs per injury were derived by dividing the average annual total claim cost by the total annual
injuries due to slips across the NHS. The latter was estimated by applying the estimated baseline
annual injury rate from the trial (of 4.06 per 100 workers, see Baseline injuries) to the 1.22 million NHS
employees,49 giving an estimated 49,800 annual slip-related injuries. Using this as the denominator
results in an estimated compensation claim cost per injury of £254.
At the societal level, the damages paid were excluded as a transfer, leaving average annual costs of
£6.66M (total defence costs plus total claimant costs), or £132 per injury.
Sensitivity analysis and uncertainty
The main sources of uncertainty in the economic evaluation relate to effectiveness of the intervention
in reducing injuries; mean impact per injury averted, in terms of unit costs and loss of QALYs;
intervention costs, depending on the model of distribution adopted; and sampling variability, owing to
the rarity of injuries.
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Given the limited number of data on injury outcomes from the trial, probabilistic sensitivity analysis was
not undertaken. Instead, the effect of uncertainty in input parameters was assessed through one- and
two-way sensitivity analyses. These tested the change in values from the base case required to result
in costs per QALY equivalent to £30,000 (i.e. the NICE threshold) and £0 (i.e. financial break-even).
To simplify the analysis, combined mean cost savings per averted injury were tested, rather than the
individual cost components (absenteeism, health-care costs and compensation), as these would be highly
correlated. Although this form of sensitivity analysis does not account for all sources of uncertainty
simultaneously, it facilitates a qualitative assessment of the likelihood that the intervention is cost-
effective by placing bounds on the magnitude of parameters required to meet alternative thresholds.
A further uncertainty relating to the base-case modelling approach is that it assumes that the main
effect of the intervention footwear is to reduce the frequency of injuries and that severity of injuries
is essentially unchanged. Given this, the results from a direct comparison of outcomes by treatment
group is also presented in the sensitivity analysis, which, in principle, accounts for both effects,
although it is subject to a high degree of random variability because of the small injury numbers.
Validation of results
The Microsoft Excel analysis was quality assured by a second HSE economist.
Results
Intervention effectiveness in reducing injuries
Trial injury data
Injuries due to slips
Table 16 summarises the data on injuries reported in the trial via the SDCS and the end-of-trial 14-week
questionnaire. Via the SDCS, Thirty-one participants (1.4%) in the control group reported an injury on
the SDCS, compared with 26 participants (1.1%) in the intervention group. Forty participants (1.8%) in
TABLE 15 NHS Resolution data on successful non-clinical claims closed from 2007/8 to 2016/17 with a primary cause of












2007/8 608 5,908,829 1,585,870 5,846,194 13,340,893
2008/9 603 5,826,471 1,569,863 5,612,495 13,008,829
2009/10 459 4,645,895 1,131,722 4,276,821 10,054,437
2010/11 482 4,720,081 891,907 4,306,962 9,918,950
2011/12 801 8,732,507 1,369,108 7,260,387 17,362,002
2012/13 588 7,027,166 1,149,515 6,094,007 14,270,688
2013/14 552 7,270,611 1,207,061 6,425,411 14,903,084
2014/15 444 6,807,880 1,062,790 5,535,280 13,405,950
2015/16 410 5,190,604 867,058 4,917,494 10,975,156
2016/17 332 4,582,955 790,836 3,909,156 9,282,947
Total 5279 60,712,999 11,625,731 54,184,207 126,522,937
Average annual 528 6,071,300 1,162,573 5,418,421 12,652,294
Source: reproduced with permission from NHS Resolution freedom of information request (FOI_3312) (NHS Resolution,
28 February 2018, personal communication).
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the control group reported an injury on the 14-week questionnaire, and reported 49 separate incidents
in total (a rate of 2.2%), compared with 23 (1.0%) participants reporting injury in the intervention group,
reporting 29 incidents in total (1.3%).
Superficial wounds were the most common type of injury across both groups, accounting for 48.0%
of injuries in the control group and 47.1% of injuries in the intervention group at 14 weeks. Pulled
muscles and sprained ligaments were the second most commonly reported injury overall, accounting
for 42.0% of injuries in the control group and 23.5% of injuries in the intervention group at 14 weeks.
One broken bone was reported, by a participant in the control group.








n % n % n %
Injuries due to slips reported on SDCS
Participants reporting injury (% of participants in group) 31 1.4 25 1.1 56 1.2
Number of injury typesa 32 26 58
Injury reported (% of all injury types)
Superficial wounds 17 53.1 12 46.2 29 50.0
Broken bones 0 0.0 0 0.0 0 0.0
Pulled muscles/sprained ligaments 12 37.5 10 38.5 22 37.9
Other injuries 3 9.4 4 15.4 7 12.1
Injuries due to slips reported on the 14-week questionnaire
Participants reporting injury (% of participants in group) 40 1.8 22 1.0 62 1.4
Number of slips resulting in injuryb 49 2.2 26 1.1 75 1.6
Number of injury typesa 50 33 83
Injury reported (% of all injury types)
Superficial wounds 24 48.0 16 48.5 40 48.2
Broken bones 1 2.0 0 0.0 1 1.2
Pulled muscles/sprained ligaments 21 42.0 8 24.2 29 34.9
Other injuries 4 8.0 9 27.3 13 15.7
Injuries due to falls not resulting from a slip reported on the 14-week questionnaire
Participants reporting injury (% of participants in group) 5 0.2 4 0.2 9 0.2
Number of falls not due to slips resulting in injuryb 6 0.3 4 0.2 10 0.2
Number of injury typesa 16 10 26
Injury reported (% of all injury types)
Superficial wounds 7 14.0 5 15.2 12 14.5
Broken bones 0 0.0 0 0.0 0 0.0
Pulled muscles/sprained ligaments 4 8.0 2 6.1 6 7.2
Other injuries 5 10.0 3 9.1 8 9.6
a Participants could report multiple types of injury caused by a single slip or fall incident.
b Participants could report multiple slip or fall incidents.
ECONOMIC EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
48
A total of 32 participants reported an injury on the SDCS but did not report injury at 14 weeks.
Of these participants, 23 had completed at least some of the 14-week questionnaire.
Injuries due to falls not resulting from a slip
Of the nine participants reporting an injury from a fall not resulting from a slip, five were in the control
group (0.2% of control group participants) and four were in the intervention group (0.2% of intervention
group participants). As with injuries due to slips, superficial wounds were the most common reported
injury, accounting for 14.5% of injuries reported across both groups.
As the trial statistical analysis did not find a statistically significant reduction in the rate of falls not due
to slips, data relating to these are not accounted for further in the economic evaluation.
Baseline injuries
Table 17 shows the estimates of baseline injuries applied in the economic evaluation. Of the 4553
participants providing trial baseline questionnaire data, 185 (4.06 per 100 participants) reported an
injury due to a slip at work in the past 12 months. In the trial, 49 injuries were reported on the 14-week
questionnaire (a rate of 2.15 per 100 control group participants). Scaling this to an annual rate (making no
adjustment for seasonal variation, given that participant involvement in the trial was spread throughout
the year) suggests an annual injury rate of 8.00 per 100 participants in the control group, giving an
expected 364 baseline injuries across the trial population.
Both baselines are used in the analysis to construct alternative scenarios.
Measures of effectiveness in reducing injuries
The primary measure of effectiveness is based on the proportional reduction in the rate of slips due to
the intervention, as estimated in the primary statistical analysis. This is estimated as an intention-to-
treat IRR of 0.63 (central estimate), implying a reduction of 37% in the rate of slips in the intervention
group. Applying this to the expected number of annual injuries over the trial population gives an
expected reduction in annual injuries over the trial population of 68 under baseline 1 and 135 under
baseline 2.
Health-related quality of life
Baseline health utility
The baseline health utility weight was based on responses to the 1002 SDCSs completed by participants
who provided complete EQ-5D data and did not report an injury (Table 18). Applying the crosswalk
approach set out in van Hout et al.40 gave a mean utility of 0.911 (SD 0.130, minimum 0.088, maximum 1).
Quality-adjusted life-years and quality-adjusted life-year loss during the trial
Total QALY loss associated with an injury was estimated from the differences between baseline QALYs
and observed QALYs for each injured participant with complete QALY data, for the duration of each
reported injury. Mean QALY loss per injury was estimated by dividing total QALY loss by the number of
injuries with complete QALY data.
TABLE 17 Baseline injury rates applied in the economic evaluation
Baseline option
Number of injuries at
14 weeks, n (%) of participants
Annual injury rate
per 100 people
Expected injuries for trial
population over 1 year
Trial baseline survey (n = 4553) n/a 4.06 185
Trial control group (n = 2775) 49 (2.15) 8.00 364
n/a, not applicable.
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Total QALY loss over the duration of the trial was 0.817 QALYs, with 0.521 QALY loss (63.8% of total)
occurring in the control group and 0.296 QALY loss (36.2% of total) occurring in the intervention group
(Table 19). Mean loss per injury across both groups was 0.017 (SD 0.028) QALYs, with a higher mean
loss in the control group (0.019 QALYs, SD 0.032 QALYs) than in the intervention group (0.016 QALYs,
SD 0.022 QALYs).
Calculation of quality-adjusted life-years: anomalies and exclusions
Quality-adjusted life-years were estimated up to the point of final follow-up (when the injury was
resolved, the participant no longer wished to be contacted or the trial data collection ended). Nine of
the 16 participants who provided complete data on monthly injury follow-ups had not fully recovered
by the time of their final follow-up observation. This suggests that estimated QALY loss for these
participants is incomplete and will be underestimated for participants as a whole. The paucity of data
precludes modelling QALY loss beyond the period of data collection.
TABLE 18 Numbers and proportions of reporting levels within EQ-5D-5L dimensions: participants reporting no injury on
SDCS (n = 1002)
Level
EQ-5D-5L domension
Mobility Self-care Usual activities Pain/discomfort Anxiety/depression
n % n % n % n % n %
1 907 91 995 99 930 93 683 68 817 82
2 81 8 7 1 62 6 234 23 133 13
3 11 1 0 0 9 1 71 7 44 4
4 3 0 0 0 0 0 12 1 5 0
5 0 0 0 0 1 0 2 0 3 0










Number of injured participants with
complete data, minus exclusions
21 15 36 –6.00
Number of complete observations 21 15 36 –6.00
Total duration of period (years)a 1.02 0.80 1.82 –0.21
Mean duration of period per participant,
years (SD)
0.05 (0.05) 0.05 (0.04) 0.05 (0.05) 0.01
Total QALYs lived for injured participants 0.78 0.59 1.37 –0.19
Weighted average injured HRQoL weight
for period
0.76 0.73 0.75 –0.03
Total QALYs lived: baseline 0.93 0.73 1.66 –0.19
Total QALY loss 0.150 0.142 0.292 –0.008
Average QALY loss per injury with
complete data, minus exclusions (SD)
0.007 (0.009) 0.009 (0.017) 0.008 (0.013) 0.002
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As described in Health-related quality of life, observations with complete data for which participants
have reported injury and perfect health (11111) have been excluded, as this indicates that the
participant has recovered from the injury and otherwise results in estimated QALY gains due to injury,
relative to baseline HRQoL. This removed 10 participants at the SDCS stage and six participants from
the monthly follow-ups. Including these participants would reduce the mean QALY loss per injury
across control and intervention groups to 0.010 (SD 0.026) QALYs.
Two participants were followed up and provided complete data to estimate QALYs but reported no
injury on either the SDCS or the 14-week questionnaire. Both participants were excluded from the
analysis. One participant stated explicitly on the follow-up questionnaire that they were injured from a
trip at home, whereas the other participant did not provide sufficient data to determine whether or
not an injury occurred at all and, if so, if this was due to a slip or fall at work, or some other cause.










Number of injured participants with complete
data, minus exclusions
15 8 23 –7.00
Number of complete observations 20 23 43 3.00
Total duration of period (years)a 1.77 0.74 2.51 –1.03
Mean duration of period per participant,
years (SD)
0.12 (0.04) 0.08 (0.04) 0.10 (0.04) –0.04
Total QALYs lived for injured participants 1.24 0.52 1.77 –0.72
Weighted average injured HRQoL weight
for period
0.70 0.70 0.70 0.00
Total QALYs lived: baseline 1.61 0.68 2.29 –0.94
Total QALY loss 0.371 0.154 0.525 –0.218
Average QALY loss per injury with complete
data, minus exclusions (SD)
0.025 (0.039) 0.017 (0.021) 0.023 (0.033) –0.008
Over the trial
Number of injured participants with complete
data, minus exclusions
28 18 46 –10
Number of complete observations 41 38 79 –3
Total duration of period (years)a 2.79 1.55 4.33 –1.43
Mean duration of period per participant,
years (SD)
0.10 (0.14) 0.08 (0.08) 0.09 (0.12) –0.02
Total QALYs lived for injured participants 2.02 1.11 3.13 –0.91
Weighted average injured HRQoL weight
for period
0.72 0.72 0.72 0.00
Total QALYs lived: baseline 2.54 1.41 3.95 –1.13
Total QALY loss 0.521 0.296 0.817 –0.226
Average QALY loss per injury with complete
data, minus exclusions (SD)
0.019 (0.032) 0.016 (0.022) 0.017 (0.028) –0.003
a As defined in Calculating duration.
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Health-care resource use
Health-care use reported on the 14-week and post-14-week follow-up
questionnaires
Table 20 reports total health-care use by follow-up point and treatment group. Over the duration of
the trial, a total of 13 participants required health care for an injury caused by a slip at work [seven
participants in the control group and six participants in the intervention group (one participant in
the intervention group reported health-care use in the post-14-week period but not at 14 weeks)].
Physiotherapy was the most commonly used care (39 visits in the control group and 10 visits in the
intervention group), followed by a nurse appointment at a general practice (15 visits in the control
group and seven visits in the intervention group) and accident and emergency attendance (14 visits in
the control group and four visits in the intervention group).
Table 20 also reports the associated costs of health care, calculated by applying the unit costs in
Table 14. Total costs of care across the duration of the trial were £13,000, of which the vast majority
(£11,400, 87.9%) occurred in the control group. Three participants in the control group accounted for
£10,500, or 80.4% of total health-care costs.
Average health-care costs per injury were £233 in the control group, £61 in the intervention group
and £173 across all participants.
The following anomalies and exclusions should be noted:
l Six respondents selected ‘other’ health-care use and provided information. It was evident that all
but one of these respondents duplicated information provided in the specified categories and so
these responses were removed. One respondent reported five sessions of sports therapy, which
were recoded as physiotherapy.
l One participant answered ‘yes’ to needing health care, but did not provide details. The injury was a
sprain and the participant indicated on the 14-week questionnaire that they had recovered from
injury. No health-care use was included for this participant.
l One participant provided a large number of health-care use data but was excluded from the results
because the participant’s comments on the questionnaire indicated that the injury was due to a trip
at home.
Additional health-care use reported on the slip data collection sheet
Eight participants reported health-care use on the SDCS that was not reported on the 14-week
questionnaire or post-14-week follow-ups, amounting to £3800 in resource costs. These costs were not
included in the CEA, as per the methodology, but are discussed as follows:
l Four participants did not report an injury on either the SDCS or 14-week questionnaire and were
not followed up for injury.
l One of the eight participants reported a slip-injury on the 14-week questionnaire, although the
comments suggested that the reported outpatient appointment related to a pre-existing injury.
l Of the remaining three participants, one participant reported a fall injury not related to a slip on the
14-week questionnaire, with a similar date to the slip reported on the SDCS. The reported health-
care use and costs (£1110) would be taken as relating to a fall not caused by slipping and so are not
included in the analysis. The remaining two participants reported an injury on SDCS, but did not
complete the 14-week questionnaire. Given that the associated health-care use and costs for these
were very low (£145), they would not have made a material difference to the results.
Of those participants who reported health-care use on both the SDCS and during later follow-up
questionnaires, none reported higher costs on the SDCS.
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Total participants reporting health-care use 6 6 12 0
GP visit 4 6 10 2
Nurse at general practice 0 0 0 0
Occupational therapist 0 0 0 0
Physiotherapist 13 10 23 –3
Podiatrist 1 0 1 –1
Outpatient 2 1 3 –1
A&E 5 4 9 –1
Hospital visit as a day case 0 0 0 0
Days inpatient stay 0 0 0 0
Total costs of care (£) 1931 1535 3466 –396
Post-14-week monthly follow-ups
Total participants reporting health-care use 3 1 4 –2
GP visit 11 1 12 –10
Nurse at general practice 0 0 0 0
Occupational therapist 1 0 1 –1
Physiotherapist 26 0 26 –26
Podiatrist 0 0 0 0
Outpatient 0 0 0 0
A&E 9 0 9 –9
Hospital visit as a day case 4 0 4 –4
Days inpatient stay 2 0 2 –2
Total costs of care (£) 9492 43 9536 –9449
Over the trial
Total participants reporting health-care use 6 7 13 1
GP visit 15 7 22 –8
Nurse at general practice 0 0 0 0
Occupational therapist 1 0 1 –1
Physiotherapist 39 10 49 –29
Podiatrist 1 0 1 –1
Outpatient 2 1 3 –1
A&E 14 4 18 –10
Hospital visit as a day case 4 0 4 –4
Days inpatient stay 2 0 2 –2
Total costs of care (£) 11,423 1579 13,002 –9844
Number of injuries at 14 weeks 49 26 75 –23
Mean costs of care per injury (£) 233 61 173 –172
A&E, accident and emergency.
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Absenteeism costs
The data on self-reported absence from work because of injuries caused by slips at work are summarised
in Table 21. Most participants suffering an injury due to a slip at work reported taking no time off work.
A total of 57 participants reported no absence (37 participants in the control group, amounting to 86% of
those reporting injury, and 20 participants in the intervention group, amounting to 80% of those reporting
injury). A total of 11 participants reported taking time off work (six participants in the control group and
five participants in the intervention group).
Control group participants reported a total of 1162 lost working hours because of an injury caused
by a slip (compared with 388 lost working hours in the intervention group). Injuries in the control
group resulted, on average, in a much longer absence (194 hours, SD 200 hours) than injuries in the
intervention group (78 hours, SD 74 hours). Over half of the hours lost in the control group occurred
during the long-term monthly follow-ups, whereas no participants reported hours lost past 14 weeks in
the intervention group. One injury in the control group accounted for almost half (45.2%) of the total
time off work in that group.
Table 22 summarises the distribution of time off work for injuries due to slips at work taken by
participants over the duration of the trial, by treatment group. Overall, over the period of data
collection, the vast majority of participants (84% across both groups) who reported an injury resulting
TABLE 21 Self-reported lost working hours by treatment group and follow-up point








Reported on 14-week questionnaire
Total lost working hours 520 388 908 –132
Number of participants reporting absence 5 5 10 0
Of those reporting absence
Mean duration (hours) per participant (SD) 104 (113) 78 (74) 91 (91) –26
Median (minimum, maximum) hours 60 (2, 263) 30 (16, 180) 45 (2, 263) –30
Post-14-week follow-up
Total lost working hours 643 0 643 –643
Number of participants reporting absence 3 0 3 –3
Of those reporting absence
Mean duration (hours) per participant 214 (137) 0 214 (137) –214
Median (minimum, maximum) hours 263 (60, 320) 0 263 (60, 320) –263
Total over the trial
Total lost working hours 1162 388 1550 –774
Number of participants reporting absence 6 5 11 –1
Number of participants reporting injury
but no absence
37 20 57
Of those reporting absence
Mean duration (hours) per participant (SD) 194 (200) 78 (74) 141 (161) –17
Median (minimum, maximum) hours 150 (2, 525) 30 (16, 180) 120 (2, 525) –120
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from a slip reported no time off work due to the injury. Participants in the control group were more
likely to have reported longer absence from work, although this is based on a small number of
observations and so is subject to a high degree of random variation.
Table 23 summarises the number of lost working hours and hourly wage rates (including on-wage
costs) by occupation. Other qualified staff and health-care professionals account for the largest
absence (525 hours, 33.9% of lost working hours due to slips), resulting from the absence of one
participant. Health-care assistants accounted for the second largest amount of time off work (two
participants, 300 hours, 19.4% of total hours). Qualified nurses and midwives accounted for the largest













Doctor/consultant 0 0 0 68
Qualified nurse/midwife 5 257 51 17
Physiotherapist 0 0 0 21
Porter 0 0 0 11
Occupational therapist 0 0 0 21
Health-care assistant 2 300 150 12
Ward clerk 0 0 0 12
Pharmacist/pharmacy technician 0 0 0 30
Social worker 0 0 0 21
Support worker 1 132 132 12
Podiatrist 0 0 0 21
Administrator/receptionist/secretarial 2 336 168 11
Other qualified staff/health-care
professional
1 525 525 21
Catering 0 0 0 12
Imaging 0 0 0 47
Total 11 1550 141
TABLE 22 Distribution of time off work taken by participants reporting an injury over the duration of the trial for
injuries due to slips (working time), by treatment group
Time off work
Control group Intervention group Total
Participants, n % total Participants, n % total Participants, n % total
No time off 37 86 20 80 57 84
Up to 1 week 2 5 3 12 5 7
Between 1 and 2 weeks 0 0 0 0 0 0
Between 2 weeks and 1 month 1 2 1 4 2 3
> 1 month 3 7 1 4 4 6
Total 43 100 25 100 68 100
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number of participants reporting time off. All participants reporting their occupation as ‘other’ were
recoded to the nearest category. None of the four participants who failed to complete the occupation
field (i.e. missing data) reported injury or time off work.
Table 24 presents the total estimated sickness payments, overtime payments and value of lost working
time due to slip-related injuries. The total value of lost working time in the control group was £19,100,
compared with £4850 in the intervention group. Overtime payments were similarly larger in the
control than in the intervention group (£28,700 vs. £7270, respectively). The costs of sickness
payments are equivalent to the value of lost working time, given the modelling assumption that
workers are paid their full wage when absent.
Table 24 also shows the estimated mean costs per injury by treatment group. The estimated mean unit
cost per injury to the NHS was £479 across both groups, £585 in the control group and £280 in the
intervention group. The total mean cost to society per injury was £320 (£390 in the control group and
£186 in the intervention group).
Two participants reported needing time off work due to a slip-related injury (one superficial injury,
one not specified); however, the participants did not provide the number of hours. Therefore, it was
assumed that no time off was taken in both cases.
A comparison of the absence data identified that 7.5 hours’ absence reported on the SDCS was
missing from the 14-week questionnaire. Given that the participant completed some of the 14-week
questionnaire but did not report an injury at that point, and to avoid further complication to the
analysis, these hours are excluded.
Compensation costs
Compensation costs estimated that the mean compensation cost per slip-related injury to the NHS was
£254, based on secondary data. Applying this value, the number of injuries observed in the trial gave a
total compensation cost of £19,100 to the NHS, with £12,400 incurred in the control group and £6600
in the intervention group.









Total sickness payments (£) 19,117 4846 23,963 –14,270
Total cost of overtime staff (£) 28,675 7270 35,945 –21,405
Total value of lost working time (marginal employee cost) (£) 19,117 4846 23,963 –14,270
Total cost to the NHS (£) 28,675 7270 35,945 –21,405
Total cost to society (£) 19,117 4846 23,963 –14,270
Total injuries (n) 49 26 75 –23
Mean sickness payments per injury (£) 390 186 320 –204
Mean overtime payments per injury (£) 585 280 479 –306
Mean staff costs not paid for injured workers per injury (£) 390 186 320 –204
Mean cost to the NHS per injury (£) 585 280 479 –306
Mean cost to society per injury (£) 390 186 320 –204
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Total mean costs per averted injury
Accounting for all cost components, total mean cost per injury was £907 from the NHS perspective across
both treatment groups (£1072 in the control group and £594 in the intervention group) (Table 25) and £625
from the societal perspective (£755 in the control group and £379 in the intervention group). Absenteeism
costs accounted for over half of the total mean costs from both the NHS and societal perspectives.
Intervention costs
Costs to the NHS
Data on the frequency and prices of slip-resistant footwear styles ordered for the trial were available for
2201 pairs of footwear, from which a weighted average purchase cost of £23.80 per pair was derived.
Based on the testing of the trial footwear, presented in Chapter 3, SSHeW trial footwear testing, we assumed
that the footwear would be replaced on average every 12 months. Across the 2278 intervention group
participants, this resulted in an annual footwear purchase cost to the NHS of £54,200. As per Costing
framework, Distribution costs, the distribution costs are assumed to be negligible and so total intervention
costs equal the footwear purchase cost.
Costs to society
From a societal perspective, the purchase of the trial footwear would displace footwear that employees
would otherwise purchase and wear. Based on data from 312 participants on the costs and longevity of
baseline footwear gathered during recruitment to the trial, we estimated mean baseline footwear costs
of £44.52 (SD £19.88) and mean time to replacement of 1.47 (SD 1.20) years, giving an estimated cost
of £30.20 per year. This exceeded the mean cost of the trial footwear by £6.40, suggesting a saving to
society from each pair of intervention footwear provided. Applied across all control group participants,
this gives a total purchase cost saving of £14,600.
Cost–utility analysis
An incremental cost per QALY from the NHS perspective was estimated at £38,900 when applying
baseline 1 (Table 26). The equivalent value when applying a higher annual baseline injury rate of 8.00
per 100 workers based on the trial control group was –£5900 (i.e. cost saving).
The intervention was substantially more cost-effective from the societal perspective. The purchase of
intervention footwear offsets more expensive baseline footwear, resulting in a net saving in purchase cost.
TABLE 25 Summary of mean costs per injury by treatment group











Health-care costs (£) 233 61 173 –172
Absenteeism costs (£) 585 280 479 –306
Compensation costs (£) 254 254 254 0
Total mean costs per injury (£) 1072 594 907 –478
Society
Health-care costs (£) 233 61 173 –172
Absenteeism costs (£) 390 186 320 –204
Compensation costs (£) 132 132 132 0
Total mean costs per injury (£) 755 379 625 –376
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As a result, intervention costs are effectively negative and the intervention is unequivocally cost-effective,
with cost per QALY values of –£60,400 under baseline 1 and –£48,400 under baseline 2.
Sensitivity analysis
Direct comparison by treatment group
The base-case results are not based on a direct comparison of outcomes between treatment groups,
due to limited data. The difference in mean costs per participant between treatment group was
compared in sensitivity analysis. In principle, this captures the effect of the intervention in reducing the
severity as well as the frequency of injuries, although it is subject to a high degree of random variability.
The incremental cost per QALY based on this comparison is –£99,670. This implies a mean cost saving
per averted injury, prior to intervention costs, of £1610, 77.8% higher than the base-case analysis.
One-way sensitivity analysis: threshold tests on unit cost values
Table 27 reports one-way sensitivity analysis to test the proportional change from base mean values
(cost savings and QALY gains per averted injury) required to meet a £30,000 cost-per-QALY threshold,
and for zero net intervention costs. As these values will be positively correlated, Table 27 will
overestimate the extent of change required to achieve thresholds.
Cost savings per averted injury at around one-fifth higher would meet the £30,000 NICE threshold
under baseline 1, whereas unit cost savings could be around 70% lower under baseline 2, as the base-
case estimate was below the £30,000 threshold. QALY loss per avoided injury at around 30% higher
than base case would produce a cost-effective result at the £30,000 threshold (results under baseline 2
were cost saving, so QALY loss was not tested).
Sensitivity analysis also conducted threshold tests on the intervention cost per employee. Cost-effectiveness
results are highly sensitive to changes in this parameter (a ± 20% change from the base value results
in a ± 47% change in the cost-per-QALY estimate). The threshold test suggests that an intervention
cost per employee of £20 would result in £30,000 costs per QALY under baseline 1, with costs of up to
£40 producing a cost-effective outcome at the higher baseline injury rate.
A baseline injury rate of 4.50 per 100 participants (11% higher than the baseline derived from the trial
baseline questionnaire) would result in a cost per QALY of £30,000. This is considerably lower than the
injury rate of 8.00 per 100 participants observed in the trial control group.
TABLE 26 Cost–utility analysis results
Cost–utility analysis Injury baseline 1 Injury baseline 2
NHS perspective: inputs
Estimated averted annual injuries over trial population, n 68 135
Cost savings per averted injury (£) 907 907
QALY gain per averted injury (£) 0.017 0.017
Intervention costs per averted injury (£) 1583 804
Societal perspective: inputs (if different to NHS perspective)
Cost savings per averted injury (£) 625 625
Intervention costs per averted injury (£) –425 –216
Cost per QALY
NHS perspective (£) 38,900 –5902
Societal perspective (£) –60,412 –48,372
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Two-way sensitivity analysis
Table 28 reports two-way sensitivity analysis, testing the percentage reduction in injuries required to
achieve zero net intervention costs (i.e. a financial break-even) from the NHS perspective, at varying
magnitudes of avoided injury cost. In this analysis, the effect of the intervention on QALYs and the
uncertainty associated with their estimation are irrelevant. The percentage reduction can be compared
with the estimated 95% CIs for intervention effectiveness in reducing slips in the primary analysis
(IRR 0.57–0.70, implying a reduction in the slip rate between 30% and 43%), assuming a commensurate
reduction in the injury rate.
The intervention would deliver net cost savings to the NHS in the lower bound of the effectiveness CI,
with unit costs savings per averted injury at 60% higher (around £1450). This is lower than the cost
saving per averted injury derived from the direct comparison of treatment groups (£1610).
Cost-effectiveness analysis
Costs per slip or injury averted may be of interest to decision-makers for comparison purposes,
although there is no established cost-effectiveness threshold for these measures. For brevity, the
values are presented for the injury baseline 1. From the NHS perspective, cost per slip averted was
estimated to be £27 and cost per injury averted was £676.
These values are negative from a societal perspective, at –£43 per slip averted and –£1050 per
injury averted.
TABLE 28 Two-way sensitivity analysis: reduction in injuries required for £0 net intervention cost at increasing avoided
injury cost
Parameter


























to home address), %
> 100 81 65 54 46 40 36 32
TABLE 27 One-way sensitivity analysis: change from base value required for cost-effectiveness at £0 and £30,000
per QALY









Mean cost saving per averted injury £907 0 £1583 75 –11
30,000 £1061 17 –69
Mean QALY gain per averted injury 0.017 30,000 0.023 30 (Cost saving)
Intervention cost per participant £24 0 £14 –43 £27 13





0 7.09 75 n/a
30,000 4.50 11 n/a
n/a, not applicable.
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Chapter 5 Qualitative evaluation
A qualitative study was undertaken to explore participants’ experiences and acceptability of wearingthe slip-resistant shoes, their thoughts on slips and falls in the workplace, and their experiences of
being in the trial.
Qualitative methods
Design
Semistructured interviews were used to gather information from trial participants. These interviews
were conducted over the telephone after completion of the trial with participants who were allocated
to the intervention group.
Sampling
A purposive sampling strategy was used to select participants to be invited to take part in a telephone
interview. This was to ensure that there was variation in the sample in terms of job roles, both clinical
(nursing, medical and other health-care professional staff) and non-clinical (domestic services and
catering), shoe types and participating sites. We planned to interview a total of 30–40 intervention
participants.
Recruitment and consent
All participants who had agreed to be invited to take part in a one-to-one telephone interview on their
SSHeW trial consent form and who had been in the intervention group (i.e. been offered a pair of trial
shoes to wear for the intervention period) were eligible to take part in the qualitative study.
Following sampling, selected participants were sent an invitation letter, a qualitative study participant
information sheet and a qualitative study consent form (see Report Supplementary Material 6 and 7),
along with a prepaid return envelope. The invitation letter informed participants that they would be
contacted by a researcher from the YTU (SC or RCB) by telephone, text or e-mail a few days later. If,
when contacted, the participant indicated a willingness to take part in an interview, a suitable time was
arranged. The response to these invitations was poor and, consequently, the protocol was amended to
allow members of the local research teams at participating trusts to approach participants directly and
ask if they were willing to take part. It was felt that the local research team were in a good position to
identify possible participants because of their contact with them during the day-to-day running of the
trial. The protocol was also changed to include the provision of a £20 high street voucher, by way of a
thank you, for participants who completed a telephone interview. Additionally, some SSHeW trial
participants who contacted the Trial Research Team at YTU regarding issues with their shoes were
also invited to take part in an interview.
Prior to the start of the interview, the researcher explained the aims of the interview and gave
participants an opportunity to ask questions. Participants were reminded that the interview would be
recorded for transcription purposes and confidentiality and anonymity was assured. Informed consent
was gained by the researcher before the start of the interview.
Data collection
Semistructured interviews with trial participants were carried out over the telephone by researchers at
the University of York, between May 2018 and July 2019. A total of 35 interviews were carried out.
The calls lasted on average 25 minutes (ranging from 10 to 35 minutes). A topic guide (see Appendix 11)
was used to provide a framework for the interview and to ensure that all participants were asked
similar questions. This allowed comparisons to be made in the analysis. However, flexibility in the
wording and order of the questions allowed adaptation to the unique conversations and enabled
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participants to raise any issues important to them. All of the interviews were audiotaped, transcribed
verbatim and anonymised before data analysis. Analysis was carried out on 34 transcripts as
unfortunately, for technical reasons, one interview failed to record.
Data analysis
Transcripts were checked for accuracy against the original recordings. The data were analysed
independently by two researchers; one researcher (RCB) used NVivo software (version 12, QSR
International, Warrington, UK) to assist data analysis, the other (SC) used Microsoft Word® (2016,
Microsoft Corporation, Redmond, WA, USA). An initial thematic analysis was carried out based on the
stages outlined by Braun and Clarke.50
The transcripts were read and re-read to ensure familiarisation with the data. An initial coding
framework was developed based on a priori themes related to issues covered in the topic guide.
Emerging themes and subthemes were discussed, reviewed and agreed by both researchers. Three
themes were identified and named. Data were reported with quotes to illustrate the underlying points,
ensuring that both overall views and individual perspectives were considered.
Both researchers were academic research fellows, had previously worked in health-care settings
and were involved in the management of the SSHeW trial, but had no connection with the shoe
manufacturer.
To ensure quality, the data collection and analysis process was transparent. There was comprehensive
data analysis, with interpretations supported by illustrative quotes. Interpretations of the data were
shared with members of the trial team for confirmation of the findings. The sample was selected to
include a range of job roles and working environments, and specifically to include some participants
who had experienced issues with their trial shoes so that we could explore these problems in more
detail. The researchers had declared their involvement in the management of the trial and were
therefore aware of how this connection would have shaped their approach to the data.
Qualitative results
Participants
Qualitative semistructured interviews were conducted with 35 SSHeW trial participants who had been
allocated to the intervention arm of the trial and had therefore been offered the slip-resistant shoes to
wear during the 14-week trial period. The sample comprised 30 women and five men, and represented
a range of job roles across all seven participating NHS trusts. Further details of the participants who
took part in the qualitative interview are provided in Table 29.
During the interviews participants discussed their job roles; their thoughts about, and personal
experiences of, slips and slip prevention within the NHS workplace; work footwear, including their
experience of the slip-resistant shoes; and their experiences of being involved in the trial. Three
themes were identified in the interviews: (1) slips and slip prevention, (2) footwear and (3) experience
of being a trial participant. These themes were shaped by the topic guide (see Appendix 11). Each
theme is discussed as follows.
Theme 1: slips and slip prevention
Awareness and experience of slips, trips and falls in the workplace
Although most participants had not considered slips and falls to be a particular issue among NHS staff,
some, through prior experience, were aware of the issue. Many reported minor slips, describing them
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TABLE 29 Demographic characteristics of participants in qualitative study
Participant ID Gender Age (years) Job role Shoe style
1 Female 46 Research nurse Mary Jane
2 Female 53 Specialist nurse Mary Jane
3 Male 34 Practice education facilitator Cambridge
4 Female 41 Ward manager Old School III
5 Female 58 Dental nurse Old School III
6 Female 56 Community staff nurse Falcon II
7 Female 57 Domestic Old School III
8 Male 45 Domestic Evolution II
9 Female 40 Research co-ordinator Mary Jane
10 Female 36 Qualified nurse Mary Jane
11 Female 56 Domestic Revolution II
12 Female 40 Occupational therapist Jenni
13 Male 34 Doctor Falcon II
14 Female 35 Physiotherapist Revolution II
15 Female 32 Research midwife Mary Jane
16 Female 48 Research nurse Revolution II
17 Female 58 Clerical officer Mary Jane
18 Female 41 Specialist nurse Mary Jane
19 Female 53 Ward clerk Mary Jane
20 Female 29 Specialist nurse Old School III
21 Female 64 Specialist nurse Jenni
22 Female 50 Pathology team Ollie II
23 Male 58 Health roster co-ordinator Executive Wing Tip
24 Female 56 Community specialist nurse Mary Jane
25 Female 35 Support worker Carter
26 Female 49 Specialist nurse Mary Jane
27 Female 47 Research nurse Mary Jane
28 Male 33 Specialist nurse Evolution II
29 Female 30 Physiotherapist Falcon II
30 Female 43 Research radiographer Old School III
31 Female 59 Community therapy assistant Mary Jane
32 Female 55 Specialist nurse Willa
33 Male 45 Assistant practitioner Ollie II
34 Female 57 Health visitor Pegasus
35 Female 56 Health visitor Mary Jane
ID, identification.
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as a ‘skid’ or ‘loss of footing’; however, some described more serious incidents that resulted in an injury
and/or a fall:
I have had my foot go from under me while coming out of the lift and not seeing the patch of fluid and
just had my foot go, not actually fallen and hurt myself but it’s sort of jarred the pelvis, almost done
the splits.
Participant 9
We had a room deep cleaned and it was left really, really wet, literally there was a big layer of water on
the surface. They did put a cone out to say, careful wet floors but somebody moved it around the corner
. . . and went absolutely flying. I had a very, very swollen painful knee . . . spent the entire weekend sitting
with my leg up with ice on it but I couldn’t kneel, you know, for a few months, it was very painful.
Participant 22
Several of the participants interviewed who had worked in the community had experienced slips
outside when undertaking home visits:
I had one and what happened was I was coming away from my car and the ground was quite wet, slippy
but I didn’t have the shoes on that you provided me with, it was before the trial and it was quite a nasty
slip. I gouged my knee and my elbow but that was before we started.
Participant 24
Others had become aware of the issue of slips in the workplace by witnessing colleagues slipping or
through professional experience of dealing with the consequences of slips, trips and falls among staff.
One participant had worked in staff rota management and was therefore aware of sickness absences
as a result of slips, trips and falls at work. Another participant, a physiotherapist, had previously
treated staff who had sustained musculoskeletal injuries at work, including those who had fallen.
Although participants did not identify that slips and falls were a particular problem for staff, they did
consider them an issue for patients:
Not in staff groups no. I’m a ward nurse by background, very familiar with slips and falls in patients but
not particularly in staff to be honest.
Participant 28
Some staff were more concerned about other risks encountered when undertaking their duties at
work, rather than the risk of slips, trips and falls:
I didn’t realise it [the issue of slips, trips and falls among NHS staff] was such a problem. I’m always
alerted to back problems and things like that being a nurse . . . so more from that point of view. I wouldn’t
have automatically brought to my mind slips, trips and falls really.
Participant 27
The weekly text messages asked specifically for the number of slips. Although the definitions of a slip
and a fall were provided in the participant documentation, we wanted to explore whether or not
participants understood the difference between slips and trips. All participants who were asked this
felt that the distinction was clear. One went on to describe how she differentiated these events:
Well to me you slip if something is caused by something underfoot like you stand on something or it’s
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Risks for slips in the workplace: environment
The participants interviewed reported a large range of potential slip hazards when undertaking their
roles in different NHS settings. Flooring was one area of particular concern. Staff described the
flooring in their work area as ‘smooth’, ‘hard’, ‘shiny’ and ‘highly polished’. Wet floors were a major
concern: floors could become wet through cleaning or as a result of spillages from drinks, food or
bodily fluids. Participants described how weather conditions can also pose a risk for slips (e.g. wet
floors at entrances and slippery paths outside).
Participants reported that warning signs were widely used to alert them to wet floors during the
cleaning process. However, these signs could present a hazard in themselves when incorrectly placed:
The biggest hazard, other than the terrible carpet in the office, is the actual non-slip signs. They just get
left in the most stupid places, so like behind a door and you fall over them.
Participant 30
One particular job role posed quite a specific slip risk because of the nature of the procedures being
undertaken; this occurred in the endoscopy suite:
There certainly can be fluids yes and every day the scopes spit out water, so water is an issue. Obviously
it’s more wires is the issue in endoscopy, but yes fluids there is a problem as well.
Participant 26
Risks for slipping were not the only hazards staff encountered in their work environment as trips were
also raised as a cause for concern by several participants. Trip hazards arose from uneven flooring, rips
and tears in carpets, slopes, overcrowding, clutter or equipment related to clinical care:
No, not slipping. I mean trip hazards all over the place but I would say more of a thing there’s not enough
room and equipment being left out, so more of a trip hazard but not slipping, no.
Participant 12
Risks for slips in the workplace: behaviours
Participants described a variety of behaviours that could increase their risk of slips, trips and falls.
These included rushing, carrying too much equipment or being so focused on patient care that they
were not concentrating on their surroundings:
I think I just because I walk fast, I don’t know. I just want to do things as quickly as possible, get as much
done, so I walk a lot up and down, so I think I have more slips than normal.
Participant 10
Staff wearing unsuitable shoes was identified as another potential risk factor for slips at work by a
participant who commented:
Yes there are some people that wear heels for work and some people wear shoes without a grip because
you’re not provided with shoes, so a shoe suitable for work everyone has got their own ideas haven’t they?
Participant 34
Preventing slips at work
Participants reported several ways to prevent slips. These included avoiding running to incidents (even
emergencies) and a personal responsibility to clear up spillages rather than leaving for cleaning staff. A
few staff recalled undertaking health and safety training which included slips, trips and falls prevention,
and one member of staff reported a risk assessment being carried out before entering a potentially
hazardous area. Preventing slips was seen as important in avoiding injuries. These injuries have an
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effect on individual’s health, short and long term, and also have the potential to reduce staffing levels,
which could ultimately have an impact on patient care:
Yeah obviously when I was a manager on the ward, you know, you did have people that slipped and back
injuries and that sort of thing, so that can impact on your staffing. Like the job that I do if I was to [go off
sick] then nobody else sees my patients, if you know what I mean, so from that point of view yeah and
also for your own long-term health.
Participant 32
Theme 2: footwear
Two subthemes were identified: (1) usual work shoes and (2) slip-resistant shoes provided as part of
the trial, referred to as ‘trial’ shoes.
Usual work shoes
When choosing their shoes for work, participants considered several criteria, including comfort,
compliance with dress code, the appearance and the sole of the shoe. Comfort was of primary
importance; however, other considerations included whether or not the shoes were sturdy, easy to
clean, would last well and cost:
Well I think I look for comfort mostly . . . I think when you’re wearing them all day for a long time, yeah so
I look for comfort.
Participant 19
Definitely comfort and then like a decent sole, you know, something that feels like it’s actually cushioning
your foot.
Participant 30
Something that is robust, is hopefully going to last a long time . . . So they have to be closed toe. They
have to be wipeable and I think comfort is a big thing as well because we are on our feet for such a long
time, you know, something that isn’t going to cause you any pain or, you know, sensible shoes really.
Participant 29
Participants’ choice was also shaped by the need to comply with dress code requirements, meaning
that work shoes had to be ‘black’ and ‘low heeled’ and have a ‘closed toe’. However, some participants
mentioned that the dress code was not always adhered to. The appearance of work shoes was also
important, as some participants wanted their shoes to be smart and professional looking, but at the
same time fashionable. For others the appearance or style was less important:
Both because I wouldn’t want something that’s completely flat underneath and thin, you know, the type
where you can feel the floor through it. That’s not my thing and then I’d definitely look for how it looks as
well, maybe. The trendiness of the shoe [laugh] . . . and not look too old fashioned.
Participant 30
Yeah I’m not really bothered about what things look like as long as they were comfy.
Participant 32
Although most participants did not consider slip resistance a priority when choosing shoes for work, they did
make an assessment of the sole. They judged the grip by looking at the texture and the tread. Participants
also believed a thick sole would ‘cushion the foot’, whereas a thin sole was associated with slipping:
Well I wouldn’t get something that’s completely flat, you know, because I would slip in that case. But I
certainly wouldn’t prioritise oh that’s got a really good grip, I’ll go for those.
Participant 20
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In addition, one participant also considered a thin sole to be noisy. This participant looked for a
‘rubbery’ sole to be quiet around patients. As a consequence of being in the trial, some participants
would now consider the slip-resistant properties of shoes when purchasing footwear in the future.
Generally, participants preferred to purchase their shoes from high street retailers, as opposed to
online, so that they could try them on. The amount of money spent on work shoes varied from £10 to
£90, with a majority of participants spending between £40 and £50. Many participants also mentioned
waiting for sales before making their purchase. Work shoes lasted between 3 months and 3 years, with
most participants saying they lasted around 1 year:
I obviously try to spend as little as possible but I think because I’m in them so much and so often I would
normally go up to about £50 if I couldn’t find anything cheaper.
Participant 30




The majority of participants were very happy with the pair of slip-resistant shoes they were given as
part of the trial, describing them as ‘brilliant’, ‘lovely’, ‘smart’ and ‘comfortable’. One participant
commented that they were a better-quality shoe than they would normally buy:
They were comfortable and I really loved them, I’m never out of them.
Participant 9
Yeah I thought it was a suitable work shoe, it must be comfortable and it would look smart and yeah
definitely grippy.
Participant 20
Participants in the trial could select a style of shoe from a range offered at their trust. They often
selected shoes similar to their usual work shoes. Other participants saw the trial as an opportunity to
try a style that they would not normally wear for work, such as a trainer:
Yeah. I personally think a trainer looks a bit scruffy with a uniform but I think for how long we are on our
feet and how many miles we cover a day, I think it’s better. They normally feel much more comfortable to
be in, so I can see why people have got . . . I’ve never had a trainer style before, so I can now see why
people do have trainers.
Participant 30
Although some of the participants thought that the range of shoes offered was good and varied,
others, both male and female, felt that it was limited, particularly in offering smarter styles rather than
a more casual shoe:
I was quite surprised actually because I only thought you’d have one choice. One for girls and one for
boys. It was quite nice to be able to have different choices of design for the shoes that was good.
Participant 4
Yeah I thought there was a really good range. Different styles to suit different people as well.
Participant 20
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. . . I thought there was a good choice . . . There were some that I wouldn’t feel comfortable wearing
because I do wear a dress at times, you know, the trainer type ones I didn’t feel I could wear those with
my dress. So my options were kind of limited to those ones that looked a bit smarter and that would work
with both.
Participant 18
It could probably be a little bit wider. People do tend to care a lot about what they wear on their feet in
terms of style and stuff like that don’t they, so I think some more streamlined versions would be more
appealing but to be honest I’m still quite happy with them.
Participant 3
There were conflicting opinions regarding the appearance of the shoes. Some participants thought that
they looked good, whereas others described them as ‘old-fashioned’ or ‘clunky’. Others felt that some
styles were not smart enough for work. A few participants commented that the shoes looked better
than they expected:
They have been fairly comfy and they look better than I thought they would. I expected to them sort of
look like, you know, orthopaedic correction shoes or something like that but they look pretty good and it
was good that there was a range of choice that you could choose from.
Participant 3
Experience of wearing the trial shoes
Overall, experiences of wearing the trial shoes were positive, with the shoes being described as
comfortable and practical. However, some found that the shoes made their feet hot or were heavy to
wear. The style of one shoe was a particular issue with one participant who felt that they were going
to fall when wearing the shoes:
I couldn’t wear them because they hurt my feet so much and they . . . the shoes were lovely, don’t get me
wrong, but they made my feet tilt in and it was like I was gonna fall.
Participant 17
Some participants experienced discomfort for a short time when first wearing the shoes; however, it
was felt that it was no more than expected for new shoes. In the minority of cases participants were
unable to persevere with wearing the shoes because of persistent foot problems. A few participants
felt that the shoes altered the way they walked; however, this settled in the majority of cases as they
adapted to the new shoes:
Yeah I think they did but I don’t think it was any more than I would expect from any other pair of work
shoes really. I think because we do wear them such a lot you kind of, whenever I’ve bought new work
shoes I’ve thought, god I’ve got blisters or whatever. Yeah they were a bit uncomfortable at the beginning
but they’ve soon worn in.
Participant 29
As much as it sounds silly I think sometimes, and I know other colleagues had the same thing, the actual
non-slip took a bit of getting used to, you kind of felt like you were going to slip, I know that sounds mad
but it did feel like because it’s like . . . I’m trying to think of the word. You put your foot down, there is no
give if you’re not used to that so at first I felt like I was going to fall over.
Participant 32
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The slip-resistant sole
Participants noticed a difference in both the appearance and the performance of the slip-resistant
soles, compared with their usual shoes, commenting on how well they gripped and prevented slips:
I know you could tell straightaway by looking at the bottom that they were a different, I’ve never seen a
grip like that on the bottom and when you walked on them there was no give in them, you know, you did
feel safe walking in them.
Participant 34
There was a situation . . . where I’d gone to a residential setting with two other professionals and the floor
had been mopped but there was no sign and I walked in and walked straight along the corridor. The
person behind me slipped, really slipped. So it was then I thought, oh my gosh, you know, it made me
think about the shoes, you know, she slipped and as I say I went ahead of her and she slipped and she
had flat shoes on but she slipped. That’s when I became aware and thought probably these shoes
prevented that.
Participant 24
Participants noticed that the increased grip on the soles posed a problem when walking on carpeted areas.
This caused feet to stick, resulting in trips or stumbles. However, participants quickly adapted to this:
They are very grippy particularly on carpet because my office is carpet. At first, but actually you start to
think about it and actually you pick your feet up a bit more and don’t drag.
Participant 28
The deep tread itself caused a few issues, particularly for staff who went outside:
The only one thing I found with them is if I walked anywhere that was muddy, because they’ve got quite
an intense grip on them, they’re quite a deep tread and then when the mud has dried off, like I’d be
walking on the wards and I’d be leaving little piles of mud where I’ve walked.
Participant 1
The only thing that’s a negative about them is in the snow, snow seems to clump up underneath them
and I think it might have made them even more slippy because it kind of went slippy underneath and
then when I got in my car and put my feet on the pedals, it was slippy and I had to scrape it off.
Participant 6
Many participants continued to wear their shoes beyond the 14-week intervention period. They
reported a few signs of wear and tear, such as scuffs and wear on straps, but they did not notice any
difference in the sole over that time. Owing to their positive experience of wearing the shoes, most
participants would consider buying slip-resistant shoes again for work, depending on the price and
styles available, and some would recommend the shoes to colleagues.
Theme 3: experiences of being a trial participant
Participants generally had a positive experience of being in the trial. Participants reported hearing
about the trial via various routes at their NHS trust, including advertising, e-mails, posters, staff
bulletins, or by word of mouth from colleagues or the research staff themselves. Most participants
found signing up for the trial straightforward. Issues were reported in trying on sample shoes, which
sometimes were in short supply at busy recruitment events:
There were queues and if you went in your break and then they didn’t have maybe the size of another
style and you didn’t really have the same kind of patience or time to try two or three pairs on and walk
around with them on the floor for a couple of minutes to see which ones were the most comfortable.
Participant 22
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The predominant reason given by interviewed participants for taking part in the trial was the prospect
of getting a pair of shoes. Other reasons cited included an interest in the research area, the need to
provide an evidence base and wanting to support colleagues:
I think one that you got a free pair of shoes [laugh] that you don’t have to pay for and two I suppose as
physios [physiotherapists] we read a lot about research and evidence and stuff and I think I was just quite
keen to help, you know.
Participant 29
Although participants reported mainly positive experiences of being in the trial, one participant reported
some feelings of resentment from some colleagues who, because of their job, were ineligible for the trial:
I think there was an issue with some people not being eligible and I do think that was an issue, yes and
particularly with the porters because they’ve got a new contract and, you know, staff that are in that
category and I think that made it quite hard for the staff that were running it. But otherwise I’ve seen
people, I’ve been onto wards and you know they’ve said, oh you’re in the shoe trial too, they’ve looked at
my shoes and recognised them.
Participant 27
Despite the research team being aware of delays with some participants receiving their trial shoes,
the majority of participants interviewed experienced no problems. The participants described either
collecting their shoes or having them delivered directly to them at work.When delays were experienced,
they were due to stock issues, ordering or delivery problems, or participants requiring an exchange.
Data collection
Participants generally found the methods of data collection acceptable: questionnaires were reported
as being clear and easy to complete, and the use of text messaging was particularly well received.
Participants reported that text messages were quick, convenient and immediate. Participants found it
helpful that the text messages were sent weekly, meaning that they had to recall slips that occurred
over only the previous week:
It was really good. It was quick. Obviously because you’re working, you’re on the go all the time, you don’t
want anything that’s going to take time. It was quick, easy. It was good.
Participant 24
In addition to the weekly slip data collection text message, participants were also sent a compliance
text message at three time points during the intervention period. One participant did report getting
confused between these text messages, despite them being sent on different days:
Yeah and I think if you put zero for slips, trips and falls but you could put zero if I’m never wearing them
and I think on the text I glanced your text, thought it was asking me about slips, trips and falls and
answered it zero for not wearing the shoes and I think I did text back, I think, and say I didn’t mean,
you know, whatever at some point. So I think the texts were quite similar.
Participant 27
Summary
Although participants had not considered slips and falls to be a particular issue for staff in the
workplace, they identified many potential hazards (e.g. wet floors, clutter from equipment and rushing).
Some participants had experienced slips and described the impact of these for both themselves and
others (e.g. in terms of staffing levels). Staff interviewed reported little training in slips, trips and falls
prevention and felt that any health and safety training received focused more on manual handling
safety to prevent back injury.
QUALITATIVE EVALUATION
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Participants took several factors into account when choosing work shoes. The main factor was comfort;
however, appearance was also considered important, as was the shoes meeting dress code requirements.
The consideration of slip resistance was not a predominant thought, although some participants did make
an assessment of the sole. Many trial participants were happy with the slip-resistant shoes provided to
wear in the trial, finding them comfortable, hard-wearing and smart. A few participants, however, reported
problems with them and were unable to wear them. Participants noticed a difference when walking in the
trial shoes (associated with the grip) and some reported slips being prevented.
Participants generally had a positive experience of being in the trial. The trial was well promoted within
the trusts, making signing up easy. The predominant reason given for taking part was the prospect of
receiving a free pair of shoes. Participants found the methods of data collection acceptable and
particularly liked the use of text messages to collect data.
Interviews were undertaken via the telephone. This was more practical and allowed easy communication
with dispersed participants at convenient and flexible times. This method also minimised costs.
We acknowledge that conducting the interviews via the telephone would have prevented us from
picking up on non-verbal cues.
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Here we report the results of a large RCT assessing the clinical effectiveness and cost-effectivenessof 5-star, GRIP-rated, slip-resistant footwear for preventing slips in NHS staff. There is some
evidence to indicate the potential effectiveness of appropriately specified slip-resistant footwear to
prevent slips.22,24,27 However, only one of these studies, which reported a 67% reduction in the number
of slips, was a RCT,27 which is considered the ‘gold-standard’ experimental design for evaluating
effectiveness. In this discussion, we summarise our key findings, compare these with previous studies,
and discuss the strengths and limitations of our study.
Summary of main findings
Trial population
This large multicentre RCT included NHS staff aged ≥ 18 years, working at least 22.5 hours per week
in clinical, general or catering areas who owned a mobile phone. The majority (85%) of the trial
population were female and the average age was 42 years. We included a wide age range in the trial,
from 18 to 74 years. Approximately one-third of participants reported at baseline that they had
experienced at least one slip at work in the previous 12 months. Indeed, a similar proportion reported
at least one slip in the pre-randomisation text messages; this was over a much smaller time frame of up
to 6 weeks, which indicates that slipping is a genuine problem in this population.
Primary outcome
Compared with usual footwear, the offer and provision of slip-resistant footwear reduced the mean
number of slips over the 14-week period by roughly one-third. The primary, intention-to-treat analysis
showed a statistically significant reduction in the slip rate in the intervention group relative to the
control group (IRR 0.63, 95% CI 0.56 to 0.70; p < 0.001). Pre-randomisation slip rate was seen to be a
significant predictor of post-randomisation slip incidence rate. For every increase of 1 in the average
weekly number of slips a person experienced, their post-randomisation incidence rate of slips was
predicted to increase by a factor of 5.7 (95% CI 5.0 to 6.5). Gender was also a significant factor and
females were, on average, 23% more likely than males to experience a slip (IRR 1.23, 95% CI 1.06 to
1.43). Analyses indicated that although beneficial for both males and females, the intervention had
a greater effect in males. This is surprising, given that females had a higher slip rate and therefore
had more potential for improvement. This may have been a chance finding. Alternatively, we could
hypothesise that the shoe styles worn by males tended to have a larger sole surface area and so were
more effective than the female styles.
When compliance with the intervention was accounted for using an instrumental variable CACE
analysis approach, receipt of the shoes by week 7 was seen to have a similar benefit as in the
intention-to-treat analysis (IRR 0.65, 95% CI 0.58 to 0.73). This was expected, as most (two-thirds of)
intervention participants had received their shoes by this point. Compliance text messages indicated
that, once they had received their trial shoes, approximately 50% of intervention participants wore
them all of the time when at work. Further CACE analysis indicated that participants with more
exposure to the trial shoes (i.e. received them earlier and/or wore them more often) were likely to
benefit more from the intervention than those with less exposure.
Secondary outcomes
Statistically significant results were also observed in the incidence rate of slips as reported on the
14-week questionnaire (IRR 0.56, 95% CI 0.48 to 0.66); the incidence rate of falls resulting from a
slip (IRR 0.51, 95% CI 0.28 to 0.92); the proportion of participants reporting a slip over 14 weeks
(OR 0.58, 95% CI 0.50 to 0.66); the proportion of participants who reported a fall (whether or not
resulting from a slip) (OR 0.73, 95% CI 0.54 to 0.99); and time to first slip (HR 0.73, 95% CI 0.67 to 0.80).
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There was little evidence of a difference in the incidence rate of falls not resulting from a slip in the
workplace (IRR 0.82, 95% CI 0.50 to 1.34).
Cost-effectiveness
Under the base-case scenario, the cost per QALY from the NHS perspective was £38,900 (–£5900
when applying the higher baseline injury rate). From the societal perspective, the trial footwear
displaces usual footwear, meaning that the intervention was unequivocally cost-effective at –£60,400
cost per QALY (–£48,400 when applying a higher baseline injury rate).
Sensitivity analysis indicates that the intervention would be cost-effective from the NHS perspective at
a £30,000 cost-per-QALY threshold if the cost savings per averted injury were roughly one-fifth higher.
This is plausible, given that the costing method is likely to underestimate the cost savings attributable
to the intervention and that the intervention could also result in net cost savings to the NHS (i.e. a
positive return on investment) within plausible levels of effect in reducing injuries.
The CEA is based on limited data: the number of injuries due to slips observed in the trial was small
(n = 79), with the majority of slips being minor and not requiring health-care treatment or time off
work. To mitigate a high level of random variability between treatment groups and maximise available
data, the costing approach aggregated injury outcome data across both groups to derive mean values
per injury averted. If the intervention reduced both the frequency and severity of injuries due to slips,
the costing approach would underestimate the resulting reduction in injury costs. A direct comparison
of costs in the intervention and control groups was undertaken in sensitivity analysis and indicated
an improved incremental cost per QALY from the NHS perspective of –£99,700 (i.e. cost saving),
suggesting that costs in the base-case analysis may be underestimated. Improved cost-effectiveness
should also be observed in practice if higher compliance with the footwear is achieved (e.g. if it is
compulsory) with all else equal.
Qualitative findings
The qualitative study explored participants’ thoughts about slips and falls in their workplace and
their experience of being in the trial, particularly with respect to their views of the slip-resistant
shoes provided.
Through exploration of participants’ job roles and working environments, we were able to understand
the risks for slips and falls that these health professionals were aware of when undertaking their work.
Slip and fall hazards were encountered from cleaning activities and through clinical care, as well as
from busy, often cluttered, work spaces. Participants described many different types of flooring in their
workplaces and reported that they would often traverse several types in a working day. Although most
of their time was spent on typical ‘hard, shiny’ hospital flooring, some participants crossed onto carpet
in certain hospital areas, such as their offices. Furthermore, community staff encountered carpets in
patients’ homes. A few participants described some difficulties due to the grip of the trial shoes in
carpeted areas.
Many participants went outside in the course of their work, either in community work or in moving
from one part of the hospital to another. This external environment was seen to present slip risks that
were unavoidable because of the weather conditions and the slip-resistant shoes were seen to be of
benefit in these areas.
Participants described many features they sought when choosing shoes for work and the slip-resistant
shoes offered in the trial met many of these requirements: they were comfortable, practical and
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complied with the trusts’ dress codes. Participants noticed the increased grip when wearing the
slip-resistant shoes and reported instances of slip avoidance. Most participants were happy with the
slip-resistant shoes and continued to wear them beyond the 14-week intervention period. However,
the shoes were not suitable for all participants and some would have preferred a wider range which
included smarter styles.
Participants described that the trial was well promoted and received in their NHS trusts, and found
trial processes for recruitment and data collection straightforward and not too burdensome. The
collection of slip data by text messaging was particularly well received.
The qualitative sample was purposefully selected to include participants from several different job
roles and working in different health-care environments. The sample also included participants who
had reported some issues with the trial shoes, so we could explore this in greater detail. Owing to
modification to the recruitment strategy involving the research teams at site, the resultant qualitative
sample included several health-care workers who worked in the research field. These participants may
have had a better understanding of the trial processes, including familiarity with questionnaires and
the importance of accurate data.
Comparison with other studies
Our results corroborate the limited evidence to support the potential effectiveness of appropriately
specified slip-resistant footwear to prevent slips in the workplace. A longitudinal study by Bell et al.21
indicated a 58% reduction in the number of workers’ compensation claims when a comprehensive slip,
trip and fall prevention programme (which included slip-resistant footwear among other strategies) for
hospital employees was introduced in the USA. A before-and-after study22 in Denmark suggested that
new slip-resistant boots reduced slips, trips and falls compared with older boots by around 80% among
fishermen. Additionally, a prospective cohort study of 475 fast food restaurant workers found that the
use of slip-resistant footwear was associated with a 54% reduction in the reported rate of slipping.24
To the best of knowledge, there has been only one other RCT27 of slip-resistant footwear. In this
cluster trial, undertaken in the USA, 226 school districts were randomised to receive appropriately
specified slip-resistant footwear or continue with the usual company policy, which generally required
staff to purchase slip-resistant footwear but did not specify performance requirements. The participants
in the study were food service workers and a 67% reduction in slipping injuries was observed (adjusted
OR 0.33, 95% CI 0.17 to 0.63). Our population was different to this trial in that only 1.5% of our
population included food service workers. In contrast, a cross-sectional study of 125 fast food workers
in the USA23 did not find an association between slipping and use of footwear perceived to be slip
resistant. However, this finding may have been as a result of the way in which footwear was classified
as slip resistant, which was by visual inspection of the tread only (as opposed to any scientific evaluation
of slip resistance).
Strengths and limitations of the study
To the best of our knowledge, this is the largest pragmatic trial evaluating the clinical effectiveness
and cost-effectiveness of 5-star, GRIP-rated slip-resistant shoes conducted to date, randomising a
total of 4554 participants. The trial was well powered. We had anticipated that the proportion of
participants in the control group who slipped would be 10% and powered the trial at 90% to detect a
30% relative reduction, to 7%, in the intervention group. In the event, of the 4505 participants who
provided slip data, 36% in the intervention group and 45% in the control group reported at least one
slip, so the power for this outcome was increased.
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The trial design had several strengths: a short data collection period (14 weeks), use of text messages
to collect slip and compliance outcomes, and use of a run-in period with outcome data collection, which
could have reduced the incidence of post-randomisation attrition. The use of text messages to collect
primary outcome and compliance data was acceptable to trial participants. Response rates to the
primary outcome were high. Both groups responded in a similar way, with the intervention group
responding to an average of 12.3 of the possible 14 (SD 3.1, median 14) text messages and the control
group responding to an average of 12.6 (SD 3.0, median 14) text messages. Participants reported that
it was a quick way to report outcomes with minimal effort. Text messages were sent weekly to
minimise the risk of recall bias.
There were some limitations to the study. Exposure to the intervention was perhaps lower than
intended. It was hoped that most intervention participants would receive their footwear within 2 weeks
of randomisation; however, the actual median time to receipt of shoes was approximately 4 weeks.
The logistics of ordering and distributing large numbers of shoes to staff working varying schedules
and over geographically dispersed areas was greater than trusts had anticipated, leading to delays.
In addition, despite their best efforts, the trusts could not always get every intervention participant to
collect their shoes in a timely manner, if at all. Further delays were experienced if participants needed
to exchange their shoes, despite the shoe manufacturer amending their usual returns policy to
accommodate swift exchanges.
Once the trial shoes were received, around 50% of intervention participants reported wearing them all
of the time when at work, which means that about 50% of participants wore the shoes some, or even
none, of the time. This is not necessarily a problem for the trial, as we were primarily testing the offer
and provision of slip-resistant footwear without mandating and checking that participants were wearing
the footwear. However, it does affect the generalisability of results to other work environments where
use of appropriate footwear may be more closely monitored. The primary analysis was based on
intention to treat and so may underestimate the true benefit of the slip-resistant footwear. Secondary
analysis indicated that intervention participants who showed greater compliance with wearing the
slip-resistant footwear had a lower incidence of slipping in the workplace than participants with less or
no exposure to the trial shoes. However, we cannot necessarily conclude that a larger effect size would
have been produced if all intervention participants wore the shoes all the time when at work. Within
the trial population, those with greater ‘compliance’ are likely to be different from those with lower
‘compliance’ (e.g. have a higher or lower slip risk).
Another potential issue is the possibility of contamination. The control group could have seen colleagues
wearing their trial shoes and purchased shoes from the same manufacturer, or other 5-star, GRIP-rated
shoes, for themselves. Although we do not have data on contamination rates, we used a waiting list
control group design whereby control participants were informed that they would receive their shoes
soon after their participation in the study ended. Anecdotally, we know from correspondence with
control participants that several participants delayed purchasing new footwear as they waited for their
trial shoes.
There were some limitations to using text messages. Some NHS staff who would have been eligible
for participation could not be recruited as they were unable or unwilling to send and receive text
messages. It is difficult to estimate how significant a problem this was. A small number of participants
(n = 13) who returned a screening form were ineligible because they explicitly reported that they did
not have a mobile phone or were unable or unwilling to send and receive text messages, although this
question was asked on an early version of the baseline form only. Following this, we assumed that if
participants provided a valid mobile phone number on the contact sheet then they were willing and
able to send and receive text messages.
Up to a further 68 screened individuals were ineligible as they had missing or invalid consent or
contact details, which may have involved an issue with their mobile phone number. What we cannot
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know is the number of potential participants in the hospital who did not even express an interest in
the trial because they would be unable or unwilling to send and receive text messages, or the number
that were ‘screened out’ before being handed a recruitment pack to complete. We tried initially to
encourage sites to retain a screening log to record the reason why potential participants who
expressed an interest in the trial were not handed a recruitment pack because they were deemed
ineligible. However, owing to the overwhelming interest in the trial, and often frenetic recruitment
activities, this proved infeasible.
Another limitation was that the text messages were automated and, because of the timing, some text
messages were sent out on Christmas Eve and New Year’s Eve 2017, resulting in some messages not
being delivered. There is also the possibility that some participants in the intervention group may have
incorrectly responded to their compliance text, believing it to be their slip data text. Although
participants were requested to send only a numerical reply in response to their text messages
requesting slip data, many participants sent non-numeric responses (e.g. messages to the study team).
Another potential limitation to the study is that the outcome data are participant self-reported, which
may have led to inaccuracies in the reported slip data. Although we asked participants to report any
slip regardless of how ‘minor’, some participants may have reported only slips that were memorable for
some reason (e.g. those resulting in an injury or a fall). This could have resulted in a lower slip number
being reported. However, as that the slip rate observed in the trial is higher than we initially thought,
it would seem unlikely that recall bias occurred, especially given the short time frame over which the
data were collected.
It may also be the case that a very small number of people experienced a major injury as a result of a
slip at work and may not have been able or willing to complete the follow-up questionnaires, thereby
further reducing the number of reported slips. However, it is likely that the research team would have
found out about such injuries because of the trusts’ reporting requirements. Conversely, although
participants were provided with a definition of a slip and a fall on the participant information sheet,
participant diary and, when possible, at recruitment, some participants may have reported some trips
as slips, resulting in an overestimate of the number of slips. At set-up, the study team did consider this
potential issue and considered sending participants multiple text messages per week. The first text
would ask if the participant had been in work that week. If the participant indicated that they had,
three further text messages would be sent asking for the number of slips, trips and falls separately.
Unfortunately, the text messaging service was not sophisticated enough to dynamically respond to
large numbers of participants in this way and so it was decided to send participants one simple text
asking if they had experienced any slips.
This raises another potential issue. We have assumed that a zero response via text message means
that the participant had worked at least some hours that week and had not experienced any slips when
at work. However, it is feasible that people could have replied zero, but not actually been at work. This
could potentially underestimate the slip rate; however, we hope that this issue was minimal (indeed,
some people replied to the slip text message to explicitly report that they had not been in work that
week) and would therefore have a limited impact on the effect size of the intervention. We asked on
the 14-week questionnaire whether or not participants had taken time off work for any reason in
the last 14 weeks and, if so, how much time they had off. The amount of time taken off was similar
between the two groups and therefore this allays some concerns about selective reporting between
the two groups. A further issue which could have affected the accuracy of the slip data is that it was
not possible to blind participants to their group allocation. Responses could have been affected by the
knowledge that they were or were not wearing potentially slip-resistant footwear.
The rate of response to the week 14 questionnaires, which were posted to participants’ homes,
was low, at 62.8%. This was despite reminders being sent to non-responders and a SWAT being
implemented in the trial to improve response rates to this questionnaire. The response rate was
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slightly higher in the control group than in the intervention group (64.1% vs. 61.4%, respectively).
A potential reason for this is that the intervention group had already received their shoes by the time
the questionnaire was sent to them and so there may have been a level of disengagement in the study
by this point. On the other hand, participants in the control group were still to receive their shoes and
so perhaps more likely to remain engaged in data collection. In general, a contributing factor to the low
response rate overall might be that participants had forgotten to expect a postal, paper questionnaire
(between being informed at trial enrolment and 14 weeks post randomisation) and were used to
providing outcome data via text messages only. Additionally, this was a busy, working population and,
as such, the are likely to struggle to find the time to complete questionnaires. It is possible, although
difficult to measure, that there is selection bias introduced in that responders are likely to be different
to non-responders.
Generalisability of the results
The SSHeW trial was a pragmatic RCT across seven trusts within England, including small and large
acute trusts, and mental health and community trusts. The trial included participants who were
undertaking a wide variety of jobs, and included clinical, administration, domestic and catering staff.
They worked in diverse environments, such as wards, offices, food preparation areas, laboratories and
in the community, and walked on a range of floorings, including lino, carpet, slip-resistant surfaces and
outside areas, such as car parks, paths and patients’ homes. We were, however, unable to include all
staff working in all of the hospitals. Some staff, such as porters and operating theatre staff, in some
trusts had to wear protective shoes provided by the trust, which made them ineligible for the study.
The number of catering staff and domestic staff who took part in our study is low. This was because in
some of the participating hospitals catering staff and domestic staff were employed by a subsidiary
trust and could not be enrolled in the trial as a consequence of indemnity issues.
Eighty-five per cent of participants were female. Certainly, we know that in one of our included trusts
their male to female ratio is split at approximately 20% male to 80% female and so our population
may be reasonably representative in terms of the gender distribution of NHS staff. In this same trust,
approximately 11% of their workforce are aged 16–29 years, 23% are aged 30–39 years, 28% are aged
40–49 years, 30% are aged 50–59 years and 8% are aged > 60 years. In our trial, the corresponding
proportions are 17%, 21%, 28%, 29% and 5%, respectively. Therefore, except perhaps being marginally
skewed to the youngest ages, our population was representative of NHS staff in terms of age. Our trial
population was representative in terms of ethnicity as, on average, the ethnicity in our participating
trusts was approximately 87% white or white British.
The findings of our study are applicable to footwear that has been tested using the HSE GRIP rating
scheme and is appropriately specified for the workplace and role. Although the footwear used in
our trial was awarded the highest 5-star rating, it is important to note that this rating may not be
appropriate for all roles and workplaces. It is the friction generated between the footwear and floor
surface that prevents slips, and footwear with lower GRIP ratings would be expected to provide similar
levels of friction in environments that are less challenging (i.e. where there are fewer contaminants or
where the floor surface has a lower slip potential). Some roles are also likely to have a lower slip risk
than some of the roles included in our trial. For example, they may involve shorter walking distances,
less rushing, and no pushing and pulling. Similar results may therefore be obtained with other types of
slip-resistant footwear, provided they have been appropriately specified for the role and workplace
environment by undertaking a risk assessment and a meaningful evaluation of the footwear’s
performance. The results may not be applicable to other footwear that claim to be ‘slip resistant’,
but have not been appropriately evaluated and rated with the GRIP rating scheme.
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Implications for health care
The preference would always be to try to minimise or adequately control a potential slip risk for all
individuals it could affect (workers and members of the public). This can be done by eliminating, for
example, floor surface contamination or by specifying floor surfaces that remain sufficiently slip
resistant when they are contaminated. However, this may not always be possible. In this situation,
employers or staff may consider the use of slip-resistant footwear. Our results suggest that there is a
role for appropriately specified footwear in reducing slips in the workplace. The qualitative work has
shown that these shoes would be acceptable to staff.
Further research
Although the staff represented a working group that was very diverse, our findings may not generalise
to all workplaces. It may therefore be worth considering replicating the trial in other high-risk
environments, such as some manufacturing and food-processing facilities, or in settings which have
different surfaces, such as in the construction industry, where surfaces are more likely to include loose
gravel or mud.
The use of text messages to collect outcome data, for which a single number response is required, was
acceptable to both the participants and the researchers conducting the study. From the participants’
perspective, text messages were an easy and convenient way to provide data. For the researchers, text
messages were a cheap way of collecting a large number of data from a wide geographical area. The
data were collected quickly, with high response rates which were similar between the two groups. As
participants did not find it burdensome to respond to the text messages, text messages could be sent
weekly, which minimised the possibility of recall bias being introduced. However, we would recommend
caution if using text messages to collect more than one variable. In this study there was the possibility
of participants confusing the text messages requesting slip and compliance data, even though the text
messages were sent out on different days. In future trials, researchers may wish to consider using
other technologies, such as accelerometers, to collect outcome data.
Further qualitative research could be undertaken to explore how the introduction of the slip-resistant
footwear could be implemented in different trusts.
In this study we took the opportunity to undertake a SWAT, which contributed to the body of evidence
regarding how to run RCTs more efficiently. The SWAT, which evaluated an intervention to improve
response rates to postal questionnaires, was cheap and easy to implement. We would recommend
researchers consider embedding a SWAT in their research. Guidance about conducting SWATs can be
found at the Trial Forge website [URL: www.trialforge.org/trial-forge-centres/ (accessed 26 May 2020)].
Conclusion
The SSHeW trial has shown clear evidence that 5-star, GRIP-rated footwear can reduce slips and falls
resulting from slips in the NHS workplace. The results indicate that the intervention could also be cost-
effective at the £30,000 per QALY threshold from NHS perspective and cost saving from a societal
perspective if the footwear is distributed to the employee’s home address rather than at NHS premises.
Participants found the shoes to be acceptable. In cases when it is not practicable to prevent floor
surfaces becoming slippery in the workplace, employers or staff may consider the use of appropriately
specified slip-resistant footwear.
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Appendix 1 Approval and confirmation of
capacity and capability
Research site Date of research and development approval
Cheshire and Wirral Partnership NHS Foundation Trust 7 March 2017
Leeds Teaching Hospitals NHS Trust 16 March 2017
York Teaching Hospital NHS Foundation Trust 27 September 2017
Lancashire Care NHS Foundation Trust 24 October 2017
Nottingham University Hospitals NHS Trust 13 June 2018
University Hospitals of Derby and Burton NHS Foundation Trust 14 September 2018
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Appendix 2 Sample shoe styles
F igures reproduced with permission from Shoes for Crews (Europe) Ltd, 2019, personalcommunication.
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Appendix 3 SSHeW trial baseline
questionnaire
Health & Safety Executive logo reproduced with permission, 2020, personal communication.
SSHeW Baseline Questionnaire  v2.1   14.09.2017
IRAS ID Number 216827
1
SSHeW Study
Stopping Slips among Healthcare Workers (SSHeW)
Participant Baseline Questionnaire
CONFIDENTIAL
Participant’s trial ID number:
Centre number:
For office use only
This Research is funded by the NIHR Public Health Research Programme and the Health and Safety Executive.
6427354506
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SSHeW Baseline Questionnaire v2.1 14.09.2017
IRAS ID Number 216827
2
PLEASE READ ALL INSTRUCTIONS BEFORE COMPLETING THIS QUESTIONNAIRE
Thank you for agreeing to take part in this study. The footwear in this study has been
found to be slip resistant, when tested using the Health and Safety Laboratory’s Grip
rating scheme. The responses you give in this questionnaire will help us find out if wearing
this footwear can prevent slips and falls when worn in the workplace.
Please answer ALL the questions. Although some of the questions may not seem relevant
to you or may appear similar, they do give us valuable information.  In this study we want
to learn about how many slips however minor, people experience during their working day,
and whether or not these slips result in falls and/or other injuries.  In this study a slip is
defined as 'a loss of traction of your foot on the floor surface, which may or may not result
in a fall.  Whilst a fall is defined as an unexpected event in which you come to rest on the
ground, floor, or lower level.’
If you find it difficult to answer any question, please give the best answer you can.
Please follow the instructions for each section carefully.
For each section, if you are asked to put a cross in the box, please use a cross rather
than a tick, as if you were filling out a ballot paper.
For example in the following question, if your answer to the question is 'yes', you should
place a cross firmly in the box next to yes.
Do you drive a car? Yes No
If you are asked to write your answer, please do so by entering your answer in the boxes
provided, for example:
How old are you? 3 1 years
Please use a black or blue pen for all the questions.
Please do not use a pencil or any other coloured pen. If you make a mistake then please
cross out the incorrect entry, by placing a single line through the words or numbers, and
write the correct information to the side.    For example  DOB 12/03/1980  12/03/1989.
If you have any queries or problems completing this questionnaire please contact the
trial co-ordinator,                                             , telephone number                          email
1089354505
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SSHeW Baseline Questionnaire v2.1 14.09.2017
IRAS ID Number 216827
3
Section 1:
This section asks about any falls and slips you have had at work in the past 12
months and about some general information about you.
Please enter the date on which you are completing
this questionnaire:
    Day            Month                  Year
/ / 2 0
1. Are you employed by
(Please cross one box only)
An NHS Trust An agency Other please specify:
1a. Do you have less than 6 months remaining on your contract?
(Please cross one box only)
Yes No
    Day            Month                  Year
/ /2. What is your date of birth?
3. Are you required to adhere to a uniform/dress code policy? Yes No
4. On average, how many hours a week do you work? .
5. What is your job? (Please cross one box only)
Doctor/consultant Qualified Nurse/midwife Physiotherapist
Porter Occupational Therapist Healthcare assistant
Ward Clerk Pharmacist/ Social worker
Support worker Podiatrist Administrator/
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SSHeW Baseline Questionnaire  v2.1   14.09.2017
IRAS ID Number 216827
4
6. As part of your job, where are you predominantly required to work?
(Please cross one box only)
In a clinical room/area On a ward In the community
In a laboratory In pharmacy In podiatry
In an office In theatre Indoor hospital ground/corridors
In a food preparation area/area where food is served?
6a. Are you ever required to work in the community? Yes No
7. How much of your time do you spend on your feet at work?  (Please circle one option only)
Most of the time Some of the time A little of the time
8. Are you provided with footwear by your employer?
(Please cross one box only)
Yes No
Section 2:
This section asks about any slips (however minor) or falls you have had in the past
12 months.
1. Have you had a slip (however minor and irrespective of whether you fell) at work in the past 12
months?  (Please cross one box only)
Yes No Don't know
1a. If ‘Yes’,  how many slips did you have in the past 12 months?
1b. Did you suffer any injuries as a result of any of these slips?
1c. How many hours did you have off work due to slips in the past
12 months?
1d. How many nights did you have to spend in hospital due to
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SSHeW Baseline Questionnaire  v2.1   14.09.2017
IRAS ID Number 216827
5
2. Have you had a fall (however minor) at work in the past 12 months?
(Please cross one box only)
Yes No Don't know
2a. If ‘Yes’,  how many falls did you have in the past 12 months?
2b. Did you suffer any injuries as a result of any of these falls?
2c. How many hours did you have off work due to falls in the past
12 months?
2d. How many nights did you have to spend in hospital due to
these falls in the past 12 months?
Yes No
.
3. How often do you worry about slipping or falling in the workplace?
(Please circle one option only)
All of Most of Some of A little of None of
the time the time the time the time the time
Section 3:
This section asks about some general information about you.
1. Are you Male Female Prefer not to say
2. Please tell us your height
3. Please tell us your weight
feet inches
stone lbs
4. Did your education continue after the minimum school leaving age? Yes No
5. Do you have a degree or equivalent professional qualification? Yes No
6. To which of these ethnic groups do you belong?  (Please cross one box only)
White/British Asian/Asian British
Black/Black British Mixed/Multiple ethnic groups
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SSHeW Baseline Questionnaire  v2.1   14.09.2017
IRAS ID Number 216827
6
Section 4:
This section asks about your footwear.
1. How long do your usual work shoes last before they need replacing? months
2. Where do you normally buy your work shoes from?
(Please cross all that apply)
High street store
store/catalogue
3. What brand of shoes do you tend to wear?
(Please cross all that apply)
Shoes for Crews Magnum Alexandra
J&M Medical
provides them
General high street brand General sports shop brand
Other please specify:
4. What style of shoes do you tend to wear at work?
(Please cross all that apply)
Trainers Pumps Work/safety boots
Clogs Heeled shoes/boots Flat shoes/boots
(over 1-inch heel height) (completely flat, no heel height)
Casual/dress shoe or boot (graduated sole/heel height up to an inch in height)
Other please specify:
5. Does your usual style of shoe have a secure fastening over
the top of your foot (such as laces or velco strap)?
Yes No
6. If you were eligible to take part in the SSHeW trial what style and size of footwear from the
trial brochure would you like to wear during the trial?
(Please select one style and size from the SFC footwear brochure)
Style
Size
Online specialist shoe My workplace
6407354504
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Participant’s trial ID number:
Centre number:
Date completed:
    Day            Month                  Year
/ / 2 0
SSHeW Contact Sheet  v2.1   14.09.2017    
IRAS ID Number 216827
7
Contact sheet











If we need to phone you, what is the best time of day to contact you?
(Please cross all that apply)
Thank you for taking the time to complete these questions.
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Appendix 4 SSHeW trial slip diary
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SSHeW SLIP DIARY – Please use this diary to record when you have a slip during the trial. You will need this informaon 
to complete the final quesonnaire. If you need further copies, please photocopy this sheet. (V2 04.01.17)
Please insert the start date for the week here: Monday 
The space below is for you to record addional informaon about the slips that may help you recall the events.  We will be asking whether or not you needed hospital treatment, how 
many nights you stayed in hospital and whether you had any me off work (to be recorded in hours).  You may find it useful to record this informaon here
Please insert the start date for the week here: Monday 
The space below is for you to record addional informaon about the slips that may help you recall the events.  We will be asking whether or not you needed hospital treatment, how 
many nights you stayed in hospital and whether you had any me off work (to be recorded in hours).  You may find it useful to record this informaon here
Please complete the following for the days that you worked: Mon Tues Weds Thurs Fri Sat Sun Total 
How many hours did you work? 
How many mes did you slip or slide (with or without falling) while at work
How many of these slips resulted in a fall (where you came to rest on the ground, floor or lower level)? 
How many of these slips resulted in injury? 
If you were injured, what was the injury? For example, sprained wrist, broken foot, cut hand) 
How many mes did you fall at work for reasons other than a slip? (For example, tripped or missed a step) 
Did you wear trial footwear at work? Leave blank if you have not yet been provided with trial foot wear 
Please complete the following for the days that you worked: Mon Tues Weds Thurs Fri Sat Sun Total 
How many hours did you work? 
How many mes did you slip or slide (with or without falling) while at work
How many of these slips resulted in a fall (where you came to rest on the ground, floor or lower level)? 
How many of these slips resulted in injury? 
If you were injured, what was the injury? For example, sprained wrist, broken foot, cut hand) 
How many mes did you fall at work for reasons other than a slip? (For example, tripped or missed a step) 







































SSHeW SLIP DIARY – Please use this diary to record when you have a slip during the trial. You will need this informaon 
to complete the final quesonnaire. If you need further copies, please photocopy this sheet. (V2 04.01.17)
Please insert the start date for the week here: Monday 
The space below is for you to record addional informaon about the slips that may help you recall the events.  We will be asking whether or not you needed hospital treatment, how 
many nights you stayed in hospital and whether you had any me off work (to be recorded in hours).  You may find it useful to record this informaon here
Please insert the start date for the week here: Monday 
The space below is for you to record addional informaon about the slips that may help you recall the events.  We will be asking whether or not you needed hospital treatment, how 
many nights you stayed in hospital and whether you had any me off work (to be recorded in hours).  You may find it useful to record this informaon here
Please complete the following for the days that you worked: Mon Tues Weds Thurs Fri Sat Sun Total 
How many hours did you work? 
How many mes did you slip or slide (with or without falling) while at work
How many of these slips resulted in a fall (where you came to rest on the ground, floor or lower level)? 
How many of these slips resulted in injury? 
If you were injured, what was the injury? For example, sprained wrist, broken foot, cut hand) 
How many mes did you fall at work for reasons other than a slip? (For example, tripped or missed a step) 
Did you wear trial footwear at work? Leave blank if you have not yet been provided with trial foot wear 
Please complete the following for the days that you worked: Mon Tues Weds Thurs Fri Sat Sun Total 
How many hours did you work? 
How many mes did you slip or slide (with or without falling) while at work
How many of these slips resulted in a fall (where you came to rest on the ground, floor or lower level)? 
How many of these slips resulted in injury? 
If you were injured, what was the injury? For example, sprained wrist, broken foot, cut hand) 
How many mes did you fall at work for reasons other than a slip? (For example, tripped or missed a step) 











































































































































































































































































































































































































Appendix 5 SSHeW trial 14-week (final)
follow-up questionnaire: control group
Health & Safety Executive logo reproduced with permission, 2020, personal communication.
SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 1
SSHeW Study
Stopping Slips among Healthcare Workers (SSHeW)




Participant’s trial ID number:
Centre number:
For office use only
Date questionnaire sent:
    Day            Month                  Year
/ / 2 0
Thank you for agreeing to take part in this study.
The footwear in this study has been found to be slip resistant when tested using the Health
and Safety Executive Grip rating scheme. The responses you give in this questionnaire will
help us find out if wearing this footwear can prevent slips when in the workplace.
4982207271
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SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 2
PLEASE READ ALL INSTRUCTIONS BEFORE COMPLETING THIS QUESTIONNAIRE
Please answer ALL the questions. In this study we want to learn about how many slips
however minor, people experience during their working day, and whether or not these slips
result in falls and/or injuries.  In this study a slip is defined as a loss of traction of your foot
on the floor surface, which may or may not result in a fall.  A fall is defined as an
unexpected event in which you come to rest on the ground, floor, or lower level.
If you find it difficult to answer any question, please give the best answer you can. You may
find your study diary helpful when completing these questions.
Please follow the instructions for each section carefully.
For each section, if you are asked to put a cross in the box, please use a cross rather than a
tick, as if you were filling out a ballot paper.
For example in the following question, if your answer to the question is 'yes', you should
place a cross firmly in the box next to yes.
Do you drive a car? Yes No
If you are asked to write your answer, please do so by entering your answer in the boxes
provided, for example:
How old are you? 3 1 years
Please use a black or blue pen for all the questions.
Please do not use a pencil or any other coloured pen. If you make a mistake then please
cross out the incorrect entry, by placing a single line through the words or numbers, and write
the correct information to the side.    For example  DOB 12/03/1980  12/03/1989.
If you have any queries or problems completing this questionnaire please contact the
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SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 3
This section asks how many slips (however minor) and falls you have had in the
past 14 weeks, if you were hurt, and if you needed hospital treatment or any time
off work.
Please enter the date you are completing this questionnaire:
    Day            Month                  Year
/ /
1 Over the past 14 weeks, have you had any time off work for any reason, for example
taken holiday or sick leave?
Yes No
.If ‘Yes’, how many hours did you take off in total?
2 How many times did you slip (with or without falling) whilst at work in the past 14 weeks? 
(If none please answer ‘000’)
If you did not have a slip please go to question 8.1 on page 7.
2a If you had a slip whilst at work in the past 14 weeks how many of these resulted in a fall
(where you came to rest on the ground, floor or lower level)?
(If none please answer “000”)
Please provide the date of the first slip which resulted in a fall:
    Day            Month                  Year
/ /
2b If you had a slip whilst at work in the past 14 weeks how many of these resulted in an injury?
(If none please answer ‘000’)
2c Thinking about each slip in which you hurt yourself, please tell us the type of injuries you had
over the page.  If you haven’t hurt yourself as a result of a slip please go to question 8.1 on
page 7.
0127207278
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SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 4
Slip 1
(Place a cross in the box against all the injuries that apply)
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
3.1
Did the slip result in a fall?3.2 Yes No
Did you have to take any time off work because of this injury?3.3 Yes No
Did you need any care from a healthcare professional because
of this injury?
Yes No
If ‘Yes’, how many hours did you take off in total? hours.
If ‘NO’, go to 'Slip 2' on page 5.
3.4
3.4a Thinking about the care you received from the NHS because of this injury, how many
times have you seen the following healthcare professionals?
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?










Thinking about the care you have received from the NHS IN the hospital because of this
injury, how many appointments/visits have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and
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SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 5
Slip 2 (If not applicable, please go to question 7 on page 7)
(Place a cross in the box against all the injuries that apply)
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
4.1
Did the slip result in a fall?4.2 Yes No
Did you have to take any time off work because of this injury?4.3 Yes No
Did you need any care from a healthcare professional because
of this injury?
Yes No
If ‘Yes’, how many hours did you take off in total? hours.
If ‘NO’, go to 'Slip 3' on page 6.
4.4
4.4a Care from the NHS NOT IN the hospital related to this injury, how many times have you:
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?










Care from the NHS IN the hospital related to this injury, how many times have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and
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SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 6
Slip 3 (If not applicable, please go to question 7 on page 7)
(Place a cross in the box against all the injuries that apply)
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
5.1
Did the slip result in a fall?5.2 Yes No
Did you have to take any time off work because of this injury?5.3 Yes No
Did you need any care from a healthcare professional because
of this injury?
Yes No
If ‘Yes’, how many hours did you take off in total? hours.
If ‘NO’, go to question question 7 on page 7.
5.4
5.4a Care from the NHS NOT IN the hospital related to this injury, how many times have you:
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?










Care from the NHS IN the hospital related to this injury, how many times have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and
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SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 7






Are you fully recovered from you injuries?7 Yes No
8.1 How many times did you fall at work for reasons other than a slip in the past 14 weeks?
(For example, tripped or miss stepped).
(If none please answer ‘000’ and go to question 9 on page 8)
Please provide the date of the first fall:
    Day            Month                  Year
/ /
If you haven’t hurt yourself as a result of a fall please go to question 9 on page 8.
How many of these falls resulted in an injury?8.2
What sort of injury did you have8.3
(Place a cross in the box against all the injuries that apply)
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
8.4 Did you have to take any time off work because of your fall? Yes No
If ‘Yes’, how many hours did you take off in total? hours.
Did you need any care from a healthcare professional because
of this injury?
Yes No
If ‘NO’, go to question 9 on page 8.
8.5
3913207274
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SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 8
How often during the past 14 weeks did you worry about slipping whilst you were at work?












How often during the past 14 weeks did you worry about falling whilst you were at work?












8.5a Care from the NHS NOT IN the hospital related to this injury, how many times have you:
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?










Care from the NHS IN the hospital related to this injury, how many times have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and
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SSHeW 14 week questionnaire control group  v4.0  15.01.2018
IRAS ID Number 216827 9
13 General comments (optional)
If you have any thoughts about the SSHeW study that you would like to share with the research
team, then please write your comments in the box below.  For example, you might want to
describe your experience of taking part in this study.
Thank you for taking the time to complete this questionnaire.
Please return it to the York Trials Unit in the pre-paid envelope provided.
11 Thinking about your experiences of wearing your usual work
shoes for the past 14 weeks, please tell us if they caused
blisters/callouses, foot or other problems?
(Please cross one box only)
Yes No
If 'Yes' did you seek treatment?
Have these fully resolved?
Yes No
Yes No
12 Over the past 14 weeks, did you have any problems as a result
of wearing your usual work shoes or taking part in the study?
Yes No
If ‘Yes’, please specify:
5121207277
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Appendix 6 SSHeW trial 14-week (final)
follow-up questionnaire: intervention group
Health & Safety Executive logo reproduced with permission, 2020, personal communication.
SSHeW 14 week questionnaire intervention group  v4.0  15.01.2018
IRAS ID Number 216827 1
SSHeW Study
Stopping Slips among Healthcare Workers (SSHeW)




Participant’s trial ID number:
Centre number:
For office use only
Date questionnaire sent:
    Day            Month                  Year
/ / 2 0
Thank you for agreeing to take part in this study.
The footwear in this study has been found to be slip resistant when tested using the Health
and Safety Executive Grip rating scheme. The responses you give in this questionnaire will
help us find out if wearing this footwear can prevent slips when in the workplace.
1379119988
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SSHeW 14 week questionnaire intervention group  v4.0  15.01.2018
IRAS ID Number 216827 2
PLEASE READ ALL INSTRUCTIONS BEFORE COMPLETING THIS QUESTIONNAIRE
Please answer ALL the questions. In this study we want to learn about how many slips
however minor, people experience during their working day, and whether or not these slips
result in falls and/or injuries.  In this study a slip is defined as a loss of traction of your foot
on the floor surface, which may or may not result in a fall.  A fall is defined as an
unexpected event in which you come to rest on the ground, floor, or lower level.
If you find it difficult to answer any question, please give the best answer you can. You may
find your study diary helpful when completing these questions.
Please follow the instructions for each section carefully.
For each section, if you are asked to put a cross in the box, please use a cross rather than a
tick, as if you were filling out a ballot paper.
For example in the following question, if your answer to the question is 'yes', you should
place a cross firmly in the box next to yes.
Do you drive a car? Yes No
If you are asked to write your answer, please do so by entering your answer in the boxes
provided, for example:
How old are you? 3 1 years
Please use a black or blue pen for all the questions.
Please do not use a pencil or any other coloured pen. If you make a mistake then please
cross out the incorrect entry, by placing a single line through the words or numbers, and write
the correct information to the side.    For example  DOB 12/03/1980  12/03/1989.
If you have any queries or problems completing this questionnaire please contact the
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SSHeW 14 week questionnaire intervention group  v4.0  15.01.2018
IRAS ID Number 216827 3
This section asks how many slips (however minor) and falls you have had in the
past 14 weeks, if you were hurt, and if you needed hospital treatment or any time
off work.
Please enter the date you are completing this questionnaire:
    Day            Month                  Year
/ /
1 Over the past 14 weeks, have you had any time off work for any reason, for example
taken holiday or sick leave?
Yes No
.If ‘Yes’, how many hours did you take off in total?
2 How many times did you slip (with or without falling) whilst at work in the past 14 weeks?  
(If none please answer ‘000’)
If you did not have a slip please go to question 8.1 on page 7.
2a If you had a slip whilst at work in the past 14 weeks how many of these resulted in a fall
(where you came to rest on the ground, floor or lower level)?
(If none please answer “000”)
Please provide the date of the first slip which resulted in a fall:
    Day            Month                  Year
/ /
2b If you had a slip whilst at work in the past 14 weeks how many of these resulted in an injury?
(If none please answer ‘000’)
2c Thinking about each slip in which you hurt yourself, please tell us the type of injuries you had
over the page.  If you haven’t hurt yourself as a result of a slip please go to question 8.1 on
page 7.
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Slip 1
(Place a cross in the box against all the injuries that apply)
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
3.1
Did the slip result in a fall?3.2 Yes No
Did you have to take any time off work because of this injury?3.3 Yes No
Did you need any care from a healthcare professional because
of this injury?
Yes No
If ‘Yes’, how many hours did you take off in total? hours.
If ‘NO’, go to 'Slip 2' on page 5.
3.4
3.4a Thinking about the care you received from the NHS because of this injury, how many
times have you seen the following healthcare professionals?
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?










Thinking about the care you have received from the NHS IN the hospital because of this
injury, how many appointments/visits have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and
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Slip 2 (If not applicable, please go to question 7 on page 7)
(Place a cross in the box against all the injuries that apply)
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
4.1
Did the slip result in a fall?4.2 Yes No
Did you have to take any time off work because of this injury?4.3 Yes No
Did you need any care from a healthcare professional because
of this injury?
Yes No
If ‘Yes’, how many hours did you take off in total? hours.
If ‘NO’, go to 'Slip 3' on page 6.
4.4
4.4a Care from the NHS NOT IN the hospital related to this injury, how many times have you:
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?










Care from the NHS IN the hospital related to this injury, how many times have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and
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Slip 3 (If not applicable, please go to question 7 on page 7)
(Place a cross in the box against all the injuries that apply)
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
5.1
Did the slip result in a fall?5.2 Yes No
Did you have to take any time off work because of this injury?5.3 Yes No
Did you need any care from a healthcare professional because
of this injury?
Yes No
If ‘Yes’, how many hours did you take off in total? hours.
If ‘NO’, go to question question 7 on page 7.
5.4
5.4a Care from the NHS NOT IN the hospital related to this injury, how many times have you:
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?










Care from the NHS IN the hospital related to this injury, how many times have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and
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Are you fully recovered from you injuries?7 Yes No
8.1 How many times did you fall at work for reasons other than a slip in the past 14 weeks? 
(For example, tripped or miss stepped).
(If none please answer ‘000’ and go to question 9 on page 8)
Please provide the date of the first fall:
    Day            Month                  Year
/ /
If you haven’t hurt yourself as a result of a fall please go to question 9 on page 8.
How many of these falls resulted in an injury?8.2
What sort of injury did you have8.3
(Place a cross in the box against all the injuries that apply)
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
8.4 Did you have to take any time off work because of your fall? Yes No
If ‘Yes’, how many hours did you take off in total? hours.
Did you need any care from a healthcare professional because
of this injury?
Yes No
If ‘NO’, go to question 9 on page 8.
8.5
9991119986
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How often during the past 14 weeks did you worry about slipping whilst you were at work?












How often during the past 14 weeks did you worry about falling whilst you were at work?












8.5a Care from the NHS NOT IN the hospital related to this injury, how many times have you:
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?










Care from the NHS IN the hospital related to this injury, how many times have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and
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This section asks about your experiences of wearing the trial shoes
11 Did you receive a pair of trial shoes? Yes No
    Day            Month                  Year
/ /If ‘Yes’, what date did you receive them?
If ‘No’, please go to question 20 on page 11.
12 Over the past 14 weeks, typically how often did you wear the trial shoes whilst you were at











13 Did you wear your trial shoes outside of worktime? Yes No
14 Did you feel more or less likely to slip at work when wearing the trial shoes compared to the









15 Did you feel more or less likely to fall at work when wearing the trial shoes compared to the
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16 Thinking about your experiences of wearing the shoes you were given for the trial please tell
us if: (please cross one box only per question)
a. You liked their appearance?
You liked the style of shoe?b.
You thought they were a good quality shoe?c.
They were a good fit?d.
They were comfortable to wear?e.
They caused blisters/callouses, foot or other problems?f.
They improved or resolved any usual problems you
have with your feet?
g.
They made problems you have with your feet worse?h.
They made your feet sweat/smell?i.
You were able to wear an insole in the shoe?j.












17 Did you have any problems as a result of wearing the trial
shoes or taking part in the study?
Yes No
If ‘Yes’, please specify:
Yes No Not sure18 Would you wear this type of shoe for work again?
If you would not wear this type of shoe again please tell us why:18a
If 'Yes' did you seek treatment?
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Yes No Not sure
19 Would you be willing to buy this range of shoes to wear
at work when your current work shoes need replacing?
Please tell us about any other comments you have about the trial shoe:
20 General comments (optional)
If you have any thoughts about the SSHeW study that you would like to share with the research
team, then please write your comments in the box below.  For example, you might want to
describe your experience of taking part in this study.
Thank you for taking the time to complete this questionnaire.
Please return it to the York Trials Unit in the pre-paid envelope provided.
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Appendix 7 SSHeW trial slip data
collection sheet
Pages 129 and 130 of this data collection sheet have been reproduced with permission from theEuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research Foundation.
© EuroQol Research Foundation. Reproduction of this version is not allowed. For reproduction, use
or modification of the EQ-5D (any version), please register your study by using the online EQ
registration page: www.euroqol.org.
Health & Safety Executive logo reproduced with permission, 2020, personal communication.
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IRAS ID Number 216827
SSHeW: Slip Data Collection Sheet
Date form sent:
 Day  Month  Year
/ / 2 0
Participant’s trial ID number:Centre number:
Please confirm that you had a slip at work between:
 Day  Month  Year
/ / 2 0
and
 Day  Month  Year
/ / 2 0 Yes No (please cross one box only)
If ‘No’, there is no need to complete the rest of the form, as it is not relevant.  Please return it in
the pre-paid envelope provided.
If ‘Yes’, we would like to find out some information about this slip  If you reported more than one
slip during that week, then please tell us about the worst slip you had.   In this study we are
defining a slip as a loss of traction of your foot - you can slip without falling.
Please enter the date you are completing this questionnaire:
 Day  Month  Year
/ /
Please tell us if you had a:
(Please cross one box only)
1.1 Slip without falling (however minor) Slip and fall
Please tell us the date of this slip?1.2
 Day  Month  Year
/ /
Were you wearing shoes provided by the trial when you slipped?
(Please cross one box only)
1.3
Yes No I don't know
How many hours did you work in the week from:
 Day  Month  Year
/ /
and
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Where did you slip? (Please cross one box only)1.4
On a ward or other clinical area in a hospital
In a non-clinical area in a hospital e.g. office, corridor
In an catering area where food is prepared or served
Outside
Inside a patient's home
Other, please specify:
Did you suffer any injuries as a result of your slip? (Please cross all that apply)1.6
No injury
Some superficial wounds, e.g. bruising, mild swelling, cut abrasion
Pulled muscles/sprained ligaments
Broken bone(s), please specify type of bone(s)
Other, please specify:
When you slipped what type of surface were you walking on? (Please cross one box only)1.5
A smooth surface A textured surface
If you did not have an injury please go to Question 2 on page 3.
Did you have to take any time off work because of this injury?1.7 Yes No
Did you need any care from a healthcare professional
because of this injury?
1.8 Yes No
If ‘Yes’, how many hours did you take off in total? hours.
If ‘No’, please go to Question 2 on page 3.
1.8a Care from the NHS NOT IN the hospital related to this injury, how many times have you:
Seen your GP at your GP practice or at home?
Seen a nurse at your GP practice or at home?
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Care from the NHS IN the hospital related to this injury, how many times have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and






If you wish to tell us anything else about your slip please write it below.2.
8521139638
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Under each heading, please tick the ONE box that best describes your health TODAY.
MOBILITY
I have no problems in walking about
I have slight problems in walking about
I have moderate problems in walking about
I have severe problems in walking about
I am unable to walk about
SELF-CARE
I have no problems washing or dressing myself
I have slight problems washing or dressing myself
I have moderate problems washing or dressing myself
I have severe problems washing or dressing myself
I am unable to wash or dress myself
USUAL ACTIVITIES (e.g. work, study, housework, family or 
leisure activities)
I have no problems doing my usual activities
I have slight problems doing my usual activities
I have moderate problems doing my usual activities
I have severe problems doing my usual activities
I am unable to do my usual activities
PAIN / DISCOMFORT
I have no pain or discomfort
I have slight pain or discomfort
I have moderate pain or discomfort
I have severe pain or discomfort
I have extreme pain or discomfort
ANXIETY / DEPRESSION
I am not anxious or depressed
I am slightly anxious or depressed
I am moderately anxious or depressed
I am severely anxious or depressed
I am extremely anxious or depressed
DOI: 10.3310/phr09030 Public Health Research 2021 Vol. 9 No. 3
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UK (English) © 2009 EuroQol Group EQ-5D™ is a trade mark of the EuroQol Group
The worst health 
you can imagine
We would like to know how good or bad your health is TODAY.
This scale is numbered from 0 to 100.
100 means the best health you can imagine.
0 means the worst health you can imagine.
Mark an X on the scale to indicate how your health is TODAY.
Now, please write the number you marked on the scale in the box
below.
The best health 
you can imagine
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For office use only
Did the slip result in an adverse event?
If 'Yes', complete an adverse event form
1. Yes No
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Appendix 8 SSHeW trial injury follow-up
questionnaire: during the trial
Pages 136 and 137 of this follow-up questionnaire have been reproduced with permission fromthe EuroQol Research Foundation. EQ-5D™ is a trade mark of the EuroQol Research Foundation.
© EuroQol Research Foundation. Reproduction of this version is not allowed. For reproduction,
use or modification of the EQ-5D (any version), please register your study by using the online EQ
registration page: www.euroqol.org.
Health & Safety Executive logo reproduced with permission, 2020, personal communication.
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IRAS ID Number 216827 1
SSHeW Study
Stopping Slips among Healthcare Workers (SSHeW)
  A randomised study of slip resistant shoes to prevent slips among healthcare workers.
INJURY FOLLOW UP QUESTIONNAIRE
(To complete during the trial)
CONFIDENTIAL
Participant’s trial ID number:
Centre number:
For office use only
Date questionnaire sent:
 Day  Month  Year
/ / 2 0
Thank you for agreeing to take part in this study.
The footwear in this study has been found to be slip resistant when tested using the Health
and Safety Executive Grip rating scheme. The responses you give in this questionnaire will
help us find out if wearing this footwear can prevent slips when in the workplace.
9065053705
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PLEASE READ ALL INSTRUCTIONS BEFORE COMPLETING THIS QUESTIONNAIRE
Please answer ALL the questions. In this questionnaire we would like to know about the
care you have received due to an injury you have had at work.
If you find it difficult to answer any question, please give the best answer you can.
Please follow the instructions for each section carefully.
For each section, if you are asked to put a cross in the box, please use a cross rather
than a tick, as if you were filling out a ballot paper.
For example in the following question, if your answer to the question is 'yes', you should
place a cross firmly in the box next to yes.
Do you drive a car? Yes No
If you are asked to write your answer, please do so by entering your answer in the boxes
provided, for example:
How old are you? 3 1 years
Please use a black or blue pen for all the questions.
Please do not use a pencil or any other coloured pen. If you make a mistake then please
cross out the incorrect entry, by placing a single line through the words or numbers, and
write the correct information to the side.    For example  DOB 12/03/1980  12/03/1989.
If you have any queries or problems completing this questionnaire please contact the
trial co-ordinator, , telephone number                        , email
         .
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Under each heading, please tick the ONE box that best describes your health TODAY.
MOBILITY
I have no problems in walking about
I have slight problems in walking about
I have moderate problems in walking about
I have severe problems in walking about
I am unable to walk about
SELF-CARE
I have no problems washing or dressing myself
I have slight problems washing or dressing myself
I have moderate problems washing or dressing myself
I have severe problems washing or dressing myself
I am unable to wash or dress myself
USUAL ACTIVITIES (e.g. work, study, housework, family or 
leisure activities)
I have no problems doing my usual activities
I have slight problems doing my usual activities
I have moderate problems doing my usual activities
I have severe problems doing my usual activities
I am unable to do my usual activities
PAIN / DISCOMFORT
I have no pain or discomfort
I have slight pain or discomfort
I have moderate pain or discomfort
I have severe pain or discomfort
I have extreme pain or discomfort
ANXIETY / DEPRESSION
I am not anxious or depressed
I am slightly anxious or depressed
I am moderately anxious or depressed
I am severely anxious or depressed
I am extremely anxious or depressed
APPENDIX 8
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The worst health 
you can imagine
We would like to know how good or bad your health is TODAY.
This scale is numbered from 0 to 100.
100 means the best health you can imagine.
0 means the worst health you can imagine.
Mark an X on the scale to indicate how your health is TODAY.
Now, please write the number you marked on the scale in the box
below.
The best health 
you can imagine
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Yes No
 If 'Yes' approximately how many days ago did you feel you had fully recovered?
 If 'No' are you happy for us to contact you again in
4 weeks to ask you these questions again?
Yes No
Thank you for taking the time to complete this questionnaire.
Please return it to the York Trials Unit in the pre-paid envelope provided.
 Please enter the date you are completing this questionnaire:
 Day  Month  Year
/ /
SECTION 2
Are you now fully recovered from this injury?
(Please cross one box only)
1.
General comments (optional)
If you have any thoughts or comments about your injury that you would like to share with the
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Appendix 9 SSHeW trial post-14-week
injury follow-up
Pages 142 and 143 have been reproduced with permission from the EuroQol Research Foundation.EQ-5D™ is a trade mark of the EuroQol Research Foundation. © EuroQol Research Foundation.
Reproduction of this version is not allowed. For reproduction, use or modification of the EQ-5D
(any version), please register your study by using the online EQ registration page: www.euroqol.org.
Health & Safety Executive logo reproduced with permission, 2020, personal communication.
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IRAS ID Number 216827 1
SSHeW Study
Stopping Slips among Healthcare Workers (SSHeW)
 A randomised study of slip resistant shoes to prevent slips among healthcare workers.
POST 14 WEEK INJURY FOLLOW UP QUESTIONNAIRE
CONFIDENTIAL
Participant’s trial ID number:
Centre number:
For office use only
Date questionnaire sent:
 Day  Month  Year
/ / 2 0
Thank you for agreeing to take part in this study.
The footwear in this study has been found to be slip resistant when tested using the Health
and Safety Executive Grip rating scheme. The responses you give in this questionnaire will
help us find out if wearing this footwear can prevent slips when in the workplace.
2016386950
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PLEASE READ ALL INSTRUCTIONS BEFORE COMPLETING THIS QUESTIONNAIRE
Please answer ALL the questions. In this questionnaire we would like to know about the
care you have received due to an injury you have had at work.
If you find it difficult to answer any question, please give the best answer you can.
Please follow the instructions for each section carefully.
For each section, if you are asked to put a cross in the box, please use a cross rather
than a tick, as if you were filling out a ballot paper.
For example in the following question, if your answer to the question is 'yes', you should
place a cross firmly in the box next to yes.
Do you drive a car? Yes No
If you are asked to write your answer, please do so by entering your answer in the boxes
provided, for example:
How old are you? 3 1 years
Please use a black or blue pen for all the questions.
Please do not use a pencil or any other coloured pen. If you make a mistake then please
cross out the incorrect entry, by placing a single line through the words or numbers, and
write the correct information to the side.    For example  DOB 12/03/1980  12/03/1989.
If you have any queries or problems completing this questionnaire please contact the
trial co-ordinator, , telephone number                        , email
        .
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UK (English) © 2009 EuroQol Group EQ-5D™ is a trade mark of the EuroQol Group
Under each heading, please tick the ONE box that best describes your health TODAY.
MOBILITY
I have no problems in walking about
I have slight problems in walking about
I have moderate problems in walking about
I have severe problems in walking about
I am unable to walk about
SELF-CARE
I have no problems washing or dressing myself
I have slight problems washing or dressing myself
I have moderate problems washing or dressing myself
I have severe problems washing or dressing myself
I am unable to wash or dress myself
USUAL ACTIVITIES (e.g. work, study, housework, family or 
leisure activities)
I have no problems doing my usual activities
I have slight problems doing my usual activities
I have moderate problems doing my usual activities
I have severe problems doing my usual activities
I am unable to do my usual activities
PAIN / DISCOMFORT
I have no pain or discomfort
I have slight pain or discomfort
I have moderate pain or discomfort
I have severe pain or discomfort
I have extreme pain or discomfort
ANXIETY / DEPRESSION
I am not anxious or depressed
I am slightly anxious or depressed
I am moderately anxious or depressed
I am severely anxious or depressed
I am extremely anxious or depressed
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UK (English) © 2009 EuroQol Group EQ-5D™ is a trade mark of the EuroQol Group
The worst health 
you can imagine
We would like to know how good or bad your health is TODAY.
This scale is numbered from 0 to 100.
100 means the best health you can imagine.
0 means the worst health you can imagine.
Mark an X on the scale to indicate how your health is TODAY.
Now, please write the number you marked on the scale in the box
below.
The best health 
you can imagine
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SSHeW Post 14wk Injury follow up questionnaire v1.0  20.06.2017
IRAS ID Number 216827
Did you have to take any time off work because of this slip in the
past 4 weeks?
Have you received any care from a healthcare professional because
of this injury in the past 4 weeks?
Yes No
If 'No', go to Q3.
If 'Yes', please answer 2a and 2b. Please fill in all of the boxes even if you have not had
any visits for that particular service. This information is really important for us.
For example, if you did not use a particular service then please put a '0' in both boxes:
I you have used a service three times then please write
0 0
0 3
Thinking about the care you received from the NHS because of this injury, how many times
in the past 4 weeks have you seen the following healthcare professionals:
A GP at your GP practice or at home?





Thinking about the care you received from the NHS IN the hospital because of this injury,
how many times in the past 4 weeks have you:
Attended a hospital clinic as an outpatient?
Visited Accident and emergency?
Visited hospital as a day case?
How many nights have you stayed in hospital as an in-patient as a
results of this injury? (admitted and discharged on a different day)
(admitted and discharged in the same day, e.g admitted at 2am and


















If 'Yes', how many hours did you take off in total?
9342386959
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SSHeW  Post 14wk Injury follow up questionnaire v1.0  20.06.2017
IRAS ID Number 216827
Are you now fully recovered from this injury?
(Please cross one box only)
Yes No
If 'Yes' how many days ago did you feel you had fully recovered?
If 'No' are you happy for us to contact you again in
4 weeks to ask you these questions again?
Yes No
General comments (optional)
If you have any thoughts or comments about your injury that you would like to share with the
research team, then please write them in the box below
Thank you for taking the time to complete this questionnaire.
Please return it to the York Trials Unit in the pre-paid envelope provided.
Please enter the date you are completing this questionnaire:
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Appendix 10 Changes to trial protocol
Protocol Date Changes made
SSHeW protocol v1.0 31 October 2016 This version was submitted to the DHSRGC prior to HRA approval
SSHeW protocol v2.0 4 January 2017 Version submitted with initial HRA application. Changes made
included simplifying data collection about falls by not asking for these
data in a weekly text message (so one text will be sent each week),
but asking for these data in the final 14-week questionnaire instead;
clarifications to some secondary outcomes; update of contact details
of new trial co-ordinator; clarification of exclusion criteria regarding
orthoses/modification of footwear; adding long-term follow-up data
collection and injury follow-up plan with EQ-5D and resource use for
health economics; and correcting HSL to HSE
SSHeW protocol v3.0 20 June 2017 Minor clarifications: wording of welcome text when participants join
the trial and wording of compliance text sent three times during the
trial; clarification about eligibility criteria; clarification about data
query process; and clarification about data collected from a
participant who reports an injury
SSHeW protocol v4.0 3 August 2017 Allowing a reminder to be sent to participants who have not returned
their slip data collection questionnaire or 14-week questionnaire
Allowing two additional pre-randomisation text messages to be
sent to participants who may have misunderstood the trial and not
responded to enough of the pre-randomisation text messages to be
eligible for randomisation (including sending then a letter explaining
the trial process and that they will receive two further text messages)
SSHeW protocol v5.0 26 April 2018 Inclusion of a SWAT to evaluate if inclusion of a pen with the final
questionnaire increases response rates
Change in eligibility criteria to include participants who work 60%
WTE, rather than 80% WTE
Clarifications to secondary outcomes and method of randomisation
SSHeW protocol v6.0 9 August 2018 Clarification of 60% WTE to mean 22.5 hours per week (i.e. 60% of
full-time NHS week, which is 37.5 hours)
SSHeW protocol v7.0 20 November 2018 Extension of the randomisation period
Addition of a questionnaire to help identify participants who would be
willing to return their shoes for wear testing
SSHeW protocol v8.0 14 February 2019 Changes to qualitative recruitment to ask local research teams at
sites to help identify willing volunteers to take part in an interview
and the addition of a £20 high street voucher to be given as a thank
you to those who undertake an interview
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Appendix 11 Qualitative topic guide
SSHEW trial qualitative topic guide: interviews with participants as part of
the SSHEW trial
Invitation e-mail/text/telephone call procedure to arrange interview
l The qualitative researcher will introduce themselves to the participant.
l The researcher will ask the participant if they received the invitation text, e-mail or letter.
l The researcher will explain the reason for calling (i.e. to see if the participant would like to take part
in the interview study).
l The researcher will answer questions and/or explain the study.
l The researcher will determine if the participant would like to take part in the study.
l If the participant is willing to take part, the researcher will thank them and arrange a convenient date
and time. If the participant is not willing to take part, the researcher will thank them for their time.
If the participant is unsure then the researcher will answer any questions and give the participant
more time to consider participation and arrange to contact them again (at least 24 hours later).
Interview topic guide for SSHEW trial participants
Approximately 40 participants will be interviewed. This topic guide summarises the main areas to be
explored in each interview about slips and falls in the workplace and acceptability of the trial footwear.
As with any qualitative interviews, these headings are intended as a starting point to ensure that the
primary issues are covered, while allowing flexibility for new issues to emerge. Preliminary analysis of
data from earlier interviews will shape the topics covered in later interviews.
Introduction
l The researcher introduces themselves.
l The researcher explains the background of the study and purpose of the interview.
l The researcher emphasises confidentiality, reminds the participant that the interview will be
audio-recorded and that they can stop the interview at any time if they wish.
l The researcher will remind the participant that the information from the research will be published
as a report for the Public Health Research programme and as other reports.
l The researcher will check if the participant has any questions about the study or interview before
the start.
l The researcher will confirm that the participant is still willing to take part.
Understanding reducing slips and falls in the workplace
l General background information.
¢ How long have you worked at the trust? (Number of hours worked, role, where they work,
e.g. ward, community.)
¢ Is there a history of slips and falls in the workplace? How much of a problem do you perceive
slips and falls in the workplace to be in general? What are the consequences of slips and falls?
Is reducing or preventing slips and falls important to you?
¢ How were you made aware, or were you aware, of the purpose of the intervention?
¢ Are staff in this organisation aware of the purpose of the intervention?
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l What footwear did you wear prior to the study? Did you consider them to be slip resistant?
What criteria would they use to judge if footwear were slip resistant?
l What are your thoughts on how the shoes may reduce slips and falls in the workplace?
l What is your understanding of ‘risk factors’ for slipping and falling at work?
Compliance
l Had you heard of slip-resistant footwear before the start of the study?
l Did you think they were a good idea?
l Did you think wearing the shoes provided by the study would prevent slips and falls?
l What did you think about the footwear that was provided?
l What did you think about the choice of footwear on offer?
l Did you have any concerns about the footwear?
l How did the new shoes differ from the ones you wore before the start of the study?
l How often do you wear the footwear?
l Where do you wear the shoes? For example, at work only, on the way to work, outside work?
l Did you have any problems when wearing the shoes? (Explore fitting, comfort, issues with
underlying foot pathologies.)
l What benefits and disadvantages have you seen since wearing the shoes?
l Do you feel more confident when wearing the shoes?
l Do you worry less about slipping and falling when you wear the shoes?
l Would you buy these shoes for work after the study has finished and when your current shoes
need replacing?
l Would you consider trying a different style of shoe in the slip-resistant range?
l Would you recommend these shoes to other members of staff?
l Would you consider buying this range of shoes to wear day to day in your personal life?
Participating in the study
l Explore the participant’s views on their experience of being involved in the SSHEW trial (e.g. was it
something that they really wanted to do, have they ever taken part in a study before, would they
take part in a research study again).
l How did you feel about filling in the screening form you were asked to complete? How did you find
it? Was it easy to understand? Did you like the layout? Could it have been improved in any way?
l How did you feel about responding to the text messages collecting slip and falls information?
l Views on being randomised to the intervention group (e.g. experiences of randomisation process
and understanding of this).
l Views about value of the trial.
Any other issues
l Any other issues or questions the participant would like to raise?
l The researcher will clarify what happens next in terms of the SSHEW trial.
l The researcher will thank the participant for their time.
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